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 Studies on the Structure/Reactivity Relationships of Bicyclic Epoxonium Ions 
and Tethered Nucleophiles. Efforts towards the Total Synthesis of (+)-
Lactodehydrothyrsiferol and its Analogs. Multicomponent Approach to the Synthesis of 
Oxidized Amides through Nitrile Hydrozirconation 
 
Shuangyi Wan, PhD 
 
University of Pittsburgh, 2008
 
A systematic study on the structure/reactivity relationships of bicyclic epoxonium ions 
towards tethered nucleophiles has been conducted. The cyclization results show that 
bicyclo[3.1.0] epoxonium ions have a significant to exclusive preference for exo-cyclizations 
while bicyclo[4.1.0] epoxonium ions have a strong preference for endo-cyclizations.  
A convergent approach towards the total synthesis of polycyclic ether natural product (+)-
lactodehydrothyrsiferol and its analogs is currently being pursued. This route includes the 
stereoselective reduction of the bicyclo[3.2.1] ketal which could be prepared from coupling of 
the functionalized aldehyde and vinyl iodide. Both enantiopure fragments can be obtained from 
cyclizations of the diepoxide and the monoepoxide, respectively. Key transformations involve 
two asymmetric epoxidations, a cascade cyclization of diepoxide, a Cr/Ni-mediated coupling 
reaction and a stereoselective reduction of bicyclo[3.2.1] ketal.  
An efficient one-pot synthesis of oxidized amides from nitrile hydrozirconation has been 
developed. From the common acylimine intermediates, acyl aminals can be accessed through 
alcohol addition, acyl hemiaminals can be accessed through water addition and enamides can be 
accessed through tautomerization.  
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1.0  STUDIES ON THE STRUCTURE/REACTIVITY RELATIONSHIPS OF 
BICYCLIC EPOXONIUM IONS AND TETHERED NUCLEOPHILES 
1.1 INTRODUCTION 
Polycyclic ether structures (Figure 1), which have been discovered in a number of marine 
natural products, have gained considerable attention from synthetic community due not only to 
their intrinsically complex structures but also to their interesting biological activities.1,2 From a 
biosynthetic view of point, these compounds have been proposed to arise from cascade 
cyclizations from the requisite polyepoxide precursors.3-5 A key issue associated in this process 
is the strict regiochemical control, i.e., exo- vs endo-cyclization (Figure 2). As can be envisioned 
in Figure 1, hemibrevetoxin B5 could be prepared from the polyepoxide through all endo-
cyclization, bullatacin6 could be prepared from the polyepoxide precursor through all exo-
cyclization and lactodehydrothyrsiferol7 could be prepared from the polyepoxide through a 
combination of exo- and endo-cyclizations.  
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Figure 1. Representative polyether natural products 
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Figure 2. Exo- vs endo-cyclization 
 
The exo-pathway is well known and commonly observed from studies on intramolecular 
cyclizations through epoxide opening. For example, epoxy alcohol 1.1, under acidic conditions, 
afforded tetrahydrofuran derivative 1.3 predominantly through exo-pathway transition state 1.2 
(Figure 3).8 However, in the presence of the catalytic antibody IgG26D9 elicited from amine 
oxide antigen 1.4, tetrahydropyran 1.6 was isolated as the sole product from endo-cyclization,8 
which formally violated the Baldwin’s rules9 for ring closure reactions.  
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Figure 3. Cyclizations of epoxy alcohol under acid- and antibody-catalyzed conditions 
 
Ab initio calculations performed by Houk10,11 and Coxon12,13 showed that under acid-
catalyzed conditions, the exo-transition structure (TS) has a nearly ideal trajectory for the attack 
of the hydroxyl oxygen atom via an SN2 manner and therefore has lower energy than endo-TS, 
resulting in the formation of 1.3 as the major product through a kinetically and chemically 
 2 
favored process. The exclusive formation of 1.6 under antibody-catalyzed (enzymatic) conditions 
was attributed to the similarity between endo-TS 1.5 and N-oxide 1.4. Calculations showed that 
endo-cyclization proceeds through an SN1-type transition structure.  
Due to the difficulty in the polycyclic ether formation through endo-pathway and the high 
efficiency in increasing complexity in cascade cyclizations of polyepoxides, a number of 
researchers have been involved in investigating the epoxide opening cascades. Murai and co-
workers14 first reported endo-selective cascade cyclizations of polyepoxides (Figure 4). Diepoxy 
alcohol 1.7, when treated with La(OTf)3, provided fused bicyclic product 1.8 in 52% yield. 
Unfortunately, when the conditions were applied to triepoxy alcohol 1.9, the cyclization 
efficiency decreased drastically and only 9.3% of the desired tricycle 1.10 was obtained from all 
endo-cyclization. In addition, the proposed mechanism requires the presence of chelation of 
La(III) ion with the epoxide oxygen and the pendent methoxy oxygen to promote the endo-
selectivity, which also limits its potential applications in natural product synthesis.  
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Figure 4. Endo-selective cascade cyclizations of polyepoxides in Murai group 
 
At nearly the same time, McDonald and co-workers15,16 studied epoxide opening cascades 
under Lewis-acid-promoted conditions, and demonstrated that endo-cyclizations could be 
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achieved in high efficiency with rationally designed substrates. Some representative examples 
are shown in Figure 5.  
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Figure 5. Representative endo-selective cyclizations of polyepoxides in McDonald group 
 
McDonald postulated that bicyclic epoxonium ions are key intermediates in cascade 
cyclizations of epoxides to generate polycyclic ethers and that endo-cyclizations were favored 
over exo-cyclizations due to the increased ring strain in exo-TSs (bicyclo[3.1.0] epoxonium 
ions).15 As illustrated in Figure 6, bicyclo[4.1.0] epoxonium ion 1.20 (from endo-cyclization) is 
presumed to be energetically lower than bicyclo[3.1.0] intermediate 1.19 (from exo-cyclization) 
in the initial cyclization as well as a similar comparison between bicyclo[4.1.0] ion 1.22 and 
bicyclo[3.1.0] ion 1.21 in the ensuing cyclization, leading to the formation of trans-fused tricycle 
1.23 with excellent endo-selectivity.  
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Figure 6. Hypothesis for regioselective cascade cyclizations 
 
McDonald also observed that terminal nucleophiles can also affect the stereochemical 
outcomes and/or regioselectivity (Figure 7).17 Cyclization of diepoxide 1.24 with a t-butyl 
carbonate group as the terminal nucleophile provided cis-fused bicycle 1.28 which arose from 
the addition of the carbonate carbonyl to the tertiary carbocation 1.26 via an SN1 fashion as the 
predominant product. Alternatively, the cyclization of diepoxide 1.29 with the better terminal 
nucleophile dimethyl carbamate gave trans-fused bicycle 1.27 as the major product which came 
from direct attack of the carbamate carbonyl to the epoxonium ion 1.25 through an SN2 pathway. 
Interestingly, triepoxy t-butyl carbonate 1.30, upon cyclization, afforded mainly tricyclic 
structure 1.32 which came from a combination of endo-cyclization and exo-cyclization and has a 
cis-ring fusion between the six- and five-membered cyclic ethers. In this case, only trace amount 
of all-fused trans,trans-tricycle 1.31 was obtained. On the other hand, reaction of 
dimethylcarbamate triepoxide 1.33 produced desired tricycle 1.31 in good yield, with 1.32 not 
being observed.  
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Figure 7. Impact of terminal nucleophiles on stereospecificity and regioselectivity 
 
Besides acidic conditions, cyclizations of epoxides can also be performed under basic18, 
neutral19 and oxidative20,21 conditions. Jamison and co-workers demonstrated that diepoxide 
1.34A and triepoxide 1.35A, under basic conditions in the protic solvent MeOH, provided THP 
triad 1.34B and tetrad 1.35B, respectively, in good yields, with the TMS group as a 
“disappearing” directing group.18 Without the “disappearing directing groups”, the diepoxide 
1.36A and triepoxide 1.37A, under essentially neutral conditions, delivered triad 1.36B and 
tetrad 1.37B, respectively, in excellent yields.19 In the total synthesis of hemibrevetoxin B, 
Holton developed a novel intramolecular epoxide opening cascade initiated by oxidation of the 
alkene with N-(phenylseleno)phthalimide to effect the formation of 1.39 in excellent yield, with 
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the B and C rings assembled  in a single operation (Figure 9).20 In this process, the highly polar 
solvent hexafluoroisopropanol was selected for the endo-selective epoxide opening through the 
SN1-type transition state, which is consistent with the computational analysis.10,11  
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Figure 8. Regioselective epoxide opening cascades under basic and neutral conditions 
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Figure 9. Key transformation in Holton’s total synthesis of hemibrevetoxin B 
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Cascade cyclizations of epoxides/polyepoxides were also studied in my laboratory22 under 
electron transfer initiated cyclization (ETIC23,24) conditions. These photochemical conditions use 
medium-pressure mercury lamp as the excitation source, catalytic amount of N-
methylquinolinium hexafluorophosphate as the sensitizer, O2 as the ultimate oxidant, 4 Å 
molecular sieves as moisture scavenger, NaOAc as the base, Na2S2O3 as the peroxide remover, 
1,2-dichloroethane as the solvent and toluene as the co-sensitizer.  Two typical examples are 
depicted in Figure 10. Under ETIC conditions, homobenzylic ether 1.40 was oxidized to radical 
cation 1.41A which fragmented to form the benzyl radical and oxocarbenium ion 1.41B in a 
reversible manner. The tethered epoxide attacked the electrophile 1.41B to generate bicyclic 
epoxonium ion 1.41C. The terminal nucleophile THP ether opened the bicyclo[3.1.0] epoxonium 
ion through exo-pathway to deliver bis-THF product 1.42 irreversibly in good yield. Similarly, 
reaction of diepoxide 1.44 gave rise to the consecutive exo,exo-cyclization product 1.45 in high 
efficiency. After removal of the anomeric center with Jones reagent,25 lactones 1.43 and 1.46 
were obtained as single diastereomers, respectively. The regioselectivity observed herein is in 
accord with Houk and Coxon’s computational studies with 5-exo-pathway being preferred over 
6-endo-pathway.  
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Figure 10. Epoxide opening cascades under electron transfer initiated cyclization conditions 
 
The oxocarbenium ion (Lewis acid) generated under ETIC conditions has the merit that it 
is able to activate the proximal epoxide specifically so that the complication from possible 
random activation of epoxides by a BrØnsted or Lewis acid can be eliminated, making this 
method ideal for investigating the reactivity of epoxonium ions with specific structures. In order 
to examine the factors that can affect the reaction pathways in epoxide opening cascades, a 
systematic study on the cascade cyclizations of monoepoxides/diepoxides under ETIC conditions 
has been conducted26 and details will be discussed in the following context.  
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1.2 STUDIES ON EPOXIDE OPENING CASCADES UNDER ETIC CONDITIONS 
As previously described, regioselectivity in epoxide opening cascades could be influenced 
by ring strain in the forming bicyclic epoxonium ions, nucleophiles and solvents. Besides these, I 
was interested in whether other factors such as bicyclic epoxonium structure and Lewis acid 
selection can also affect the reaction pathways. Towards this end, we prepared substrates shown 
in Figure 11.  
From monoepoxides 1.47-1.50, oxocarbenium-activated bicyclic epoxonium ion 
intermediates (bicyclo[3.1.0] epoxonium and bicyclo[4.1.0] epoxonium) with different 
substitution patterns (disubstituted and trisubstituted) will be formed and compared in terms of 
their regioselectivity towards terminal nucleophiles. Diepoxides 1.51-1.55 were designed to 
study the impact of different Lewis acid-activating groups (oxocarbenium ion and non-stabilized 
carbenium ion) on the regiochemical outcomes as well as the effect of relative stereochemical 
orientations of epoxides on the cyclization efficiency. Figure 12 shows the corresponding 
bicyclic epoxonium ion intermediates that will be compared in this study. Also of note is that the 
more reactive diphenylmethyl group was employed in the monoepoxide substrates 1.47-1.50 
instead of benzyl group (cf. Figure 10) as the electroauxiliary to initiate the oxocarbenium ion 
formation due to the reduced nucleophilicity of epoxides by the proximal t-butyl carbonate 
groups. For consistency throughout the studies, the diphenylmethyl group was also incorporated 
in the diepoxide substrates 1.51-1.55 though benzyl group is sufficiently reactive for this 
purpose.  
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Figure 11. Substrates for cyclizations 
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Figure 12. Bicyclic epoxonium ion intermediates to be investigated 
 
1.2.1 Synthesis of epoxide substrates 
The synthesis of disubstituted monoepoxide 1.47 proceeded from commercially available 
4-pentenal in a straightforward manner (Figure 13). Addition of diphenylmethyllithium to 4-
pentenal followed by methylation of the secondary alcohol and cleavage of the terminal alkene 
afforded aldehyde 1.56. A sequence of Horner-Emmons olefination, ester reduction, allylic 
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alcohol epoxidation and primary hydroxyl group protection with Boc2O27 provided carbonate 
1.47. Likewise, epoxide 1.48 was prepared from 5-hexenal which was obtained from Swern 
oxidation of 5-hexen-1-ol.  
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(d) (EtO)2P(O)CH2CO2Et, NaH, THF, 0 °C, 94% 
(e) DIBAL-H, THF, -78 °C
(f) m-CPBA, NaHCO3, CH2Cl2, 0 °C, 70%
(g) Boc2O, N-methylimidazole, PhMe, 0 °C to rt, 90%
HO
(h) (COCl)2, DMSO, -78 °C, then Et3N
(i) Ph2CH2, n-BuLi, THF, 0 °C, 70%
  
(j) NaH, DMF, 0 °C, then MeI, rt, 95%
(k) O3, CH2Cl2, -78 °C, then PPh3, rt, 96%
Ph2CH
OMe
O
H
(l) (EtO)2P(O)CH2CO2Et, NaH, THF, 0 °C, 93% 
(m) DIBAL-H, THF, -78 °C
(n) m-CPBA, NaHCO3, CH2Cl2, 0 °C, 91%
(o) Boc2O, N-methylimidazole, PhMe, 0 °C to rt, 84%
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Figure 13. Synthesis of disubstituted monoepoxides 1.47 and 1.48 
 
The synthesis of trisubstituted monoepoxides 1.49 and 1.50 is illustrated in Figure 14. 
Opening of epoxide 1.59 using Yamamoto’s aluminum-amide promoted protocol28 followed by 
Johnson-Claisen rearrangement29 of the allylic alcohol and reduction of the ethyl ester provided 
aldehyde 1.60, which was converted into 1.49 through a sequence of diphenylmethyllithium 
addition, methylation, silyl ether deprotection, epoxidation and protection of the primary alcohol 
with Boc2O. For the synthesis of homologous substrate, aldehyde 1.60 was homologated through 
Wittig olefination and mercury-mediated enol ether hydrolysis30 to give the corresponding 
aldehyde which was further transformed into 1.50 in a similar manner.  
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(e) NaH, DMF, 0 °C, them MeI, rt
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(i) Ph3PCH2OMeCl, NaHMDS, THF, -78 °C
    then Hg(OAc)2, THF, H2O, KI, 82%.
(j) Ph2CH2, n-BuLi, THF, 0 °C, 79%
(k) NaH, DMF, 0 °C, them MeI, rt
(l) TBAF, THF, 97%
(m) m-CPBA, NaHCO3, CH2Cl2, 0 °C, 99%
(n) Boc2O,  N-methylimidazole, PhMe, 0°C to rt, 89%1.60                                                                                                                                           1.50
1.59                                                                                                            1.60
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Figure 14. Synthesis of trisubstituted monoepoxides 1.49 and 1.50 
 
The trisubstituted diepoxides 1.51-1.52 were prepared similar to 1.49 and 1.50. 
Monoepoxide 1.61 was converted into aldehyde 1.62 in excellent yields through epoxide 
opening, Johnson-Claisen rearrangement and reduction (Figure 15). Dienol 1.63 was obtained in 
good yields after a three-step sequence of diphenylmethyllithium addition, methylation and silyl 
group removal. To ensure the high enantiomeric and diastereomeric control in the epoxidations, 
asymmetric epoxidation methods were utilized. Dienol 1.63 was converted into diepoxy 
carbonate 1.51 through  double Shi epoxidation31 and protection of the primary hydroxyl group 
with Boc2O in excellent yields. A sequence of Sharpless epoxidation,32 Shi epoxidation and the 
primary hydroxyl group protection of 1.63 efficiently provided diastereomeric counterpart 1.52. 
The stereochemical orientations of the epoxides in 1.51 and 1.52 were given based on the 
mechanistic analysis. 
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     CH3CN, H2O, 0 °C, 88%
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    PhMe, 0 °C to rt, 93%
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    Ti(OiPr)4, CH2Cl2, -25 °C, 96%
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(l) Boc2O, N-methylimidazole
    PhMe, 0 °C to rt, 86%
1.51
1.52
O
O
O
O
O
O
Shi ketone
1.63
 
Figure 15. Synthesis of diepoxides 1.51 and 1.52 
 
Aldehyde 1.62 was homologated to aldehyde 1.64 to prepare diepoxides 1.53 and 1.54 
through olefination and mercury-mediated enol ether hydrolysis in 91% yield (Figure 16). Dienol 
1.65 was obtained in a similar manner to 1.63 through diphenylmethyllithium addition, 
methylation and deprotection. Subsequently, dienol 1.65 was converted into carbonate 1.53 
through double Shi epoxidation and carbonate formation, or carbonate 1.54 through a sequence 
of Sharpless epoxidation, Shi epoxidation and carbonate formation.  
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Figure 16. Synthesis of diepoxides 1.53 and 1.54 
 
Diepoxide 1.55 was prepared in a convergent manner (Figure 17). Reduction of δ-lactone 
followed by diphenylmethyllithium addition to the crude lactol provided the diol in 82% yield 
over the two steps, which was converted to sulfone 1.66 through a sequence of Mitsunobu 
reaction, methylation and oxidation33 of the resulting sulfide with mCPBA. A Kocienski-
modified Julia olefination34 between sulfone 1.66 and aldehyde 1.60 afforded the desired diene 
in 63% yield. Further operations similar to the synthesis of 1.51 and 1.53 provided carbonate 
1.55 in excellent yields.  
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Figure 17. Synthesis of diepoxide 1.55 
 
1.2.2 Cyclizations of epoxide substrates under ETIC conditions 
With these epoxides in hand, I examined their reactions under ETIC conditions to explore 
the factors that could affect the regioselectivity in the opening of bicyclic epoxonium ions by 
pendent nucleophiles. First, I carried out the reactions of disubstituted monoepoxides and the 
cyclization results are illustrated in Figure 18. The reaction of 1.47 exclusively provided 5-exo-
product 1.68 through a disubstituted bicyclo[3.1.0] epoxonium ion intermediate, which is 
consistent with the previous observations that disubstituted bicyclo[3.1.0] ions prefer 5-exo-
cyclization (cf. Figure 10).35 Interestingly, cyclization of the homologated epoxide 1.48 gave a 
mixture of 5-exo- and 6-endo-products 1.71 and 1.72, respectively, with exo-pathway being 
slightly favored. The difference between these two reactions is that the initial cyclization of 1.47 
forms a bicyclo[3.1.0] intermediate while the cyclization of 1.48 forms a bicyclo[4.1.0] ion. The 
exo-products were fully characterized by oxidation to the corresponding lactones.25,36,37  
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Figure 18. Cyclizations of disubstituted monoepoxides 1.47 and 1.48 
 
Cyclization of trisubstituted epoxide 1.49 produced a complex mixture of exo- and endo- 
products from trisubstituted bicyclo[3.1.0] ion 1.74. The trans-fused endo-product 1.77 arose 
from the SN2 attack of the carbonate to the epoxonium ion 1.74 while the syn-fused endo-product 
1.78 was from the addition of the carbonate carbonyl oxygen to the tertiary carbocation 1.75 in 
an SN1 manner. The formation of 1.78 is in accord with McDonald’s observation17 of cis-fused 
bicycle 1.28 from 1.24 (cf. Figure 7). On the contrary, the reaction of 1.50 cleanly afforded 
trans-fused bicycle 1.81 as the only isolable product in excellent yield. These cyclization results 
clearly demonstrate that the combination of both the methyl substitution and the bicyclo[4.1.0] 
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epoxonium ion can reverse the regiochemical outcomes from complete exo-pathway to exclusive 
endo-pathway.  
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Figure 19. Cyclizations of disubstituted monoepoxides 1.49 and 1.50 
 
Having obtained the general information on the regioselectivity of monoepoxide 
opening/cyclization with carbonates as the nucleophile, I next investigated the cyclizations of 
diepoxides. Diepoxide 1.51, under ETIC conditions, provided a mixture of consecutive exo,exo- 
and endo,endo-products 1.85 and 1.86, respectively, in a combined 40% yield and with a 5.5:1 
ratio (Figure 20). Mechanistic analysis suggests that initial cyclization formed bicyclo[3.1.0] 
epoxonium intermediate 1.82, which could be opened by the epoxide either in an exo-mode to 
form a second bicyclo[3.1.0] epoxonium 1.83, or in an endo-mode to form bicyclo[4.1.0] 
epoxonium 1.84. It is noteworthy that no endo-cyclization product from 1.83 was isolated, 
indicating that bicyclo[3.1.0] epoxonium ions activated by non-stabilized carbeniums (stronger 
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Lewis acids) prefer exo-pathway towards tethered nucleophiles. Also of note is that no cis-fused 
endo-product was observed from 1.84, indicating that epoxides are better nucleophiles than 
carbonates or that the addition of carbonate to the epoxonium ion is reversible before the loss of 
the t-butyl cation. A similar regioselectivity was observed and a better overall yield was obtained 
when diastereomeric counterpart 1.52 was exposed to the ETIC conditions.  
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Figure 20. Cyclizations of diepoxides 1.51 and 1.52 
 
Following the completely endo-selective opening of bicyclo[4.1.0] epoxonium ions 1.80 
and 1.84, reaction of diepoxides 1.53 and 1.54 afforded trans,syn,trans-fused tricycles 1.91 and 
1.93 in all endo-modes as expected since the intermediates were trisubstituted bicyclo[4.1.0] 
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epoxonium ions. The cyclization of 1.54 is highly efficient in consideration of the product 
complexity. The higher yield observed in cyclization of 1.54 compared with 1.53 is probably due 
to the diminished steric interactions in the cyclization processes. To simplify characterizations, 
acetals 1.91 and 1.93 were oxidized by treatment with mCPBA and BF3•OEt2 followed by 
addition of Et3N36,37 to form lactones 1.92 and 1.94. The structure of 1.92 was unambiguously 
confirmed through single crystal X-ray analysis (Figure 22).38  
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Figure 21. Cyclizations of diepoxides 1.53 and 1.54 
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 Figure 22. ORTEP structure of lactone 1.92 
 
Since no selectivity was observed in the cyclization of 1.42, I was not surprised to observe 
that when diepoxide 1.55 was subjected to ETIC conditions, consecutive exo,exo- and 
endo,endo-products 1.97 and 1.98 were obtained in comparable yields, with the disubstituted 
bicyclo[4.1.0] epoxonium 1.95 from initial cyclization being non-regioselective (Figure 23). 
Tricycle 1.98 was converted into lactone 1.99 and its stereochemical outcomes were established 
through single crystal X-ray analysis (Figure 24).39  
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Figure 23. Cyclization of diepoxide 1.55 
 
 
Figure 24. ORTEP structure of lactone 1.99 
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1.3 COMPUTATIONAL ANALYSIS 
The cyclization results of the epoxide opening cascades under ETIC conditions show that 
the regioselectivity is highly dependent on the bicyclic epoxonium ion structures. Trisubstituted 
bicyclo[4.1.0] epoxonium ions prefer exclusive endo-pathways while disubstituted bicyclo[4.1.0] 
epoxonium ions essentially show no preference towards exo- or endo-pathways. I also found that 
trisubstituted bicyclo[3.1.0] epoxonium ions, when formed from attack of epoxides to non-
stabilized carbenium ions, favor exo-selectivity exclusively; when formed from attack of 
epoxides to oxocarbenium ions, give lower selectivity towards exo-cyclization. In order to better 
understand the origin of the regioselectivity, especially endo-selectivity in cascade cyclizations 
of epoxides, computational analysis was initiated using the B3LYP/6-31G(d) method40,41 to 
mimic the cyclization transition structures in the gas phase. This was performed by using 
Gaussian0342 program in the Houk group at UCLA.  
Initial study was carried out on a model reaction of bimolecular nucleophilic addition of 
dimethyl carbonate to 1,2,2,3-tetramethyloxiranium ion (Figure 25). The dimethyl carbonate can 
add to either the tertiary or secondary center of the epoxonium ion, with no geometrical 
constraints in either case. As shown in Figure 25, TS1 corresponds to the transition structure for 
nucleophilic addition to the secondary center and TS2 corresponds to the transition structure for 
nucleophilic addition to the tertiary center. In both TSs, the breaking and forming C-O bond 
distances are within the range of 2.0 and 2.2 Å, indicating that both reactions proceed through 
SN1-like transition states. The observation of the longer partial C-O bonds in TS2 is an indicative 
of a looser SN1 transition state, resulting from the formation of a partial tertiary carbocation. The 
partial tertiary carbocation formation can better stabilize the transition state, making TS2 lower 
in energy than TS1 by 4.3 kcal/mol. The dihedral angles in the absence of geometrical 
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constraints in TS1 (Oep-Cep-H-O) and TS2 (Oep-Cep-C-O) are 141.3° and 147.4°, respectively. 
The bond distances in TS1 and TS2 will be used as the references in the following context, with 
shorter bond distances being SN2-like transition structures.  
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ΔHrel (kcal/mol)              4.3                                                     0.0 
ΔGrel (kcal/mol)              5.0                                                     0.0 
Figure 25. Transition structures for the addition of dimethyl carbonate to the 1,2,2,3-tetramethyl-
oxiranium ion. The distances are given in Å. 
 
A model reaction was studied to elucidate the origin of the exclusive endo-selectivity from 
trisubstituted bicyclo[4.1.0] epoxonium ions. As shown in Figure 26, the difference between the 
model reaction and the real reaction (1.50 → 1.81, Figure 19) is the replacement of the anomeric 
methoxy group with a hydrogen atom and the tert-butyl carbonate with a methyl carbonate. This 
model reaction can also be employed to account for the formation of 1.86, 1.88, 1.91, 1.93 and 
1.98 in the terminal cyclizations of the corresponding substrates.  
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The methyl carbonate carbonyl can add either to the secondary or tertiary center of 
bicyclo[4.1.0] epoxonium ion to form 5-exo- or 6-endo-cyclization products. The transition 
structure for endo-cyclization (TS3_endo) has a lower energy than that of exo-cyclization 
(TS3_exo) by 4.5 kcal/mol, which is nearly identical to the energy difference in the 
unconstrained system. The longer forming C-O bond in TS3_endo means a looser SN1-like 
transition state presumably due to the partial formation of the tertiary carbocation. However, 
TS3_exo has an SN2-like transition state as evidenced by the shorter breaking and forming C-O 
bond distances. The dihedral angle in TS3_exo has a greater distortion from the unconstrained 
system (161.1° vs 147.4°) than that in TS3_endo (135.5° vs 141.3°). The higher energy and 
greater distortion of the dihedral angle of TS3_exo than those of TS3_endo result in the 
complete preference towards endo-cyclization pathway. 
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ΔHrel (kcal/mol)          4.5                                                  0.0 
ΔGrel (kcal/mol)          4.6                                                  0.0 
Figure 26. Transition structures for the 5-exo- and 6-endo-cyclizations from trisubstituted 
bicyclo[4.1.0] epoxonium ion. The distances are given in Å. 
 25 
 The effect of the anomeric methoxy group was investigated using the model reaction 
illustrated in Figure 27. The methoxy group can be either cis or trans to the epoxonium ion ring, 
with the cis-isomer being more stable than the trans-isomer by 0.3 kcal/mol in the gas phase. It is 
clear that the incorporation of the methoxy group has negligible effect on the geometries of the 
transition structures, though TS4_trans_endo shows a slightly better leaving group departure 
and enhanced bond formation compared with TS3_endo. The trans- and cis-methoxy isomers 
favor the endo-cyclization pathway by 4.6 and 4.8 kcal/mol relative to the corresponding exo-
pathway, respectively, which is similar to the energy difference (4.5 kcal/mol) observed between 
TS3_endo and TS3_exo.    
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ΔHrel (kcal/mol)  5.8                             1.2                              4.8                              0.0 
ΔGrel (kcal/mol)  5.9                             1.5                              5.2                              0.0 
Figure 27. Transition structures for 5-exo- and 6-endo-cyclizations of cis- and trans-methoxy 
trisubstituted bicyclo[4.1.0] epoxonium ions. The distances are given in Å. 
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 As depicted in Figure 18, almost no regioselectivity was obtained from the cyclization of 
disubstituted epoxide 1.48 which does not have the methyl group on the epoxide. To explain the 
role of the methyl group, an additional model was employed with the angular methyl group being 
replaced by a hydrogen atom, in which both 5-exo- and 6-endo-cyclization modes would have 
partially formed secondary carbocations (Figure 28).  
The calculations in the gas phase revealed that the absence of the methyl group has 
negligible influence on the 5-exo-transition structures. However, the two 6-endo-transition 
structures are perturbed substantially, with shorter breaking and forming bond distances being 
observed, indicating more SN2-like character in the transition states. The corresponding dihedral 
angles are also distorted significantly from 137.8° to 154.3°, and from 136.3° to 154.2° for the 
trans- and cis-isomers, respectively. The transition structures of endo-modes are energetically 
lower than the corresponding transition structures of exo-modes by 1.4 kcal/mol for both cis- and 
trans-isomers, meaning that endo-cyclization is slightly favored over exo-cyclization for 
disubstituted bicyclo[4.1.0] epoxonium ions. While experimental results show that exo- and 
endo-cyclizations are two competitive pathways as illustrated in Figure 18, computational studies 
still support that bicyclo[4.1.0] epoxonium ions have a strong tendency towards endo-
cyclizations.  
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Figure 28. Transition structures for 5-exo- and 6-endo-cyclizations of cis- and trans-methoxy 
disubstituted bicyclo[4.1.0] epoxonium ions. The distances are given in Å. 
 
In the terminal annulations of diepoxides 1.51 and 1.52, the bicyclo[3.1.0] epoxonium ions 
(activated by non-stabilized carbenium ions) preferentially generated 5-exo-cyclization products, 
which is in accord with Baldwin’s ring closure rules. This was mimicked by a model reaction 
depicted in Figure 29. The transition structure for exo-cyclization (TS6_exo) is similar to the 
transition structure for the bicyclo[4.1.0] epoxonium ion (TS3_exo) in terms of the forming and 
breaking bond distances and the dihedral angle. The transition structure for endo-cyclization 
(TS6_endo), though having similar bond breaking and forming features to the corresponding 
transition structure for the bicyclo[4.1.0] epoxonium ion (TS3_endo), shows a significant 
decrease in the dihedral angle (123.6° vs 135.5°). As a result, this perturbation leads to the 
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increase of the energy for TS3_endo, making 5-exo-pathway energetically favored over 6-endo-
pathway by 2.7 kcal/mol.  
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Figure 29. Transition structures for 5-exo- and 6-endo-cyclizations of trisubstituted 
bicyclo[3.1.0] epoxonium ion. The distances are given in Å. 
 
When the epoxide was activated by the oxocarbenium ion instead of a non-stabilized 
carbenium ion, a small amount of trans-fused endo-cyclization product 1.78 was also isolated 
from trisubstituted bicyclo[3.1.0] epoxonium ion 1.74. To elucidate the impact of the anomeric 
methoxy group on the regiochemical outcomes, another model reaction was employed, as shown 
in Figure 30. Similar to the transition structures in Figure 27, the methoxy group could be cis or 
trans to the epoxonium ion ring. The trans-isomer 1.0 kcal/mol more stable than the cis-isomer 
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because of the stabilization between the lone pair of the epoxide oxygen and the anti-bonding 
orbital of the C-O (methoxy) bond when they are antiperiplanarly oriented.  
For the transition structures for the two cis-isomers, TS7_cis_exo shows a greater leaving 
group departure in the presence of the anomeric methoxy group while the bond forming 
character and the dihedral angle remain approximately the same. TS7_cis_endo, however, has 
enhanced bond formation and a widened dihedral angle which is close to those in the transition 
structures (TS3_endo, TS4_cis_endo and TS4_trans_endo) of trisubstituted bicyclo[4.1.0] 
epoxonium ions. For the trans-isomers, the geometry of TS7_trans_exo is essentially unaffected 
by the incorporation of the methoxy group. Although the breaking and forming bond distances 
remain nearly the same in TS7_trans_endo, the dihedral angle is distorted from 123.6° to 
132.9°, which is similar to that in TS7_cis_endo. From an energetic view of point, 
TS7_trans_endo has the lowest energy which is attributed to the stabilization of the anomeric 
effect when the electronegative methoxy group assumes a pseudoaxial position in the forming 
tetrahydropyran ring. The two transition structures for exo-cyclizations have slightly higher 
energy. In addition, TS7_cis_endo, without benefiting from the developing anomeric effect, is 
the highest in energy.  
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Figure 30. Transition structures for 5-exo- and 6-endo-cyclizations of cis- and trans-methoxy 
trisubstituted bicyclo[3.1.0] epoxonium ions. The distances are given in Å. 
 
The role of the methoxy group is consistent with the previous observations that the 5-exo-
regioselectivity decreased when bicyclo[3.1.0] epoxonium ions were generated from 
combination of epoxides with oxocarbenium ions (1.74 and 1.82) rather than non-stabilized 
carbenium ions (1.83 and 1.96A). Also of note is the isolation of trans-fused bicycle 1.77 as a 
single anomer with the methoxy group adopting an axial position.  
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1.4 CONCLUSIONS 
A systematic study has been carried out on the oxocarbenium ion-initiated cascade 
cyclizations of epoxides under ETIC conditions, in which the impact of the epoxide substitution 
pattern, ring size of the bicyclic epoxonium ions and the Lewis acidic carbocation structures on 
regiochemical outcomes was fully investigated. These results clearly revealed that ring size is an 
important determinant on the regioselectivity of bicyclic epoxonium ion opened by tethered 
nucleophiles. That is, bicyclo[3.1.0] epoxonium ions show significant to exclusive preference 
towards exo-cyclization pathways while bicyclo[4.1.0] epoxonium ions show a strong tendency 
towards endo-cyclizations. This observation could be explained from the computational studies 
that larger rings can adopt a looser transition state with more SN1 character, thereby favoring 
endo-cyclizations. As for smaller rings, endo-TSs are more distorted than exo-TSs, making endo-
TSs energetically higher and exo-pathways more favorable. In addition, epoxide substitution 
pattern also has significant influence on the regioselectivity, especially when bicyclo[4.1.0] 
epoxonium ions serve as the key intermediates. Trisubstituted bicyclo[4.1.0] epoxonium ions 
prefer exclusive endo-cyclization pathways with the cyclization proceeding through an SN1-like 
transition state due to the better stabilization from a partially formed tertiary carbocation. 
However, disubstituted bicyclo[4.1.0] epoxonium ions show  almost no preference towards exo- 
or endo-cyclizations. Though Lewis acid selection has negligible effect on the regiochemical 
outcomes of bicyclo[4.1.0] intermediates, it can affect the reaction pathways in a subtle manner 
when reactions proceed through bicyclo[3.1.0] epoxonium ions. That is, when bicyclo[3.1.0] 
epoxonium ions are formed from combination of epoxides and non-stabilized carbenium ions, 
exclusive exo-selectivity is observed; when bicyclo[3.1.0] epoxonium ions are formed from 
combination of epoxides and oxocarbenium ions, exo-selectivity decreases to some extent. The 
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endo-cyclization in this process arises from the anomeric effect that generates from the forming 
tetrahydropyran ring through endo-pathway when the methoxy group adopts a pseudoaxial 
position, which makes endo-transition structure lower in energy. This delicate effect undoubtedly 
demonstrates that endo-cyclization can be achieved to generate tetrahydropyran rings through 
modification of bicyclic epoxonium ions. The current studies definitely provide a solid base for 
designing new epoxide substrates to provide polycyclic ether structures efficiently. 
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2.0  EFFORTS TOWARDS THE TOTAL SYNTHESIS OF (+)-
LACTODEHYDROTHYRSIFEROL AND ITS ANALOGS 
2.1 INTRODUCTION 
(+)-Lactodehydrothyrsiferol (2.1), a marine polycyclic ether natural product, was isolated 
as an amorphous white solid by Fernandez and co-workers in 2002 from seeds of Laurencia 
viridis around the Canary Islands (Figure 31).7 Spectroscopic analysis shows that it has a central 
trans-fused pyranopyran structure with a pendent 5-membered lactone ring and an aliphatic side 
chain that connects the central unit to a trans-tetrahydrofuran ring. It is interesting to note that 
the B ring assumes a chair conformation while the C ring adopts a twist-boat-like conformation. 
This has also been observed in structurally related natural products through X-ray and NMR 
spectroscopic analyses.7,43-45  
Biological assay shows that 2.1 has modest inhibitory effect on serine/threonine protein 
phosphatase (PP2A) with IC50 value of 100 μM.46 The structurally related natural product 
thyrsiferyl-23-acetate (TA) is more potent toward the inhibition of PP2A with IC50 values of 4-
16 μM depending on the enzyme concentration. It is worth noting that TA exhibits specific 
inhibitory effect on PP2A, and has no effect on protein phosphatase 1 (PP1), 2B (PP2B), 2C 
(PP2C), or protein tyrosine phosphatases (PTP).47 Though other structurally diverse natural 
products, such as polyether okadaic acid, polyketide tautomycin, and terpenoid cantharidin, are 
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much more potent inhibitors of PP2A (IC50 = 0.2 ~ 40 nM) than 2.1 and TA, they also show 
inhibitory effect on PP1 and/or PP2B (Figure 31).48,49 The exclusive selectivity of TA is 
presumably due to its unique structural features and makes itself an ideal tool to study the 
cellular processes mediated by PP2A. However, it is unclear whether 2.1 can affect the activity 
of other protein phosphatases besides PP2A. Up to now, no total synthesis of 2.1 has been 
reported. I am currently pursuing a convergent approach toward the total synthesis of 2.1 and its 
analogs to further explore their biological activity. 
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Figure 31. Biologically active natural products and the conformation of the B and C rings in 2.1 
and TA 
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2.2 SYNTHETIC PROGRESS 
2.2.1 Preliminary results 
Previous studies on the cascade cyclizations of epoxides showed that the reaction of 
diepoxide 2.2 under ETIC conditions gave a mixture of exo,exo-product 2.3 and endo,endo-
product 2.4 in a combined 61% yield and with a 6.1:1 ratio. In this reaction, tricycle 2.5 from an 
exo-cyclization followed by an endo-cyclization was not observed (Figure 32).26 Therefore, 
construction of the A, B and C rings of 2.1 in a single operation from the diepoxide similar to 2.2 
is difficult and a new strategy is required for this purpose.  
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Figure 32. Cyclization of diepoxide 2.2 
 
As depicted in Figure 33, an alternative approach was proposed.  The reaction of diepoxide 
2.6 under ETIC conditions is expected to give bicyclic epoxonium ion 2.7 and the terminal 
cyclization will proceed through addition of carbonate carbonyl to the proximal tertiary center in 
a kinetically favored fashion to generate tricycle 2.8. With 2.8 in hand, further elaborations will 
provide tetracyclic compound 2.9 with the A, B and C rings being installed.  
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Figure 33. Proposed cyclization of diepoxide 2.6 
 
To validate the transformation from 2.7 to 2.8, I prepared epoxy carbonate 2.14, which 
will form an epoxonium ion intermediate similar to 2.7 upon cyclization (Figure 34). Oxidation 
of known alkene 2.1026 with KMnO4 afforded α-hydroxyl ketone 2.11 in 57% yield.50 
Olefination of the ketone under Lebel’s Rh-catalyzed conditions provided allylic alcohol 2.12 in 
72% yield.51 Epoxidation52 of 2.12 catalyzed by VO(acac)2 in the presence of tert-butyl 
hydroperoxide followed by protection of the primary hydroxyl group with Boc2O27 gave 
carbonate 2.14 in excellent yield.  
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Figure 34. Synthesis of epoxide 2.14 
 
Reaction of 2.14 under ETIC conditions cleanly afforded the desired spiro product 2.17 in 
excellent yield through addition of carbonate to the tertiary center of bicyclic epoxonium ion 
2.16, which was completely consistent with my expectations (Figure 35).  
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Figure 35. Cyclization of epoxide 2.14 
 
2.2.2 Current progress 
Following the smooth conversion of 2.14 into bicycle 2.17, I proposed a retrosynthetic 
approach toward 2.1. As shown in Figure 36, 2.1 can be obtained from a stereoselective 
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reduction of ketal 2.18 which will be prepared from coupling of aldehyde 2.19 and vinyl iodide 
2.20.53 These two coupling components can be accessed from cyclizations of diepoxide 2.21 and 
2.22, respectively.  
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Figure 36. Retrosynthetic analysis of 2.1 
 
Due to the availability of the chiral reagents for asymmetric epoxidations, ent-2.21 was 
initially prepared to explore the feasibility of the above route (Figure 37). Coupling of known 
vinyl bromide 2.2354 and aldehyde 2.24 under Fürstner-modified Nozaki-Hiyama-Kishi 
conditions53 provided allylic alcohol 2.25 in 85% yield. It was subsequently converted into ethyl 
ester 2.26 through a Johnson-Claisen rearrangement.54 Trost54 emphasized that the rearrangement 
efficiency of a similar allylic alcohol is highly dependent on the reaction temperature, with 
higher temperatures leading to decreased Z/E stereoselectivity and lower temperatures leading to 
decreased yields. Subsequently, 2.26 was converted into allylic alcohol 2.27 through reduction 
with DIBAL-H and addition with isopropenylmagnesium bromide. Another Johnson-Claisen 
rearrangement of 2.27 followed by reduction/addition gave homobenzylic alcohol 2.29 in 65% 
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yield over two steps. Methylation of the secondary alcohol followed by removal of the two silyl 
groups provided diol 2.30 in good yield. A sequence of Sharpless asymmetric epoxidation,32 Shi 
asymmetric epoxidation,31 and protection of the two hydroxyl groups with Boc2O afforded the 
cyclization substrate ent-2.21. It is worth noting that the first epoxidation gave modest yield due 
to the unexpected cyclization through addition of the distal hydroxyl group to the epoxide and 
the diastereoselectivity after the two epoxidations was low (dr ~ 2:1) based on NMR analysis.  
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Figure 37. Synthesis of ent-2.21 
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Subjecting diepoxide ent-2.21 to ETIC conditions produced desired tricycle 2.31 in 43% 
yield which contained small amounts of unknown materials (Figure 38). Also isolated from this 
reaction was tricycle 2.32. Both 2.31 and 2.32 were oxidized by Jones reagent25 to the 
corresponding lactones 2.33 and 2.34, respectively. The relative stereochemical outcomes of the 
central cis-tetrahydropyran and the orientation of the 5-membered carbonate ring in lactone 2.33 
were fully confirmed through 2D NMR NOESY studies. Subsequently, the Boc group was 
removed with TMSOTf in the presence of 2,6-lutidine55 to give primary alcohol 2.35 in nearly 
quantitative yield. Oxidation of the hydroxyl group with Dess-Martin periodinane56,57 provided 
aldehyde ent-2.19 in 61% yield.  
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Figure 38. Synthesis of advanced intermediate ent-2.19 
 
The above results clearly revealed that aldehyde 2.19 can be prepared from diepoxide 2.21. 
As previously mentioned, there are two problems in this sequence. One is the low yield in 
Sharpless epoxidation and the other is low diastereoselectivity in the epoxidations of 2.30 
presumably because of the interference of the hydroxyl group in Sharpless and/or Shi 
epoxidations. In order to circumvent these two problems, I proposed an alternative route to 2.19 
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with replacement of one of the tert-butyl carbonates with a terminal alkene (Figure 39). I 
envisioned that oxidative cleavage of the terminal alkene would yield the desired aldehyde.  
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Figure 39. An alternative approach to 2.19 
 
The synthesis of 2.36 began with known dienol 2.37, which was prepared from methyl 
acrylate and 4-pentenal through a Morita-Baylis-Hillman reaction (Figure 40).58,59 Reduction of 
the methyl ester followed by selective protection of the primary hydroxyl group with TBDPSCl 
provided silyl ether 2.38. Conversion of 2.38 into trienol 2.40 was achieved through a sequence 
similar to the synthesis of 2.30. After Sharpless epoxidation, Shi epoxidation and protection of 
the hydroxyl group with Boc2O, diepoxide 2.36 was obtained in higher efficiency compared to 
ent-2.21. Additionally, in this case, the diastereoselectivity in the epoxidations is about 4.6:1 
with regard to the stereochemical orientations of the two epoxide functionalities.  
Under ETIC conditions, diepoxide 2.36 underwent a cascade cyclization to afforded 
tricyclic product 2.37 (Figure 40). After removal of the anomeric center with Jones reagent, the 
corresponding lactone was obtained in 17% yield over two steps as a single diastereomer. The 
lower efficiency in the cascade cyclization is attributed to the intervention of the nucleophilic 
terminal alkene in the final cyclization process, suggesting that the terminal alkene must be 
replaced by non-nucleophilic groups. The ensuing cleavage of the terminal olefin under 
ozonolytic conditions smoothly afforded aldehyde 2.19 in 83% yield.  
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Figure 40. New approach to aldehyde 2.19 
 
With aldehyde 2.19 in hand, I next addressed to the preparation of vinyl iodide 2.45 
(Figure 41). Sharpless asymmetric epoxidation of geraniol followed by Sharpless asymmetric 
dihydroxylation60 gave a mixture of triol 2.22 and tetrahydrofuran 2.42, which was converted 
into 2.42 completely with the promotion by pyridinium 10-camphorsulfonate complex.61 The 
stereochemical outcome in 2.42 was established through mechanistic analysis. Activation of the 
primary hydroxyl group with TsCl followed by elimination under basic conditions provided the 
epoxide62 whose tertiary hydroxyl group was protected as silyl ether 2.43 in excellent yield. The 
epoxide was opened by 1,3-dilithiopropyne63 and the nascent secondary hydroxyl group was 
protected with TESCl to give bis-silyl ether 2.44. The terminal alkyne was transformed into the 
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vinylstannane in the presence of the Bu3Sn-AlEt2 complex and CuCN in 29% (59% brsm) yield, 
which was further converted into vinyl iodide 2.45 in good yield.64,65  
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Figure 41. Synthesis of vinyl iodide 2.45 
 
2.3 FUTURE WORK 
Though aldehyde 2.19 could be produced from diepoxides 2.21 and 2.36, the efficiency for 
the substrate preparation or cascade cyclization was still low. Therefore, a better substrate is 
necessary for the total synthesis. I am intended to prepare a new diepoxide 2.49 from known 
vinyl bromide 2.4666,67 to differentiate the protecting groups for the two primary hydroxyl groups 
(Figure 42). Coupling of 2.46 with aldehyde 2.24 will afford the allylic alcohol, which will be 
converted into ethyl ester 2.47 through a Johnson-Claisen rearrangement. Similarly, 2.48 can be 
obtained through a repeated ester reduction/nucleophilic addition protocol followed by 
methylation of the secondary alcohol. Removal of the PMB group with DDQ followed by 
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epoxidations and carbonate formation will deliver diepoxide 2.49. Since no extra hydroxyl group 
in the two epoxidations, a better yield from Sharpless epoxidation can be expected and the 
diastereoselectivity can be retained at a level of 4~5:1. Cyclization of 2.49 under ETIC 
conditions will give a comparable yield to that of ent-2.21 due to the bulky and non-nucleophilic 
tert-butyldiphenylsilyloxy group.  
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Figure 42. New approach to aldehyde 2.19 
 
With sufficient amounts of aldehyde 2.19 and vinyl iodide 2.42 in hand, I will next 
investigate the coupling of these two fragments under Fürstner-modified Nozaki-Hiyama-Kishi 
conditions (Figure 43).53 Once 2.50 is formed, the allylic alcohol can be selectively oxidized 
with MnO2 and the rest two hydroxyl group will be appropriately protected to give 2.51. 
Opening of the 5-member carbonate under basic conditions68 followed by BiBr3-promoted ketal 
formation69 will afford pentacycle 2.18.  
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Figure 43. Future plan for completion of the total synthesis  
 
From the retrosynthetic analysis, a challenging stereoselective reduction is required to 
complete the total synthesis. In the presence of suitable Lewis acids, ketal 2.18 will be opened to 
form oxocarbenium ion 2.52, and various hydride sources will be examined in hope that bulkier 
hydrides will provide a better diastereoselectivity by favoring approach from the bottom face in 
order to avoid the severe steric repulsion from the axial substitution groups when approaching 
from the top face.70 Subsequently, the hydroxyl group can be removed through sulfonate 
formation and reduction71,72 to give desired angular methyl group. Removal of the two hydroxyl 
groups will furnish the natural product 2.1. Modification of C-12 stereochemical orientation or at 
other positions will generate a number of analogs. Biological activity of 2.1 and these analogs 
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will be investigated toward a series of protein phosphatases and the structure-activity relationship 
pattern can be established accordingly.  
 
2.4 SUMMARY 
I am currently pursuing a convergent approach to the total synthesis of (+)-
lactodehydrothyrsiferol and its analogs. This route includes the coupling of two functionalized 
intermediates aldehyde 2.19 and vinyl iodide 2.42, both of which result from cyclizations of 
chiral epoxides with the former being obtained through oxocarbenium ion-initiated cascade 
cyclizations under ETIC conditions and the latter being obtained through a BrØnsted acid-
mediated cyclization. All the stereocenters in 2.1 will be ultimately derived from chiral reagents 
except the stereochemical outcome at the C-12 center which will be formed through a 
stereoselective reduction controlled by both substrate and the reducing agent. This remains a 
challenge to be explored.   
 
 
 
 48 
3.0  MULTICOMPONENT APPROACH TO THE SYNTHESIS OF OXIDIZED 
AMIDES THROUGH NITRILE HYDROZIRCONATION 
3.1 BACKGROUND 
Oxidized amides, in which the carbon atom connected to the nitrogen has a higher 
oxidation state than the normal (+1) valence, have been discovered in a number of natural 
products. These compounds usually possess acyl aminal, acyl hemiaminal or enamide 
functionalities, as exemplified by protein synthesis inhibitors pederin73,74 and psymberin,75,76 
cytotoxin zampanolide,77 and cytotoxins apicularen A78 and salicylihalamide A,79 respectively 
(Figure 44).  
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Figure 44. Representative natural products containing oxidized amides 
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 Structure-activity relationship studies have shown that the oxidized amide moieties are 
closely related to the biological acitivities of these complex compounds (Figure 45).80-84 For 
example, apicularen A shows strong growth inhibitory effect against the human melanoma cell 
line SK-MEL-5 with GI50 value of 6 nM. However, its synthetic analogs, with the enamide side 
chain being replace by simple alkenes or other enamides, have significantly reduced activity.82 
Due to the structural complexity and interesting biological activities, these natural products have 
attracted considerable attention from synthetic organic community.  
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Figure 45. Apicularen A analogs  
 
As for the synthesis of acyl aminals, a common method is through a Curtius rearrangement 
of acyl azide followed by nucleophilic addition to the isocyanate intermediate, as evidenced in 
the synthetic efforts towards mycalamides A and B (Figure 46, A).85 A direct coupling of the 
activated carboxylic acid with α-alkoxy amine provides acyl aminal and this strategy has been 
successfully applied to the total synthesis of mycalamides A and B by Kishi (Figure 46, B).86  
Alternatively, coupling of carboxylic acid chlorides with alkyl imidates followed by reduction of 
the newly-formed acyl imines could also deliver acyl aminals (Figure 46, C), whereas the 
diastereoselectivity in the reduction varies with the substrates.87 Our group also developed an 
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efficient approach to the acyl aminals through addition of oxygen-containing nucleophiles to 
oxidatively generated acyl iminium ions under very mild conditions (Figure 46, D).88  
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Figure 46. Preparation of acyl aminals 
 
Acyl hemiaminals are relatively more difficult to prepare than acyl aminals. In the total 
synthesis of (+)-zampanolide, Smith employed a Curtius rearrangement of the acyl azide to set 
up the acyl aminal functionality (Figure 47, A).89 After installation of the side chain, the PMB 
group was removed with DDQ and the desired acyl hemiaminal was obtained as a 1.3:1 mixture 
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of the two epimers, with the desired antipode of the natural product being slightly favored. 
Subsequently, Hoye developed a unique approach to the total synthesis of naturally occurring (-)-
zampanolide through an aluminum-mediated aza-aldol reaction of the aluminum imidate with (-) 
-dactylolide and a mixture of 1:1 diastereomers was obtained (Figure 47, B).90 In an effort 
toward the model synthesis of the zampanolide side chain, Porco91 studied the oxidative 
decarboxylation of the amino acid derivative and obtained α-acyloxy amide (Figure 47, C). 
Hydrolysis of the acetate yielded the desired acyl hemiaminal in good yield.  
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Figure 47. Preparation of acyl hemiaminals 
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Enamide synthesis has been extensively investigated. A Curtius rearrangement has also 
been employed to generate isocyanate intermediate from α,β-unsaturated acyl azides, which can 
be added by alkyllithium or Grignard reagents to afford enamides (Figure 48, A).92 This strategy 
has been utilized in the total synthesis of salicylihalamide A93,94 and palmeralide.95 Fürstner 
developed an approach to either E-enamides or Z-enamides from E- or Z-alkenylsilanes 
stereospecifically (Figure 48, B).96 Starting from alkenylsilanes, a sequence of epoxidation, 
epoxide opening with NaN3 and reduction gives α-silyl amines which are further converted into 
the corresponding enamides through acylation and Peterson olefination. Coupling of amides with 
vinyl iodides, cyclic enol triflates or tosylates under Cu (I)- or Pd (0)-catalyzed conditions 
delivers enamides (Figure 48, C and D).97,98 Recently, Goossen reported a stereoselective 
enamide formation via a Ru(II)-catalyzed hydroamination of terminal alkynes, with E-enamides 
being favored in the presence of tributylphosphine and Z-enamides being preferred when 
bis(dicyclohexylphosphino)methane was used as the ligand (Figure 48, E).99 A traditional Wittig 
olefination of N-acyl formamides with phosphonium ylides have also been utilized to generate E-
enamides (Figure 48, F).100 
While most of the aforementioned methods provide entries into oxidized amides 
specifically, a general and mild route to all these three types of oxidized amides from a common 
intermediate needed to be developed. Details will be followed in the subsequent section. 
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Figure 48. Preparation of enamides 
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3.2  RESEARCH DESIGN AND RESULTS 
Based on the structural features, I proposed that oxidized amides can be accessed from 
common acylimine intermediates. As depicted in Figure 49, acyl aminals can be prepared from 
acylimines through alcohol addition,101 acyl hemiaminals can be prepared from acylimines 
through water addition and enamides can be prepared from acylimines through a 
tautomerization.  
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Figure 49. Oxidized amides from acylimines 
 
For the preparation of the key intermediates acylimines, the common known method is 
condensation of aldehyde with amide (Figure 50).102-104 However, when enolizable aldehydes are 
used, tautomerization of the forming acylimines could be a problem. Though this problem can be 
tackled by addition of sulfinic acids or sulfinate salts to the reaction system to form α-amido 
sulfones,105,106 reforming and isolating the acylimine is still inefficient, although it is possible.107 
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Figure 50. Generation of acylimines 
 
Metalloimines could be acylated with acid chlorides or carboxylic acid anhydrides to give 
acylimines.108,109 Majoral110 reported that when sterically hindered nitriles were treated with 
Schwartz’ reagent (Cp2Zr(H)Cl)111,112 followed by acylation with sterically hindered acid 
chlorides, acylimines were obtained in excellent yields (Figure 51).113-115 My approach to 
acylimines begins with simple nitriles as well. Hydrometallation of nitriles will be expected to 
give metalloimines which will react with acid chlorides to afford desired acylimines (Figure 52). 
Once acylimines are successfully prepared, investigations of the formation of acyl aminals, acyl 
hemiaminals and enamides under different conditions can be performed.  
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Figure 51. Hydrozirconation of nitriles 
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Figure 52. Proposed acylimine formation from nitriles through hydrometallation and acylation  
 
I initiated my study by using the known α-methoxy nitrile 1116 as the substrate, which was 
prepared from addition of TMSCN to the corresponding dimethyl acetal mediated by BiBr3 
(Figure 53).117 Subjecting 3.1 to Schwartz’ reagent in CH2Cl2 followed by sequential addition of 
PhOC(O)Cl and MeOH provided acyl aminals 3.2 and 3.3 in combined 55% yield and with a 
2.4:1 diastereomeric ratio (see below for stereochemical assignment). The observation confirmed 
the formation of acylimine intermediate 3.4 from acylation of N-zircono-imine that arose from 
the nitrile reduction. From a mechanistic point of view, the major product 3.2 resulted from 
chelation-controlled MeOH addition while the minor product 3.3 was from addition of MeOH 
through a Felkin pathway. 
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Figure 53. Acyl aminal formation in initial studies 
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To assign the relative stereochemical outcomes of the two products, I prepared the α,β-
dimethoxy carboxylic acid 3.8 from α,β-unsaturated ester 3.7 through Sharpless asymmetric 
dihydroxylation,60 double methylation118 and hydrolysis of the ethyl ester (Figure 54). 
Subsequently, 3.8 was converted into acyl azide 3.9 which underwent a spontaneous Curtius 
rearrangement to form isocyanate 3.10.119 The phenoxide anion, which arose from hydrolysis of 
diphenylphosphoryl azide with adventitious moisture, added to the isocyanate to form (-)-3.3 as a 
single enantiomer which showed identical spectroscopic features to racemate 3.3.  
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Figure 54. Confirmation of stereochemical outcomes 
 
Having established the reactivity pattern, I next addressed the formation of acyl aminals 
and acyl hemiaminals extensively. Ethoxy nitrile 3.11 (prepared in a similar manner to 3.1) was 
used as the substrate for exploring the diastereocontrol in the alcohol addition and the acyl 
aminal formation with different acylating reagents and nucleophiles.  
When 3.11 was subjected to hydrozirconation, acylation with isobutyryl chloride and 
MeOH addition at 0 °C, both CH2Cl2 and THF were suitable solvents, with the products 3.12 and 
3.13 being isolated in combined 75% and 64% yields, respectively (entries 1 and 2, Figure 55). It 
is worth noting that chelation control was preferred in CH2Cl2 while Felkin-pathway was slightly 
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favored in THF. The reversed stereoselectivity may be explained by the formation of hydrogen 
bonds between THF and MeOH, which results in the weakening of chelation control. Since 
CH2Cl2 is a good solvent for chelation control, several conditions were tested to improve it. 
Simply lowering down the temperature for MeOH addition to -78 °C gave a slightly better result 
(entry 3). When proper chelating Lewis acids were employed, chelation control could be 
enhanced to a synthetically useful level. As shown in entries 4 and 5, when MeOH addition was 
carried out in the presence of a stoichiometric amount of Zn(OTf)2 or Mg(ClO4)2, a decent 
diastereocontrol (dr = 5.0:1 or 5.7:1) was accomplished with the reaction efficiency being 
retained.  
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Figure 55. Optimization of chelation control 
 
Electrophiles other than isobutyryl chloride were also investigated (Figure 56). Acylation 
of the metalloimine with α-methoxyacetyl chloride give a mixture of 3.14 and 3.15 in a 
combined 69% yield and 1.7:1 diastereomeric ratio. The products are electronically similar to the 
acyl aminals in pederin and psymberin. CbzCl is also a suitable acylating reagent, with N,O-
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acetals 3.16 and 3.17 being isolated in 64% overall yield. In this case, the Cbz group can serve as 
a protecting group and can be removed readily. Unfortunately, when the metalloimine was 
acylated with methanesulfonic anhydride, only modest yield of sulfonyl aminals 3.18 and 3.19 
were obtained. From this reaction, considerable amounts of the aldehyde from hydrolysis of the 
metalloimine were also isolated.  
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Figure 56. Acyl aminal formation from 3.11 with various electrophiles 
 
Besides MeOH, other heteronucleophiles also afforded satisfactory results when acylimine 
3.20 was utilized as the common intermediate (Figure 57). Sterically hindered tBuOH had no 
influence on the reactivity, with the desired acyl aminals being isolated in 71% yield and the 
Felkin-pathway being favored. PhOH and PhSH are also suitable for this reaction, providing 
69% and 72% yields, respectively. It is noteworthy that the chelation-controlled product 3.23 
was dominant in the case of PhOH while the product 3.26 from Felkin-type pathway was 
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predominantly formed in the case of PhSH as the nucleophile. This observation is consistent with 
the hydrogen-bond-forming abilities of these two nucleophiles.  
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Figure 57. Acyl aminal formation from 3.11 with various nucleophiles 
 
Nitriles with different substitutions are good substrates for the synthesis of acyl aminals 
and acyl hemiaminals (Figure 58). Subjecting α-benzoyloxy nitrile 3.27120 to hydrozirconation, 
acylation with isobutyryl chloride and MeOH addition, acyl aminal 3.28 was isolated in 64% 
yield (contaminated with 4% BnOH), indicating that ester groups can be tolerated in 
hydrozirconation.121 Instead of MeOH addition, a simple aqueous workup after the acylimine 
formation provided acyl hemiaminal 3.29 in 52% yield, which is structurally relevant to the 
zampanolide side chain. Also isolated from this reaction was 3.29A in 13% yield which resulted 
from addition of BnOH to the acylimine intermediate. It is worth noting that from the reactions 
of 3.27, the side product from migration of the benzoyl group to the metalloimine nitrogen was 
not observed. Octyl cyanide 3.30, with no branching at the α-carbon, afforded the desired acyl 
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aminal 3.31 and acyl hemiaminal 3.32 in good yields as well. It was found that THF is a better 
solvent than CH2Cl2 to suppress the acylimine tautomerization to the corresponding enamide. 
Aromatic nitriles also proved to be excellent substrates, with acyl aminal 3.34 being obtained in 
73% isolated yield from phenyl cyanide 3.33 though it underwent a much slower 
hydrozirconation than aliphatic nitriles.   
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Figure 58. Acyl aminal and acyl hemiaminal synthesis from various nitriles 
 
Having achieved smooth transformations from nitriles to acyl aminals and acyl 
hemiaminals, I next examined the enamide synthesis. Octyl cyanide 3.30 and isobutyryl chloride 
were used to explore the optimum reaction conditions (Figure 59). In CH2Cl2, 22% of the desired 
E-enamide 3.36 was obtained when the metalloimine was acylated in the presence of Et3N 
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followed by addition of Lewis acid BF3•OEt2 (entry 1, Table 1). In the absence of BF3•OEt2, a 
mixture of 3.36 and 3.37 in ~1:1 ratio resulted from acylimine 3.35 (entry 2); without Et3N base, 
no product (3.36 or 3.37) was observed (entry 3). When the reaction was conducted in THF, 
acylimine 3.35 was successfully generated in the presence of Et3N and was smoothly 
tautomerized to afford E-enamide 3.36 in 57% yield in the presence of BF3•OEt2 (entry 4). From 
this reaction, only minimum amount of Z-enamide 3.37 was observed. When the tautomerization 
was performed in the absence of BF3•OEt2, only trace amount of 3.36 was observed (entry 5); 
and when the metalloimine was acylated in the absence of Et3N, less than 10% yield of 3.36 was 
isolated (entry 6). These results convincingly demonstrated that both Et3N and BF3•OEt2 are 
crucially important in this reaction, presumably due to their synergistic effect in converting 3.35 
to 3.36. Also of note is that use of more than 1 equiv. of isobutyryl chloride would result in the 
formation of significant amount of diacylation product 3.38. Following the established 
conditions, allylic nitrile 3.40, prepared in four steps from methacrolein and 1-dodecene, gave 
rise to E,E-dienamide 3.41 in 62% yield (Figure 60).  
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Figure 59. Synthesis of enamide 3.36 from octyl cyanide 3.30 
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Table 1. Optimization of reaction conditions for enamide formation 
entry solvent base (3.0 eq.) Lewis acid (1.3-1.5 eq.) yield (3.36) 
1 CH2Cl2 Et3N BF3•OEt2 22% 
2 CH2Cl2 Et3N N/A E:Z ~ 1:1 
3 CH2Cl2 N/A BF3•OEt2 no product 
4 THF Et3N BF3•OEt2 57% 
5 THF Et3N N/A trace 
6 THF N/A BF3•OEt2 <10% 
 
9NH
O
9
NC
Cp2Zr(H)Cl, THF
then iPrC(O)Cl, Et3N 9
N
O
H
9O
+
9
HO
(a) Grubbs' 2nd catalyst (10 mol%)
     CH2Cl2, reflux 
(b) NaBH4, MeOH, 58%, two steps
(c) MsCl, Et3N, CH2Cl2, then LiBr
(d) NaCN, DMF, 56%, two steps
BF3•ΟEt2
62%
3.39
3.40                                                                                                                                                     3.41  
Figure 60. Synthesis of E,E-dienamide 3.41 from allylic nitrile 3.40 
 
With successful synthesis of oxidized amides from simple nitrile substrates, I next applied 
this methodology to the synthesis of a more complex model compound that is related to pederin 
and psymberin. For this purpose, tetrahydropyranyl nitrile 3.43 was prepared (by Michael Green 
in the Floreancig group at the University of Pittsburgh) in its racemic form from known ketone 
3.4288 through methylation, aluminum-mediated reduction of ketone,122 cleavage of the terminal 
alkene, acylation and displacement of the anomeric acetate group with cyanide (Figure 61).  
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Reaction of 3.43 through a sequence of hydrozirconation, acylation with isobutyryl 
chloride and MeOH addition at 0 °C provided desired acyl aminal 3.44 and its diastereomer 3.45 
in a combined 75% yield and with a 1.9:1 ratio favoring the chelation control (entry 1, Table 2). 
Also isolated for this reaction was amide 3.46 in 8% yield, which resulted from direct reduction 
of the acylimine intermediate by the slightly excess amount of Cp2Zr(H)Cl. Conducting the 
MeOH addition at lower temperature (-78 °C) was found to slightly improve the 
diastereoselectivity (entry 2). Employment of Mg(ClO4)2, which promoted chelation control to a 
considerable extent (cf. Figure 55),  did not provide a better diastereocontrol, with acyl aminals 
being obtained in 77% yield and 2.3:1 ratio (entry 3). Although only moderate diastereocontrol 
was obtained under the conditions studied here, the high yield of the acyl aminal together with 
the desired stereochemical orientation still makes this method attractive for the synthesis of acyl 
aminals with similar structures in natural products and their analogues.  
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3.42                                                                                                                              3.43
H
N
O
O
+ OMe
H
3.44                                         3.45                                         3.46  
Figure 61. Synthesis of tetrahydropyranyl acyl aminals 
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Table 2. Reaction of 3.43 under various conditions 
entry temperature Lewis acid (1 eq.) yield (3.44+3.45) dr (3.44/3.45) yield (3.46) 
1 0 °C N/A 75% 1.9:1 8% 
2 -78 °C N/A 71% 2.3:1 10% 
3 -78 °C Mg(ClO4)2 77% 2.3:1 10% 
3.3 CONCLUSIONS 
An efficient one-pot approach to the synthesis of oxidized amides from nitriles was 
developed. In this process, the acylimines, which are generated from hydrozirconation of nitriles 
followed by acylation with suitable electrophiles, serve as the common intermediates to deliver 
acyl aminals, acyl hemiaminals or enamides through nucleophilic addition or tautomerization. In 
the acyl aminal formation, moderate to good diastereocontrol could be achieved with the 
assistance of Lewis acids through chelation-controlled nucleophilic addition. It was also found 
that the base and Lewis acid played a synergistic role in the E-enamide syntheses. In the absence 
of base or Lewis acid, low efficiency for E-enamide formation was observed. With the known 
methods for the synthesis of nitriles, along with various available electrophiles and nucleophiles, 
this method will provide a convenient and effective access to oxidized amides with diverse 
structures.  
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APPENDIX A 
STUDIES ON THE STRUCTURE/REACTIVITY REALTIONSHIPS OF BICYCLIC 
EPOXONIUM IONS AND TETHERED NUCLEOPHILES (SUPPORTING 
INFORMATION) 
General Experimental Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded at ambient temperatures on Bruker Avance 300 spectrometer at 300 MHz 
and 75 MHz, respectively, Bruker Avance 500 spectrometer at 500 MHz and 125 MHz, or at 
Bruker Avance 600 spectrometer at 600 MHz and 151 MHz if specified. The chemical shifts are 
given in parts per million (ppm) on the delta (δ) scale. The solvent peak was used as a reference 
value, for 1H NMR: CDCl3 = 7.27 ppm, C6D6 = 7.15 ppm, for 13C NMR: CDCl3 = 77.23. Data 
are reported as follows: (s = singlet; d = doublet; t = triplet; q = quartet; dd = doublet of doublets; 
dt = doublet of triplets; br = broad; app = apparently). High resolution mass spectra were 
recorded on a MICROMASS AUTOSPEC (for EI) or WATERS Q-TOF API-US (for ESI) 
spectrometer. Infrared (IR) spectra were collected on a Mattson Cygnus 100 spectrometer. 
Samples for IR were prepared as a thin film on a NaCl plate by dissolving the compound in 
CH2Cl2 and then evaporating the CH2Cl2. Optical rotations were measured on a Perkin-Elmer 
241 polarimeter. Activated 4 Å molecular sieves were obtained through drying in oven at 150 °C 
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overnight. Tetrahydrofuran and diethyl ether were dried by passage through an activated alumina 
column under positive N2 pressure. Methylene chloride and benzene were distilled under N2 
from CaH2. Diphenylmethane was purchased from Aldrich and used without further purification. 
Anhydrous DMF and MeI were purchased from Acros. mCPBA was purchased from Acros and 
purified according to the standard procedure (cf. Purification of Laboratory Chemicals, 4th Ed., 
by Armarego, W. L. F. and Perrin, D. D.). Boc2O and N-methylimidole were purchased from 
Acros and used without further purification. Anhydrous Na2S2O3 was purchased from Aldrich 
and used as received. Toluene and 1,2-dichloroethane were purchased from Fisher Scientific and 
dried with 4 Å molecular sieves overnight prior to use. Analytical TLC was performed on E. 
Merck pre-coated (0.25 mm) silica gel 60F-254 plates. Visualization was done under UV (254 
nm). Flash chromatography was done using ICN SiliTech 32-63 60 Å silica gel. Reagent grade 
ethyl acetate, diethyl ether, and hexanes (commercial mixture) were purchased from EM Science 
and used as is for chromatography. All reactions were performed in oven or flame-dried 
glassware under a positive pressure of N2 with magnetic stirring unless otherwise noted. 
 
1,1-Diphenylhex-5-en-2-ol (A1) 
A solution of diphenylmethane (1.262 g, 7.50 mmol) in THF (7.5 ml) in a 
two-necked round-bottom flask was treated dropwise n-BuLi (1.6 M in 
hexanes, 4.7 mL, 7.5 mmol). The resulting deep orange solution was refluxed for 1 h and then 
cooled to 0 °C. A solution of 4-pentenal (0.252g, 3.00 mmol) in THF (3.0 mL) was added 
dropwise and the flask formerly containing 4-pentenal was rinsed with THF (2 x 1.0 mL). The 
reaction mixture was stirred at 0 °C for 1 h, then warmed to room temperature and quenched by 
slow addition of saturated NH4Cl solution (10 mL). The mixture was poured onto water (20 mL) 
Ph2CH
OH
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and extracted with Et2O (3 x 30 mL). The organic extracts were dried over MgSO4, filtered and 
concentrated. The residue was purified by flash chromatography (3% - 12% Et2O in hexanes) to 
give the secondary alcohol A1 (0.628 g, 83.0%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 
7.42-7.17 (m, 10H), 5.80 (ddt, J = 17.0, 13.4, 6.8 Hz, 1H), 5.06-4.94 (m, 2H), 4.42-4.35 (m, 1H), 
3.90 (d, J = 8.4 Hz, 1H), 2.35-2.12 (m, 2H), 1.67-1.41 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 
142.5, 141.6, 138.7, 129.0, 129.0, 128.9  128.4, 127.1, 126.8, 115.1, 73.4, 59.1, 34.4, 30.4; IR 
(neat) 3560, 3062, 2916, 1640, 1598, 1494, 1451, 1080, 913, 745, 703 cm-1; HRMS (EI): m/z 
calcd for C18H20O (M+•) 252.1514, found 252.1523. 
 
5-Methoxy-6,6-diphenylhex-1-ene (A2) 
The secondary alcohol A1 (0.585 g, 2.32 mmol) in anhydrous DMF (14.0 
mL) at 0 °C was treated with NaH (60% dispersion in mineral oil, 0.232 g, 
5.80 mmol) and the suspension was stirred at 0 °C for 30 min. MeI (0.58 mL, 9.28 mmol) was 
added dropwise and the cold bath was then removed. After stirred for 2 h at room temperature, 
the reaction was quenched with water (20 mL) cautiously and extracted with Et2O (3 x 40 mL). 
The organic extracts were dried over MgSO4, filtered and concentrated. The resulting residue 
was purified by flash chromatography (3% - 6% Et2O in hexanes) to give the secondary alcohol 
A2 (0.598 g, 96.8%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.44-7.16 (m, 10H), 5.80 
(ddt, J = 17.0, 13.3, 6.7 Hz, 1H), 5.06-4.95 (m, 2H), 4.05 (d, J = 8.2 Hz, 1H), 3.98 (m, 1H), 3.19 
(s, 3H), 2.25-2.15 (m, 2H), 1.70-1.54 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 142.9, 142.5, 
138.7, 129.1, 128.7, 128.4, 126.5, 126.4, 114.9, 83.2, 58.1, 56.4, 31.8, 29.6; IR (neat) 3027, 
2928, 1640, 1599, 1495, 1451, 1101, 911, 745, 701 cm-1; HRMS (EI): m/z calcd for C15H15O (M-
C4H7) +• 211.1123, found 211.1125. 
Ph2CH
OMe
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 4-Methoxy-5,5-diphenylpentanal (1.56) 
At -78 °C, the terminal olefin A2 (193 mg, 0.724 mmol) in CH2Cl2 (7.5 
mL) was bubbled gently with ozone until the solution retained a deep blue 
color and then PPh3 (570 mg, 2.17 mmol) was added in one portion. The mixture was warmed to 
room temperature, stirred for 3 h and then concentrated. The residue was purified by column 
chromatography (20% - 30% Et2O in hexanes) to give the aldehyde 1.56 (186 mg, 95.8%) as a 
colorless oil: 1H NMR (300 MHz, CDCl3) δ 9.74 (t, J = 1.7 Hz, 1H), 7.44-7.21 (m, 10H), 4.04-
3.96 (m, 2H), 3.12 (s, 3H), 2.60-2.45 (m, 2H), 2.05-1.95 (m, 1H), 1.80-1.68 (m, 1H); 13C NMR 
(75 MHz, CDCl3) δ 202.3, 142.3, 142.2, 128.8, 128.6, 128.5, 126.8, 126.6, 83.0, 58.3, 56.6, 39.8, 
25.3; IR (neat) 2928, 2827, 2726, 1722, 1495, 1451, 1113, 747, 704 cm-1; HRMS (EI): m/z calcd 
for C15H15O (M-C3H5O) +• 211.1123, found 211.1124. 
Ph2CH O
OMe
H
 
(E)-Ethyl 6-methoxy-7,7-diphenylhept-2-enoate (A3) 
At 0 °C, triethyl phosphonoacetate (0.25 mL, 1.27 mmol) was 
added dropwise to a suspension of NaH (60% dispersion in mineral 
oil, 51.0 mg, 1.27 mmol) in THF (4.0 mL)  and the resulting solution was stirred at 0 °C for 30 
min. The aldehyde 1.56 (171 mg, 0.637 mmol, dissolved in 1.0 mL THF) was introduced 
dropwise and the flask formerly containing the aldehyde was rinsed with THF (2 x 0.5 mL). The 
reaction mixture was stirred at 0 °C for 1 h, then quenched with saturated NH4Cl (5 mL) and 
poured onto water (10 mL). The mixture was extracted with CH2Cl2 (3 x 25 mL) and the organic 
extracts were dried (MgSO4) and concentrated. The residue was purified by column 
chromatography (10% - 15% EtOAc in hexanes) to give the ethyl ester A3 (202 mg, 93.8%) as a 
Ph2CH
OMe
OEt
O
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colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.50-7.17 (m, 10H), 6.96 (dt, J = 15.6, 6.9 Hz, 1H), 
5.82 ( br d, J = 15.6 Hz, 1H), 4.22 (q, J = 7.1 Hz, 2H), 4.04 (d, J = 8.5 Hz, 1H), 3.99-3.94 (m, 
1H), 3.19 (s, 3H), 2.44-2.25 (m, 2H), 1.75-1.50 (m, 2H), 1.32 (t, J = 7.1 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 166.8, 149.0, 142.5, 142.2, 128.9, 128.8, 128.5, 128.5, 126.7, 126.5, 121.6, 83.0, 
60.3, 58.2, 56.4, 30.8, 27.9, 14.4; IR (neat) 2980, 2931, 1717, 1653, 1495, 1451, 1267, 1202, 
1109, 1043, 746, 704 cm-1; HRMS (EI): m/z calcd for C20H21O2 (M-C2H5O) +• 293.1542, found 
293.1538. 
 
(3-(3-Methoxy-4,4-diphenylbutyl)oxiran-2-yl)methanol (A4) 
At -78 °C, DIBAL-H (1 M in hexanes, 1.5 mL, 1.5 mmol) was 
added dropwise to a solution of the ethyl ester A3 (202 mg, 0.598 
mmol) in THF (6.0 mL). The mixture was stirred at -78 °C for 30 min, then quenched with 
saturated sodium tartrate (6.0 mL) and diluted with water (5 mL). The mixture was warmed to 
room temperature and stirred vigorously for 2 h. After that time, the mixture was extracted with 
CH2Cl2 (3 x 30 mL) and the extracts were dried (MgSO4) and concentrated. The residue was 
dissolved in CH2Cl2 (6.0 mL) and cooled to 0 °C. NaHCO3 (100 mg, 1.20 mmol) and mCPBA 
(pure, 134 mg, 0.777 mmol) were added sequentially. The suspension was stirred at 0 °C for 1.5 
h, then quenched with saturated Na2S2O3 (3 mL) and water (10 mL). The mixture was stirred at 
room temperature for 30 min, and extracted with CH2Cl2 (3 x 40 mL). The extracts were dried 
(MgSO4), and concentrated and the residue was purified by column chromatography (40% - 70% 
EtOAc in hexanes containing 0.5% Et3N) to give the epoxy alcohol A4 (132 mg, 70.4%, dr ~ 
1:1) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.39-7.17 (m, 10H), 4.02-3.94 (m, 2H), 
3.91-3.82 (m, 1H), 3.66-3.56 (m, 1H), 3.17/3.16 (s, 3H), 2.93-2.86 (m, 2H), 1.81-1.47 (m, 4H); 
Ph2CH
OMe
OH
O
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13C NMR (75 MHz, CDCl3) δ 142.6, 142.3, 142.2, 128.9, 128.8, 128.8, 128.6, 128.5, 126.7, 
126.5, 83.2, 83.1, 61.9, 61.8, 58.6, 58.6, 58.2, 57.9, 56.5, 56.1, 56.0, 28.8, 28.0, 27.4, 27.1; IR 
(neat) 3428, 2928, 1495, 1451, 1095, 746, 704 cm-1; HRMS (ESI): m/z calcd for C20H24O3Na 
[M+Na]+ 335.1623, found 335.1636. 
 
tert-Butyl (3-(3-methoxy-4,4-diphenylbutyl)oxiran-2-yl)methyl carbonate (1.47) 
The epoxy alcohol A4 (124.0 mg, 0.397 mmol) in dry toluene 
(4.0 mL) at 0 °C was treated with 1-methylimidazole (32 μL, 
0.397 mmol) followed by Boc2O (173 mg, 0.794 mmol). The mixture was stirred at 0 °C for 2 h, 
then at room temperature for 1 h. After that time, the reaction was quenched with water (15 mL) 
and extracted with CH2Cl2 (3 x 20 mL). The organic extracts were dried over MgSO4, filtered 
and concentrated. The residue was azeotroped with hexanes (3 x 10 mL) and then purified by 
flash chromatography (15% - 20% EtOAc in hexanes containing 0.5% Et3N) to give the t-butyl 
carbonate 1.47 (146.8 mg, 89.7%, dr ~ 1:1) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 
7.38-7.16 (m, 10H), 4.23-4.18 (m, 1H), 3.99-3.92 (m, 3H), 3.14/3.13 (s, 3H), 2.94-2.91 (m, 1H), 
2.81-2.77 (m, 1H), 1.79-1.42 (m, 4H), 1.48 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 153.4, 142.6, 
142.3, 142.2, 128.9, 128.9, 128.8, 128.6, 128.5, 126.7, 126.5, 83.1, 83.0, 82.7, 67.2, 67.1, 58.3, 
57.9, 56.8, 56.6, 56.5, 56.2, 55.2, 28.8, 28.0, 27.9, 27.4, 27.1; IR (neat) 2981, 2933, 1743, 1495, 
1452, 1370, 1281, 1163, 1101, 912, 733, 704 cm-1; HRMS (ESI): m/z calcd for C25H32O5Na 
[M+Na]+ 435.2147, found 435.2140. 
Ph2CH
OMe
O OtBu
O
O
 
1,1-Diphenylhept-6-en-2-ol (A5) 
At -78 °C, a solution of DMSO (1.1 mL, 15.0 mmol) in CH2Cl2 (2 mL) Ph2CH
OH
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was added dropwise to a mixture of (COCl)2 (0.65 mL, 7.5 mmol) in CH2Cl2 (20 mL). After 10 
min, a solution of 5-hexen-1-ol (0.60 mL, 5.0 mmol) in CH2Cl2 (5 mL) was introduced. The 
white suspension was stirred at -78 °C for 30 min, then Et3N (4.2 mL, 30.0 mmol) was added 
and the suspension was stirred for 30 min. After that time, the reaction was warmed to room 
temperature, diluted with CH2Cl2 (80 mL) and washed with saturated NaHCO3 (80 mL). The 
organic layer was dried (Na2SO4), filtered and concentrated to give crude 5-hexenal.  
A solution of diphenylmethane (2.52 g, 15.0 mmol) in THF (15 ml) in a two-necked round-
bottom flask was treated dropwise n-BuLi (1.6 M in hexanes, 9.4 mL, 15.0 mmol). The resulting 
deep orange solution was refluxed for 1 h and then cooled to 0 °C. A solution of as-prepared 
crude 5-hexenal in THF (3.0 mL) was added dropwise and the flask formerly containing 4-
pentenal was rinsed with THF (2 x 1.0 mL). The reaction mixture was stirred at 0 °C for 1 h, 
then warmed to room temperature and quenched by slow addition of saturated NH4Cl solution 
(15 mL). The mixture was poured onto water (40 mL) and extracted with Et2O (3 x 50 mL). The 
organic extracts were dried over MgSO4, filtered and concentrated. The residue was purified by 
flash chromatography (3% - 15% Et2O in hexanes) to give the secondary alcohol A5 (0.928 g, 
70%, two steps) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.43-7.19 (m, 10H), 5.80 (tdd, 
J = 16.9, 13.2, 6.6 Hz, 1H), 5.02-4.93 (m, 2H), 4.40-4.36 (m, 1H), 3.92 (d, J = 8.3 Hz, 1H), 2.12-
1.96 (m, 2H), 1.76-1.37 (m, 5H); 13C NMR (75 MHz, CDCl3) δ 142.6, 141.6, 138.9, 129.0, 
128.8, 128.4, 127.0, 126.7, 114.7, 73.8, 59.0, 34.6, 33.8, 25.3; IR (neat) 3561, 3453, 3026, 2918, 
1640, 1598, 1494, 1451, 1080, 911, 746, 703 cm-1; HRMS (ESI): m/z calcd for C19H22ONa 
[M+Na]+ 289.1568, found 289.1600. 
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6-Methoxy-7,7-diphenylhept-1-ene (A6) 
The secondary alcohol A5 (0.918 g, 3.45 mmol) in anhydrous DMF (20 
mL) at 0 °C was treated with NaH (60% dispersion in mineral oil, 0.345 
g, 8.62 mmol) and the suspension was stirred at 0 °C for 30 min. MeI (0.86 mL, 13.8 mmol) was 
added dropwise and the cold bath was then removed. After stirred overnight, the reaction was 
quenched with water (40 mL) cautiously and extracted with Et2O (3 x 60 mL). The organic 
extracts were dried over MgSO4, filtered and concentrated. The resulting residue was purified by 
flash chromatography (1% - 5% Et2O in hexanes) to give the secondary alcohol A6 (0.921 g, 
95.4%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.45-7.20 (m, 10H), 5.81 (tdd, J = 16.9, 
13.1, 6.7 Hz, 1H), 5.05-4.96 (m, 2H), 4.06 (d, J = 8.3 Hz, 1H), 3.98-3.94 (m, 1H), 3.22 (s, 3H), 
2.15-1.95 (m, 2H), 1.70-1.43 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 143.1, 142.6, 129.0, 128.7, 
128.4, 126.5, 126.4, 114.7, 83.6, 58.0, 56.3, 34.0, 31.7, 24.5; IR (neat) 2934, 1640, 1495, 1451, 
1101, 910, 737, 701 cm-1; HRMS (EI): m/z calcd for C20H24O (M+•) 280.1827, found 280.1823. 
Ph2CH
OMe
 
5-Methoxy-6,6-diphenylhexanal (1.58) 
At -78 °C, the terminal olefin A6 (400 mg, 1.43 mmol) in CH2Cl2 (145 
mL) was bubbled gently with ozone until the solution retained a deep 
blue color and then PPh3 (750 mg, 2.86 mmol) was added in one portion. The mixture was 
warmed to room temperature, stirred overnight and then concentrated. The residue was purified 
by column chromatography (20% - 30% Et2O in hexanes) to give the aldehyde 1.58 (386 mg, 
95.9%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ ) δ 9.71 (t, J = 1.6 Hz, 1H), 7.39-7.16 
(m, 10H), 4.02 (d, J = 8.4 Hz, 1H), 3.94-3.88 (m, 1H), 3.12 (s, 3H), 2.38 (dt, J = 7.2, 1.5 Hz, 
2H), 1.79-1.70 (m, 2H), 1.58-1.53 (m, 1H), 1.48-1.42 (m, 1H),;13C NMR (75 MHz, CDCl3) δ 
Ph2CH
OMe
O
H
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202.2, 142.7, 142.3, 128.9, 128.7, 128.6, 128.4, 126.6, 126.5, 83.5, 58.1, 56.2, 44.0, 31.7, 17.9; 
IR (neat) 2929, 2825, 2721, 1722, 1495, 1451, 1112, 747, 704 cm-1; HRMS (ESI): m/z calcd for 
C19H22ONa [M+Na]+  305.1517, found 305.1564. 
 
(E)-Ethyl 7-methoxy-8,8-diphenyloct-2-enoate (A7) 
At 0 °C, triethyl phosphonoacetate (0.52 mL, 2.60 mmol) was 
added dropwise to a suspension of NaH (60% dispersion in 
mineral oil, 104 mg, 2.60 mmol) in THF (9.0 mL)  and the resulting solution was stirred at 0 °C 
for 30 min. The aldehyde 1.58 (367 mg, 1.30 mmol, dissolved in 3.0 mL THF) was introduced 
dropwise and the flask formerly containing the aldehyde was rinsed with THF (2 x 0.5 mL). The 
reaction mixture was stirred at 0 °C for 1 h, then quenched with saturated NH4Cl (10 mL) and 
poured onto water (20 mL). The mixture was extracted with CH2Cl2 (3 x 30 mL) and the organic 
extracts were dried (MgSO4) and concentrated. The residue was purified by column 
chromatography (10% - 15% EtOAc in hexanes) to give the ethyl ester A7 (426 mg, 93%) as a 
colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.44-7.20 (m, 10H), 6.96 (td, J = 15.6, 6.8 Hz, 1H), 
5.82 (d, J = 15.6 Hz, 1H), 4.24 (q, J = 7.1 Hz, 2H), 4.05 (d, J = 8.4 Hz, 1H), 3.98-3.92 (m, 1H), 
3.21 (s, 3H), 2.25-2.10 (m, 2H), 1.71-1.44 (m, 4H), 1.34 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 166.8, 149.0, 142.8, 142.4, 128.9, 128.7, 128.5, 128.4, 126.6, 126.4, 121.6, 83.5, 60.3, 
58.1, 56.3, 32.3, 31.8, 23.6, 14.4; IR (neat) 2979, 2934, 1718, 1654, 1495, 1451, 1368, 1269, 
1186, 1098, 1043, 746, 703 cm-1; HRMS (EI): m/z calcd for C21H23O3 (M-C2H5O) +• 307.1698, 
found 307.1684. 
Ph2CH
OMe
OEt
O
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(3-(4-Methoxy-5,5-diphenylpentyl)oxiran-2-yl)methanol (A8) 
At -78 °C, DIBAL-H (1 M in hexanes, 2.9 mL, 2.9 mmol) was 
added dropwise to a solution of the ethyl ester A7(413 mg, 1.17 
mmol) in THF (12 mL). The mixture was stirred at -78 °C for 30 min, then quenched with 
saturated sodium tartrate (12 mL) and diluted with water (10 mL). The mixture was warmed to 
room temperature and stirred vigorously for 2 h. After that time, the mixture was extracted with 
CH2Cl2 (3 x 40 mL) and the extracts were dried (MgSO4) and concentrated. The residue was 
passed through a short silica gel column and eluted with 50% EtOAc in hexanes. The product 
was concentrated and dissolved in CH2Cl2 (12 mL) and cooled to 0 °C. NaHCO3 (196 mg, 2.34 
mmol) and mCPBA (pure, 262 mg, 1.52 mmol) were added sequentially. The suspension was 
stirred at 0 °C for 3.5 h, then quenched with saturated Na2S2O3 (10 mL) and water (20 mL). The 
mixture was stirred at room temperature for 20 min, and extracted with CH2Cl2 (3 x 30 mL). The 
extracts were dried (MgSO4), and concentrated and the residue was purified by column 
chromatography (50% - 70% EtOAc in hexanes containing 0.5% Et3N) to give the epoxy alcohol 
A8 (348 mg, 91%, dr ~ 1:1) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.39-7.17 (m, 10H), 
4.00 (d, J = 8.4 Hz, 1H), 3.93-3.81 (m, 2H), 3.61-3.53 (m, 1H), 3.17/3.16 (s, 3H), 2.89-2.84 (m, 
2H), 1.66-1.40 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 142.8, 142.4, 128.9, 128.6, 128.5, 128.4, 
126.5, 126.4, 83.5, 61.8, 58.6, 58.5, 58.1, 58.0, 56.2, 56.0, 55.9, 32.0, 31.7, 21.6; IR (neat) 3435, 
2929, 1599, 1495, 1451, 1098, 910, 732, 703 cm-1; HRMS (ESI): m/z calcd for C21H26O3Na 
[M+Na]+ 349.1780, found 349.1792. 
Ph2CH
OMe
OH
O
 
tert-Butyl (3-(4-methoxy-5,5-diphenylpentyl)oxiran-2-yl)methyl carbonate (1.48) 
Ph2CH
OMe
O
O
O
OtBu
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The epoxy alcohol A8 (336 mg, 1.03 mmol) in anhydrous toluene (10 mL) at 0 °C was treated 
with 1-methylimidazole (82 μL, 1.03 mmol) followed by Boc2O (449 mg, 2.06 mmol). The 
mixture was stirred at 0 °C for 30 min, then at room temperature for 1.5 h. After that time, the 
reaction was quenched with water (15 mL) and extracted with CH2Cl2 (3 x 30 mL). The organic 
extracts were dried over MgSO4, filtered and concentrated. The residue was azeotroped with 
hexanes (3 x 10 mL) and then purified by flash chromatography (15% - 20% EtOAc in hexanes 
containing 0.5% Et3N) to give the t-butyl carbonate 1.48 (369 mg, 84%, dr ~ 1:1) as a colorless 
oil: 1H NMR (300 MHz, CDCl3) δ 7.39-7.16 (m, 10H), 4.23-4.18 (m, 1H), 4.00 (d, J = 8.4 Hz, 
1H), 3.97-3.88 (m, 2H), 3.16/3.16 (s, 3H), 2.96-2.91 (m, 1H), 2.81-2.79 (m, 1H), 1.59-1.43 (m, 
6H), 1.50 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 153.4, 142.8, 142.4, 129.0, 128.7, 128.6, 128.4, 
126.6, 126.4, 83.6, 82.7, 67.2, 58.2, 58.1, 56.6, 56.5, 56.3, 55.2, 55.2, 32.0, 32.0, 31.7, 27.9, 21.6, 
21.6; IR (neat) 2980, 2936, 1742, 1495, 1452, 1370, 1280, 1163, 1099, 858, 733, 704 cm-1; 
HRMS (ESI): m/z calcd for C26H34O5Na [M+Na]+ 449.2304, found 449.2308. 
 
((3,3-Dimethyloxiran-2-yl)methoxy)(tert-butyl)dimethylsilane (1.59) 
A solution of (3-methylbut-2-enyloxy)(tert-butyl)dimethylsilane (6.012 g, 30.0 
mmol) in CH2Cl2 (300 mL) at 0 °C was treated with NaHCO3 powder (5.04 g, 
60.0 mmol) followed by m-chloroperbenzoic acid (70-75%, 7.25 g, 31.5 mmol). The reaction 
mixture was stirred at 0 °C for 1.5 h and then quenched with saturated Na2S2O3 solution (100 
mL). After warmed to room temperature, the biphasic mixture was poured into water (100 mL) 
and the two layers were separated. The aqueous layer was extracted with CH2Cl2 (2 x 150 mL) 
and the combined organic extracts were dried over MgSO4, filtered and concentrated. The 
residue was purified by flash chromatography (15% Et2O in hexanes) to give the epoxide 1.59 
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(6.312 g, 97.2%) as a colorless liquid: 1H NMR (300 MHz, CDCl3) δ 3.75 (d, J = 5.3 Hz, 1H), 
3.74 (d, J = 5.4 Hz, 1H), 2.91 (t, J = 5.4 Hz, 1H), 1.34 (s, 3H), 1.29 (s, 3H), 0.92 (s, 9H), 0.10 (s, 
3H), 0.09 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 64.2, 62.5, 58.3, 26.1, 24.9, 19.0, 18.5, -5.0, -
5.2; IR (neat) 2958, 2930, 2886, 2858, 1472, 1379, 1256, 1140, 1086, 838, 778 cm-1.  
 
1-(tert-Butyldimethylsilanyloxy)-3-methylbut-3-en-2-ol (A9) 
A solution of 2,2,6,6-tetramethylpiperidine (2.825 g, 20.0 mmol) in anhydrous 
benzene (12.0 mL) at 0 °C was treated dropwise with n-BuLi (1.6 M in 
hexanes, 12.5 mL, 20.0 mmol). After 10 min, diethylaluminum chloride (1.0 M in heptanes, 20.0 
mL, 20.0 mmol) was added dropwise and the resulting white suspension was stirred at 0 °C for 
30 min. The epoxide 1.59 (1.731 g, 8.00 mmol, dissolved in 8.0 mL of anhydrous benzene) was 
added dropwise and the flask formerly containing the epoxide was rinsed twice with benzene (2 
x 4.0 mL). The reaction mixture was stirred further for 1.5 h at 0 °C and then quenched with 
saturated sodium tartrate solution (50 mL). The biphasic mixture was poured onto water (100 
mL) and extracted with Et2O (3 x 50 mL). The organic extracts were dried over MgSO4, filtered 
and concentrated in vacuo. The resulting residue was purified by column chromatography (15% 
Et2O in hexanes) to give allylic alcohol A9 (1.5581 g, 90.0%) as a colorless liquid: 1H NMR 
(300 MHz, CDCl3) δ 5.04 (m, 1H), 4.92 (m, 1H), 4.12 (m, 1H), 3.71 (dd, J = 9.9, 3.6 Hz, 1H), 
3.48 (dd, J = 9.9, 8.0 Hz, 1H), 2.66 (d, J = 3.0 Hz, 1H), 1.75 (s, 3H), 0.92 (s, 9H), 0.09 (s, 6H); 
13C NMR (75 MHz, CDCl3) δ 144.0, 112.0, 75.4, 66.4, 26.0, 19.0, 18.4, -5.2; IR (neat) 3446, 
2955, 2929, 2858, 1472, 1256, 1113, 899, 836, 777 cm-1; HRMS (EI): m/z calcd for C7H15O2Si 
(M-C4H9)+• 159.0841, found 159.0811. 
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 Ethyl (E)-6-(tert-butyldimethylsilanyloxy)-4-methylhex-4-enoate (A10) 
A mixture of allylic alcohol A9 (2.7093 g, 12.52 mmol), triethyl 
orthoacetate (freshly distilled, 9.2 mL, 50.1 mmol) and propionic 
acid (46.4 mg, 0.626 mmol) in a round-bottom flask was equipped with a fractional distillation 
apparatus to allow for removal of ethanol. The mixture was heated to 145 °C for 4 h. (During 
this period of time, a lot of volatiles were distilled out.) The unreacted triethyl orthoacetate was 
removed by simple distillation and the residue was purified by column chromatography (5% 
EtOAc in hexanes) to give ethyl ester A10 (3.433 g, 95.7%) as a colorless liquid: 1H NMR (300 
MHz, CDCl3) δ 5.32 (qt, J = 6.3, 1.2 Hz, 1H), 4.20 (d, J = 6.3 Hz, 2H), 4.13 (q, J = 7.1 Hz, 2H), 
2.46-2.40 (m, 2H), 2.37-2.30 (m, 2H), 1.64 (s, 3H), 1.26 (t, J = 7.1 Hz, 3H), 0.90 (s, 9H), 0.07 (s, 
6H); 13C NMR (75 MHz, CDCl3) δ 173.5, 135.3, 125.3, 60.5, 60.4, 34.6, 33.0, 26.2, 18.6, 16.6, 
14.5, -4.9; IR (neat) 2956, 2930, 2857, 1739, 1472, 1255, 1158, 1110, 1068, 836, 776 cm-1; 
HRMS (EI): m/z calcd for C15H29O3Si (M-H)+• 285.1886, found 285.1840. 
O
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(E)-7-(tert-Butyldimethylsilanyloxy)-5-methyl-1,1-diphenylhept-5-en-2-ol (A11) 
Ethyl ester A10 (1.000 g, 3.49 mmol) in CH2Cl2 (10.0 mL) at -78 
°C was treated dropwise with DIBAL-H (1.0 M in hexanes, 3.7 
mL, 3.7 mmol). The reaction mixture was stirred at -78 °C for 1 h and then quenched with 
saturated sodium tartrate solution (15 mL). After warmed up to room temperature, the mixture 
was stirred vigorously for 30 min and extracted with CH2Cl2 (3 x 30 mL). The organic extracts 
were dried over MgSO4, filtered and concentrated. The crude aldehyde 1.60 was used in the next 
step without further purification.  
Ph2CH
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In a separate two-necked round-bottom flask, a solution of diphenylmethane (1.76 g, 10.5 mmol) 
in THF (10.0 ml) was treated dropwise with n-BuLi (1.6 M in hexanes, 6.5 mL, 10.5 mmol). The 
resulting deep orange solution was refluxed for 1 h, and then cooled to 0 °C. The as-prepared 
crude aldehyde (dissolved in 2.0 mL of THF) was added dropwise and the flask formerly 
containing the aldehyde was rinsed with THF (2 x 0.5 mL). The reaction mixture was stirred at 0 
°C for 1 h, then warmed to room temperature and quenched by slow addition of saturated 
NaHCO3 solution (10 mL). The mixture was poured onto water (20 mL) and extracted with Et2O 
(3 x 40 mL). The organic extracts were dried over MgSO4, filtered and concentrated. The residue 
was purified by flash chromatography (3% - 12% EtOAc in hexanes) to give the secondary 
alcohol A11 (0.997 g, 69.6%, two steps) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.42-
7.17 (m, 10H), 5.32 (qt, J = 6.4, 1.2 Hz, 1H), 4.40-4.29 (m, 1H), 4.18 (d, J = 6.2 Hz, 2H), 3.92 
(d, J = 8.4 Hz, 1H), 2.30-2.20 (m, 1H), 2.17-2.07 (m, 1H), 1.66 (d, J = 3.4 Hz, 1H), 1.70-1.44 
(m, 2H), 1.56 (s, 3H), 0.92 (s, 9H), 0.08 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 142.6, 141.7, 
136.9, 129.0, 128.8, 128.4, 127.0, 126.7, 125.0, 73.5, 60.4, 59.0, 35.9, 33.1, 26.2, 18.6, 16.4, -
4.8; IR (neat) 3458, 2954, 2928, 2856, 1599, 1494, 1451, 1386, 1254, 1112, 1067, 835, 776, 702 
cm-1; HRMS (ESI): m/z calcd for C26H38O2SiK [M+K]+ 449.2278, found 449.2287. 
 
(E)-6-Methoxy-3-methyl-7,7-diphenylhept-2-en-1-ol (A12) 
The secondary alcohol A11 (0.908 g, 2.21 mmol) in anhydrous 
DMF (10.0 mL) at 0 °C was treated with NaH (60% dispersion in 
mineral oil, 0.221 g, 5.52 mmol) and the suspension was stirred at 0 °C for 30 min. MeI (0.55 
mL, 8.84 mmol) was added dropwise and the reaction mixture was allowed to warm up to room 
temperature. After stirred for 3 h, the reaction was quenched with water (30 mL) cautiously and 
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extracted with Et2O (3 x 50 mL). The organic extracts were dried over MgSO4, filtered and 
concentrated. The resulting residue was dissolved in THF (11.0 mL) and TBAF monohydrate 
(0.693 g, 5.730 mmol) was added in one portion. The yellow solution was stirred for 1.5 h and 
then concentrated. The residue was purified by column chromatography (30% - 40% EtOAc in 
hexanes) to give allylic alcohol A12 (0.684 g, 99.7%, two steps) as a colorless oil: 1H NMR (300 
MHz, CDCl3) δ 7.40-7.08 (m, 10H), 5.37 (qt, J = 6.9, 1.2 Hz, 1H), 4.12 (d, J = 6.8 Hz, 2H), 4.02 
(d, J = 8.4 Hz, 1H), 3.92 (ddd, J = 8.2, 6.4, 4.1 Hz, 1H), 3.17 (s, 3H), 2.22-2.03 (m, 2H), 1.73-
1.48 (m, 2H), 1.58 (s, 3H), 1.30 (br s, 1H); 13C NMR (75 MHz, CDCl3) δ 142.9, 142.5, 139.7, 
129.0, 128.7, 128.4, 126.6, 126.4, 123.8, 83.4, 59.5, 58.1, 56.4, 35.1, 30.5, 16.4; IR (neat) 3396, 
3026, 2929, 1599, 1494, 1451, 1374, 1241, 1102, 1002, 756, 703 cm-1; HRMS (ESI): m/z calcd 
for C21H26O2Na [M+Na]+ 333.1831, found 333.1817.  
 
(3-(3-Methoxy-4,4-diphenylbutyl)-3-methyloxiran-2-yl)methanol (A13) 
A solution of allylic alcohol A12 (252 mg, 0.812 mmol) in CH2Cl2 
(8.0 mL) at 0 °C was treated with NaHCO3 powder (136 mg, 1.62 
mmol) followed by mCPBA (pure, 147 mg, 0.852 mmol). The reaction mixture was stirred at 0 
°C for 1 h and then quenched with saturated Na2S2O3 solution (2.0 mL). After warmed to room 
temperature, the biphasic mixture was poured onto water (5 mL) and the two layers were 
separated. The aqueous layer was extracted with CH2Cl2 (2 x 20 mL) and the combined organic 
extracts were dried over MgSO4, filtered and concentrated. The residue was purified by flash 
chromatography (40% - 50% EtOAc in hexanes) to give the epoxy alcohol A13 (251 mg, 94.9%, 
dr ~ 1:1) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.38-7.17 (m, 10H), 4.00-3.91 (m, 
2H), 3.81-3.73 (m, 1H), 3.68-3.59 (m, 1H), 3.16/3.14 (s, 3H), 2.91-2.85 (m, 1H), 1.80-1.38 (m, 
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4H), 1.19/1.17 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 142.7, 142.4, 142.3, 128.9, 128.8, 128.6, 
128.4, 126.7, 126.5, 83.4, 83.3, 63.0, 62.7, 61.5, 61.5, 61.4, 61.4, 58.1, 57.9, 56.4, 56.2, 33.9, 
33.7, 27.5, 27.2, 17.0, 16.7; IR (neat) 3418, 2931, 1599, 1495, 1452, 1385, 1099, 1032, 747, 704 
cm-1; HRMS (ESI): m/z calcd for C21H26O3Na [M+Na]+ 349.1780, found 349.1766. 
 
tert-Butyl (3-(3-methoxy-4,4-diphenylbutyl)-3-methyloxiran-2-yl)methyl carbonate (1.49) 
Epoxy alcohol A13 (192 mg, 0.588 mmol) in anhydrous 
toluene (5.8 mL) at 0 °C was treated with 1-methylimidazole 
(46.9 μL, 0.588 mmol) followed by Boc2O (321 mg, 1.47 mmol). The reaction mixture was 
stirred at 0 °C for 4 h, then diluted with CH2Cl2 (20 mL) and poured onto water (10 mL). The 
biphasic mixture was separated and the aqueous layer was washed with CH2Cl2 (3 x 15 mL). The 
combined organic extracts were dried over MgSO4, filtered and concentrated. The residue was 
purified by flash chromatography (10% - 12.5% EtOAc in hexanes containing 0.5% Et3N) to 
give the t-butyl carbonate 1.49 (216 mg, 86.3%, dr ~ 1:1) as a colorless oil: 1H NMR (300 MHz, 
CDCl3) δ 7.39-7.17 (m, 10H), 4.20-4.14 (m, 1H), 4.09 (dd, J = 11.8, 6.1 Hz, 1H), 3.99-3.91 (m, 
2H), 3.15/3.14 (s, 3H), 2.97-2.91 (m, 1H), 1.83-1.42 (m, 4H), 1.50 (s, 9H), 1.20/1.18 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 153.5, 142.6, 142.4, 142.3, 128.9, 128.9, 128.7, 128.6, 128.4, 126.7, 
126.5, 83.2, 83.0, 82.7, 65.7, 65.6, 60.8, 60.6, 59.6, 59.2, 58.1, 57.8, 56.4, 56.2, 33.5, 33.3, 27.9, 
27.4, 27.1, 17.1, 16.7; IR (neat) 2980, 2933, 1743, 1495, 1453, 1370, 1327, 1279, 1163, 1098, 
859, 738, 704 cm-1; HRMS (ESI): m/z calcd for C26H34O5Na [M+Na]+ 449.2304, found 
449.2278. 
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(E)-6-(tert-Butyldimethylsilanyloxy)-4-methylhex-4-enal (1.60) 
Ethyl ester A10 (5.84 g, 20.4 mmol) in CH2Cl2 (58.0 mL) at -78 °C 
was treated dropwise with DIBAL-H (1.0 M in hexanes, 21.4 mL, 
21.4 mmol). The reaction mixture was stirred at -78 °C for 2 h and then quenched with saturated 
sodium tartrate solution (120 mL). After warmed up to room temperature, the mixture was 
extracted with CH2Cl2 (3 x 70 mL) and the organic extracts were dried over MgSO4, filtered and 
concentrated. The residue was purified by flash chromatography (6% - 8% EtOAc in hexanes) to 
give the aldehyde 1.60 (4.31 g, 87.4%) as a colorless liquid: 1H NMR (300 MHz, CDCl3) δ 9.79 
(t, J = 1.7 Hz, 1H), 5.33 (qt, J = 6.2, 1.3 Hz, 1H), 4.19 (d, J = 6.2 Hz, 2H), 2.59-2.54 (m, 2H), 
2.35 (app t, J = 7.7 Hz, 2H), 1.65 (s, 3H), 0.91 (s, 9H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3) 
δ 202.4, 135.0, 125.6, 60.3, 42.1, 31.7, 26.2, 18.6, 16.7, -4.9; IR (neat) 2955, 2929, 2857, 2714, 
1728, 1472, 1255, 1114, 1074, 836, 776 cm-1; HRMS (EI): m/z calcd for C13H25O2Si (M-H)+• 
241.1624, found 241.1606.  
O
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(E)-7-(tert-Butyldimethylsilanyloxy)-5-methylhept-5-enal (A14) 
(Methoxymethyl)triphenylphosphonium chloride (2.587 g, 7.55 
mmol) in a dry flask under high vacuum was heated with heat gun 
for 3 min to remove the moisture. The flask was cooled to 0 °C and THF (8.0 mL) was added in. 
NaHMDS (7.55 mL, 7.55 mmol) was added dropwise and the resulting deep orange suspension 
was stirred at 0 °C for 1 h. Aldehyde 1.60 (0.610 g, 2.52 mmol, dissolved in 1.0 mL of THF) was 
added dropwise and the flask formerly containing the aldehyde was rinsed twice with THF (2 x 
0.5 mL). The reaction mixture was stirred at 0 °C for 1 h, then quenched with saturated NaHCO3 
(10 mL) and extracted with Et2O (3 x 30 mL). The organic extracts were dried over MgSO4, 
H
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filtered and concentrated. The residue was purified by flash chromatography (3.5% EtOAc in 
hexanes) to give the crude methyl vinyl ether.  
The methyl vinyl ether in THF-H2O (10:1, 40 mL) was treated with Hg(OAc)2 (1.277 g, 4.01 
mmol). The reaction mixture was stirred for 20 min and saturated KI (20 mL) was added. The 
resulting yellowish green mixture was stirred for 1 h and then diluted with Et2O (50 mL). The 
two layers were separated and the organic layer was washed with saturated KI (40 mL), dried 
over MgSO4, filtered and concentrated. The residue was purified by flash chromatography (4% - 
6% EtOAc in hexanes) to give the title aldehyde A14 (0.526 g, 81.6%) as a colorless oil: 1H 
NMR (300 MHz, CDCl3) δ 9.78 (t, J = 1.5 Hz, 1H), 5.32 (qt, J = 6.2, 1.0 Hz, 1H), 4.19 (d, J = 
6.3 Hz, 2H), 2.42 (dt, J = 7.3, 1.5 Hz, 2H), 2.04 (t, J = 7.3 Hz, 2H), 1.76 (pent, J = 7.6 Hz, 2H), 
1.62 (s, 3H), 0.91 (s, 9H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 202.6, 136.0, 125.9, 60.5, 
43.5, 39.0, 26.3, 20.3, 18.7, 16.4, -4.8; IR (neat) 2930, 2856, 2713, 1728, 1472, 1387, 1255, 
1115, 1080, 836, 776 cm-1; HRMS (ESI): m/z calcd for C14H28O2SiNa [M+Na]+ 279.1756, found 
279.1745.  
 
(E)-8-(tert-Butyldimethylsilanyloxy)-6-methyl-1,1-diphenyl-oct-6-en-2-ol (A15) 
A solution of diphenylmethane (0.80 mL, 4.77 mmol) in THF 
(4.5 mL) was treated with n-BuLi (1.6 M in hexanes, 2.74 mL, 
4.39 mmol) and the resulting deep-orange solution was refluxed for 2 h. After cooling to room 
temperature, the solution was cooled further to 0 °C and the aldehyde A14 (0.489 g, 1.91 mmol, 
dissolved in 1.0 mL of THF) was added dropwise. The flask formerly containing the aldehyde 
was rinsed with THF (2 x 0.5 mL). The deep-orange solution was stirred at 0 °C for 1 h, then 
quenched by slow addition of saturated NaHCO3 (10 mL). The biphasic mixture was diluted with 
Ph2CH
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Et2O (10 mL) and poured onto water (10 mL). The two layers were separated and the aqueous 
layer was extracted with Et2O (3 x 20 mL). The combined organic extracts were dried over 
MgSO4, filtered and concentrated. The residue was purified by flash chromatography (7% - 13% 
EtOAc in hexanes) to give the alcohol A15 (0.638 g, 78.7%) as a colorless oil: 1H NMR (300 
MHz, CDCl3) δ 7.41-7.16 (m, 10H), 5.26 (qt, J = 6.4, 1.2 Hz, 1H), 4.36 (dt, J = 8.3, 3.0 Hz, 1H), 
4.16 (d, J = 6.3 Hz, 2H), 3.88 (d, J = 8.3 Hz, 1H), 1.99-1.92 (m, 2H), 1.70-1.35 (m, 4H), 1.57 (s, 
3H), 0.91 (s, 9H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 142.6, 141.6, 137.1, 129.0, 128.8, 
128.4, 127.1, 126.7, 124.7, 73.8, 60.5, 59.0, 39.6, 34.8, 26.2, 24.0, 18.6, 16.4, -4.8; IR (neat) 
3458, 2928, 2856, 1599, 1494, 1386, 1254, 1082, 835, 702 cm-1; HRMS (ESI): m/z calcd for 
C27H40O2SiNa [M+Na]+ 447.2695, found 447.2741.  
 
(E)-7-Methoxy-3-methyl-8,8-diphenyloct-2-en-1-ol (A16) 
The secondary alcohol A15 (0.638g, 1.50 mmol) in anhydrous 
DMF (10 mL) at 0 °C was treated with NaH (60% dispersion in 
mineral oil, 150 mg, 3.75 mmol) and the yellow suspension was stirred at 0 °C for 30 min. MeI 
(0.37 mL, 6.00 mmol) was added dropwise and the reaction mixture was stirred overnight at 
room temperature. The flask was cooled to 0 °C and the reaction was quenched with ice chips. 
The mixture was poured into water (20 mL) and extracted with Et2O (3 x 30 mL). The organic 
extracts were dried over MgSO4, filtered and concentrated. The residue was dissolved in THF 
(7.5 mL) and TBAF monohydrate (0.471 g, 1.80 mmol) was added in. The yellow solution was 
stirred for 1.5 h and then concentrated in vacuo. The residue was purified by flash 
chromatography (25% - 35% EtOAc in hexanes) to give the allylic alcohol A16 (0.475 g, 97.4%) 
as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.42-7.19 (m, 10H), 5.36 (qt, J = 6.9, 1.0 Hz, 
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1H), 4.11 (d, J = 6.9 Hz, 2H), 4.04 (d, J = 8.4 Hz, 1H), 3.97-3.92 (m, 1H), 3.19 (s, 3H), 1.98-
1.96 (m, 2H), 1.62 (s, 3H), 1.58-1.41 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 142.9, 142.5, 139.4, 
128.9, 128.6, 128.4, 126.5, 126.4, 123.7, 83.6, 59.3, 58.0, 56.2, 39.5, 31.6, 22.9, 16.2; IR (neat) 
3386, 2934, 1667, 1599, 1495, 1451, 1380, 1186, 1100, 1002, 746, 703 cm-1; HRMS (ESI): m/z 
calcd for C22H28O2Na [M+Na]+ 347.1987, found 347.1966.  
 
(3-(4-Methoxy-5,5-diphenylpentyl)-3-methyloxiran-2-yl)methanol (A17) 
A solution of allylic alcohol A16 (85.0 mg, 0.262 mmol) in 
CH2Cl2 (2.6 mL) at 0 °C was treated with NaHCO3 powder (55.0 
mg, 0.655 mmol) followed by m-chloroperbenzoic acid (pure, 47.5 mg, 0.275 mmol). The 
reaction mixture was stirred at 0 °C for 50 min and then quenched with saturated Na2S2O3 
solution (2.0 mL). After warmed to room temperature, the biphasic mixture was poured into 
water (5 mL) and the two layers were separated. The aqueous layer was extracted with CH2Cl2 (5 
x 10 mL) and the combined organic extracts were dried over MgSO4, filtered and concentrated. 
The residue was purified by flash chromatography (40% - 45% EtOAc in hexanes containing 
0.5% Et3N) to give the epoxy alcohol A17 (88.7 mg, 99.4%, dr ~ 1:1) as a colorless oil: 1H NMR 
(300 MHz, CDCl3) δ 7.38-7.17 (m, 10H), 4.00 (d, J = 8.4 Hz, 1H), 3.91-3.89 (m, 1H), 3.80-3.74 
(m, 1H), 3.65 (dd, J = 12.1, 6.6 Hz, 1H), 3.17/3.16 (s, 3H), 2.92-2.87 (m, 1H), 1.64-1.34 (m, 
6H), 1.23 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 142.8, 142.4, 128.9, 128.9, 128.7, 128.6, 128.4, 
126.6, 126.4, 83.6, 83.5, 63.1, 63.0, 61.5, 61.4, 58.1, 58.0, 56.3, 38.6, 32.1, 32.0, 20.7, 20.6, 16.8, 
16.7; IR (neat) 3420, 2935, 1599, 1495, 1452, 1385, 1249, 1100, 1031, 862, 747, 704 cm-1; 
HRMS (ESI): m/z calcd for C22H28O3Na [M+Na]+ 363.1936, found 363.1947. 
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tert-Butyl (3-(4-methoxy-5,5-diphenylpentyl)-3-methyloxiran-2-yl)methyl carbonate (1.50) 
Epoxy alcohol A17 (72.9 mg, 0.214 mmol) in anhydrous 
toluene (2.0 mL) at 0 °C was treated with 1-
methylimidazole (22 μL, 0.278 mmol) followed by Boc2O (187 mg, 0.856 mmol, dissolved in 
0.5 mL of toluene). The reaction mixture was stirred at 0 °C for 4 h, then diluted with CH2Cl2 
(5.0 mL) and poured into water (6 mL). The biphasic mixture was separated and the aqueous 
layer was washed with CH2Cl2 (3 x 5 mL). The combined organic extracts were dried over 
MgSO4, filtered and concentrated. The residue was purified by flash chromatography (10% - 
15% EtOAc in hexanes containing 0.5% Et3N) to give the t-butyl carbonate 1.50 (83.9 mg, 
89.0%, dr ~ 1:1) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.39-7.17 (m, 10H), 4.18 (dd, J 
= 11.9, 4.8 Hz, 1H), 4.09 (dd, J = 11.9, 6.3 Hz, 1H), 4.00 (d, J = 8.4 Hz, 1H), 3.93-3.87 (m, 1H), 
3.17 (br s, 3H), 2.98-2.94 (m, 1H), 1.64-1.41 (m, 6H), 1.52 (s, 9H), 1.24 (br s, 3H); 13C NMR (75 
MHz, CDCl3) δ 153.4, 142.8, 142.4, 128.9, 128.6, 128.5, 128.4, 126.5, 126.4, 83.5, 82.6, 65.7, 
60.6, 59.5, 59.4, 58.1, 58.0, 56.2, 38.3, 32.0, 27.9, 20.5, 20.5, 16.8, 16.8; IR (neat) 2934, 1742, 
1495, 1452, 1369, 1279, 1255, 1163, 1098, 859, 704 cm-1; HRMS (ESI): m/z calcd for 
C27H36O5Na [M+Na]+ 463.2460, found 463.2462. 
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((E)-3-Methyl-5-(3,3-dimethyloxiran-2-yl)pent-2-enyloxy)(tert-butyl)dimethylsilane (1.61) 
((E)-3,7-dimethylocta-2,6-dienyloxy)(tert-butyl)dimethylsilane 
(5.370 g, 20.0 mmol) in CHCl3 (180 mL) at 0 °C was treated with 
mCPBA (70-75%, 5.621 g, 22.8 mmol) in small portions. The white suspension was stirred at 0 
°C for 30 min, and then quenched with saturated Na2S2O3 solution (20 mL) and saturated 
NaHCO3 solution (100 mL). The mixture was warmed up to room temperature and the two 
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layers were separated. The aqueous was washed with CH2Cl2 (2 x 100 mL) and the combination 
of the organic extracts were dried over MgSO4 and evaporated. The residue was purified by 
column chromatography (8%-12% Et2O in hexanes) to give the desired monoepoxide 1.61 
(4.375 g, 76.9%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 5.36 (qt, J = 6.3, 1.2 Hz, 1H), 
4.20 (d, J = 6.3, Hz, 1H), 4.20 (d, J = 6.3, Hz, 1H), 2.72 (t, J = 6.2 Hz, 1H), 2.25-2.06 (m, 2H), 
1.65 (s, 3H), 1.71-1.61 (m, 2H), 1.31 (s, 3H), 1.27 (s, 3H), 0.91 (s, 9H), 0.08 (s, 6H).  
 
(E)-8-(tert-Butyldimethylsilanyloxy)-2,6-dimethylocta-1,6-dien-3-ol (A18) 
A solution of 2,2,6,6-tetramethylpiperidine (5.297 g, 37.5 mmol) in 
anhydrous benzene (25.0 mL) at 0 °C was treated dropwise with n-
BuLi (1.6 M in hexanes, 23.4 mL, 37.5 mmol). After 10 min, diethylaluminum chloride (1.0 M 
in heptanes, 37.5 mL, 37.5 mmol) and the resulting white suspension was stirred at 0 °C for 30 
min. Monoepoxide 1.61 (4.268 g, 15.0 mmol, dissolved in 5.0 mL of anhydrous benzene) was 
added dropwise and the flask formerly containing the epoxide was rinsed twice with benzene (2 
x 2.5 mL). The reaction mixture was stirred further at 0 °C for 1.5 h and then quenched with 
saturated sodium tartrate solution (100 mL). The biphasic mixture was poured into water (100 
mL) and extracted with Et2O (3 x 150 mL). The organic extracts were dried over MgSO4, filtered 
and concentrated in vacuo. The resulting residue was purified by column chromatography (12%-
21% Et2O in hexanes) to give the allylic alcohol A18 (3.924 g, 91.9%) as a colorless liquid: 1H 
NMR (300 MHz, CDCl3) δ 5.34 (qt, J = 6.3, 1.2 Hz, 1H), 4.94 (t, J = 0.8 Hz, 1H), 4.84 (t, J = 1.5 
Hz, 1H), 4.19 (d, J = 6.3 Hz, 2H), 4.05 (t, J = 6.2 Hz, 1H), 2.17-1.95 (m, 2H), 1.73 (s, 3H), 1.64 
(s, 3H), 1.70-1.60 (m, 2H), 0.90 (s, 9H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 147.6, 
136.8, 124.9, 111.3, 75.8, 60.4, 35.6, 33.0, 26.2, 18.6, 17.8, 16.6, -4.8; IR (neat) 3382, 2929, 
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2857, 1472, 1382, 1255, 1112, 1070, 836, 776 cm-1; HRMS (EI): m/z calcd for C12H23O2Si (M-
C4H9)+• 227.1467, found 227.1450. 
 
(4E,8E)-Ethyl 10-(tert-butyldimethylsilanyloxy)-4,8-dimethyl-deca-4,8-dienoate (A19) 
A mixture of allylic alcohol A18 (3.671 g, 12.90 mmol), 
triethyl orthoacetate (freshly distilled, 10.46 g, 64.50 
mmol) and propionic acid (47.8 mg, 0.645 mmol) in a round-bottom flask was equipped with a 
fractional distillation apparatus to allow for removal of ethanol. The mixture was heated to 145 
°C for 1.5 h. (During this period of time, a lot of volatiles were distilled out.) The unreacted 
triethyl orthoacetate was removed by simple distillation and the residue was purified by column 
chromatography (3% EtOAc in hexanes) to give the ethyl ester A19 (4.281 g, 93.6%) as a 
colorless liquid: 1H NMR (300 MHz, CDCl3) δ 5.30 (qt, J = 6.3, 1.2 Hz, 1H), 5.14 (qt, J = 6.9, 
1.2 Hz, 1H), 4.19 (d, J = 6.3 Hz, 1H), 4.19 (d, J = 6.3 Hz, 1H), 4.12 (q, J = 7.1 Hz, 2H), 2.42-
2.35 (m, 2H), 2.31-2.26 (m, 2H), 2.14-2.06 (m, 2H), 2.02-1.97 (m, 2H), 1.62 (s, 3H), 1.61 (s, 
3H), 1.25 (t, J = 7.1 Hz, 3H), 0.90 (s, 9H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 173.7, 
136.9, 133.7, 125.0, 124.7, 60.5, 60.4, 39.6, 34.9, 33.5, 26.4, 26.2, 18.6, 16.5, 16.1, 14.5, -4.8; IR 
(neat) 2929, 2856, 1738, 1463, 1254, 1158, 1063, 836, 776 cm-1; HRMS (ESI): m/z calcd for 
C20H38O3SiNa [M+Na]+ 377.2488, found 377.2513.  
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(4E,8E)-10-(tert-Butyldimethylsilanyloxy)-4,8-dimethyldeca-4,8-dienal (1.62) 
Ethyl ester A19 (2.3345g, 6.58 mmol) in CH2Cl2 (20.0 mL) 
at -78 °C was treated dropwise with DIBAL-H (1.0 M in 
hexanes, 6.91 mL, 6.91 mmol). The reaction mixture was stirred at -78 °C for 40 min and 
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DIBAL-H (1.0 M in hexanes, 0.66 mL, 0.66 mmol) were added. The mixture was stirred for 30 
min more and then quenched with saturated sodium tartrate solution (30 mL). After warmed up 
to room temperature, the mixture was extracted with CH2Cl2 (3 x 40 mL) and the organic 
extracts were dried over MgSO4, filtered and concentrated. The residue was purified by flash 
chromatography (4% - 20% EtOAc in hexanes) to give the aldehyde 1.62 (1.884 g, 92.1%) as a 
colorless liquid: 1H NMR (300 MHz, CDCl3) δ 9.75 (t, J = 1.9 Hz, 1H), 5.30 (qt, J = 6.3, 1.1 Hz, 
1H), 5.15 (qt, J = 6.8, 1.0 Hz, 1H), 4.19 (d, J = 6.3 Hz, 2H), 2.52 (dt, J = 7.9, 1.7 Hz, 2H), 2.32 
(t, J = 7.5 Hz, 2H), 2.15-2.08 (m, 2H), 2.03-1.98 (m, 2H), 1.62 (s, 6H), 0.91 (s, 9H), 0.08 (s, 6H); 
13C NMR (75 MHz, CDCl3) δ 202.8, 136.8, 133.4, 125.3, 124.8, 60.5, 42.4, 39.5, 32.0, 26.4, 
26.2, 18.6, 16.5, 16.3, -4.8; IR (neat) 2928, 2856, 1728, 1472, 1386, 1254, 1110, 1066, 836, 776 
cm-1; HRMS (ESI): m/z calcd for C18H35O2Si [M+H]+ 311.2406, found 311.2386.  
 
(5E,9E)-11-(tert-Butyldimethylsilanyloxy)-5,9-dimethyl-1,1-diphenylundeca-5,9-dien-2-ol 
(A20) 
A solution of diphenylmethane (1.625 g, 9.66 mmol) in 
THF (9.0 ml) was treated dropwise with n-BuLi (1.6 M 
in hexanes, 6.04 mL, 9.66 mmol). The resulting deep orange solution was stirred at 75 °C for 1 h 
and cooled to 0 °C. Dienal 1.62 (1.000 g, 3.22 mmol, dissolved in 2.0 mL of THF) was added 
dropwise and the flask formerly containing the aldehyde was rinsed with THF (2 x 0.5 mL). The 
reaction mixture was stirred at 0 °C for 1 h and quenched by slow addition of saturated NaHCO3 
solution (10 mL). The mixture was poured onto water (15 mL) and extracted with Et2O (3 x 30 
mL). The organic extracts were dried over MgSO4, filtered and concentrated. The residue was 
purified by flash chromatography (4% - 10% EtOAc in hexanes) to give the secondary alcohol 
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A20 (1.243 g, 80.6%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.41-7.16 (m, 10H), 5.30 
(qt, J = 6.3, 1.1 Hz, 1H), 5.14 (app t, J = 6.2 Hz, 1H), 4.38-4.30 (m, 1H), 4.18 (d, J = 6.3 Hz, 
2H), 3.91 (d, J = 8.4 Hz, 1H), 2.20-2.00 (m, 6H), 1.62 (s, 3H), 1.52 (s, 3H), 1.67-1.42 (m, 2H), 
0.92 (s, 9H), 0.08 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 142.7, 141.8, 137.1, 135.2, 129.0, 
129.0, 128.8, 128.5, 127.0, 126.7, 124. 8, 124.6, 73.6, 60.5, 58.9, 39.7, 36.1, 33.3, 26.5, 26.2, 
18.6, 16.6, 16.1, -4.8; IR (neat) 3466, 2928, 2855, 1598, 1494, 1450, 1384, 1254, 1067, 835, 776, 
702 cm-1; HRMS (ESI): m/z calcd for C31H46O2SiNa [M+Na]+ 501.3165, found 501.3150. 
 
(2E,6E)-10-Methoxy-3,7-dimethyl-11,11-diphenylundeca-2,6-dien-1-ol (1.63) 
The secondary alcohol A20 (1.200 g, 2.507 mmol) in 
anhydrous DMF (14.0 mL) at 0 °C was treated with NaH 
(60% dispersion in mineral oil, 0.251 g, 6.268 mmol) and the suspension was stirred at 0 °C for 
30 min. MeI (0.62 mL, 10.0 mmol) was added dropwise and the reaction mixture was allowed to 
warm up to room temperature. After stirred for 3 h, the reaction was quenched with water (25 
mL) cautiously and extracted with Et2O (3 x 35 mL). The organic extracts were dried over 
MgSO4, filtered and concentrated. The resulting residue was dissolved in THF (12.5 mL) and 
TBAF monohydrate (0.787 g, 3.01 mmol) was added in one portion. The yellow solution was 
stirred for 1.3 h and then concentrated. The residue was purified by flash chromatography (20% - 
30% EtOAc in hexanes) to give the allylic alcohol 1.63 (0.923 g, 97.2%) as a colorless oil: 1H 
NMR (300 MHz, CDCl3) δ 7.40-7.16 (m, 10H), 5.40 (qt, J = 6.9, 1.1 Hz, 1H), 5.10 (t, J = 5.5 
Hz, 1H), 4.14 (d, J = 6.7 Hz, 2H), 4.02 (d, J = 8.3 Hz, 1H), 3.92-3.87 (m, 1H), 3.16 (s, 3H), 2.11-
2.01 (m, 6H), 1.68 (s, 3H), 1.51 (s, 3H), 1.62-1.46 (m, 2H), 0.92 (br s, 1H); 13C NMR (75 MHz, 
CDCl3) δ 143.0, 142.5, 139.8, 135.3, 129.1, 128.7, 128.6, 128.4, 126.5, 126.4, 124.3, 123.6, 83.3, 
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59.6, 58.0, 56.2, 39.7, 35.3, 30.8, 26.4, 16.5, 16.1; IR (neat) 3388, 3026, 2925, 1599, 1494, 1451, 
1382, 1189, 1102, 1002, 755, 703 cm-1; HRMS (ESI): m/z calcd for C26H34O2Na [M+Na]+ 
401.2457, found 401.2477.  
 
((2R,3R)-3-(2-((2R,3R)-3-(3-Methoxy-4,4-diphenylbutyl)-3-methyloxiran-2-yl)ethyl)-3-
methyloxiran-2-yl)methanol (A21) 
To a solution of dienol 1.63 (100 mg, 0.264 mmol) in 
CH3CN/DMM (8.0 mL, 1:2, v/v) were added a 0.05 M 
solution of Na2B4O7 in 4x10-4 M Na2(EDTA) (5.2 mL), Bu4NHSO4 (7.2 mg, 21.1 μmol) and Shi 
ketone (68.2 mg, 0.264 mmol) sequentially. The mixture was cooled to 0 °C, and the Oxone (448 
mg, 0.729 mmol), dissolved in 4x10-4 M Na2(EDTA) (3.4 mL), and K2CO3 (424 mg, 3.06 
mmol), dissolved in water (3.4 mL), were added simultaneously via a syringe pump over 2.0 h. 
After the addition was completed, the slightly blue reaction mixture was stirred further for 15 
min at 0 °C, then diluted with water (10 mL) and extracted with CH2Cl2 (3 x 30 mL). The 
organic extracts were dried over MgSO4, filtered and concentrated. The residue was purified by 
flash chromatography (40% - 80% EtOAc in hexanes) to give the diepoxy alcohol A21 (95.8 mg, 
88.4%, dr ~ 1:1 regarding the stereochemical outcomes of the homobenzylic center and the two 
epoxide groups) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.42-7.17 (m, 10H), 4.00-3.85 
(m, 2H), 3.81-3.61 (m, 2H), 3.16/3.14 (s, 3H), 2.96 (t, J = 6.0 Hz, 1H), 2.64-2.60 (m, 1H), 2.01 
(br s, 1H), 1.86-1.73 (m, 2H), 1.66-1.42 (m, 6H), 1.31/1.30 (s, 3H), 1.15/1.13 (s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 142.7, 142.4, 142.2, 129.0, 128.9, 128.7, 128.7, 128.6, 128.4, 126.7, 126.5, 
83.3, 63.1, 62.6, 62.5, 61.4, 61.2, 61.1, 61.0, 60.7, 58.2, 57.9, 56.4, 56.1, 35.2, 33.9, 33.8, 27.6, 
27.3, 24.4, 17.1, 16.8, 16.4; IR (neat) 3435, 3026, 2929, 1495, 1452, 1386, 1100, 1032, 747, 704 
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cm-1; HRMS (ESI): m/z calcd for C26H34O4Na [M+Na]+ 433.2355, found 433.2348; [α]D = +13.3 
(CHCl3, c 1.34). 
 
tert-Butyl ((2R,3R)-3-(2-((2R,3R)-3-(3-methoxy-4,4-diphenylbutyl)-3-methyloxiran-2-yl)eth-
yl)-3-methyloxiran-2-yl)methyl carbonate (1.51) 
To a solution of diepoxy alcohol A21 (112 mg, 
0.273 mmol) in anhydrous toluene (2.7 mL) at 0 
°C were added N-methylimidazole (22 μL, 0.273 mmol) and Boc2O (119 mg, 0.546 mmol) and 
the reaction mixture was stirred overnight, allowing the temperature to warm to room 
temperature slowly. After that time, the reaction was quenched with water (10 mL) and extracted 
with CH2Cl2 (3 x 25 mL). The organic extracts were dried over MgSO4, filtered and 
concentrated. The residue was azeotroped with hexanes (3 x 10 mL) and then purified by column 
chromatography (20% - 25% EtOAc in hexanes containing 0.5% Et3N) to give the tert-butyl 
carbonate 1.51 (129 mg, 92.7%, dr ~ 1:1 regarding the stereochemical outcomes of the 
homobenzylic center and the two epoxide groups) as a colorless oil: 1H NMR (300 MHz, CDCl3) 
δ 7.39-7.17 (m, 10H), 4.27-4.10 (m, 2H), 4.00-3.88 (m, 2H), 3.17/3.16 (s, 3H), 3.02 (t, J = 5.8 
Hz, 1H), 2.63-2.59 (m, 1H), 1.84-1.38 (m, 8H), 1.52 (s, 9H), 1.32 (s, 3H), 1.14/1.13 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 153.5, 142.7, 142.4, 142.3, 129.0, 128.9, 128.8, 128.7, 128.6, 128.4, 
126.7, 126.5, 83.3, 82.8, 65.6, 61.1, 61.0, 60.3, 59.2, 58.2, 57.9, 56.4, 34.8, 33.9, 33.8, 27.9, 27.4, 
24.3, 17.2, 16.9, 16.8, 16.4; IR (neat) 2978, 2932, 1743, 1495, 1453, 1370, 1279, 1256, 1163, 
1098, 858, 756, 704 cm-1; HRMS (ESI): m/z calcd for C31H42O6Na [M+Na]+ 533.2879, found 
533.2859; [α]D = +17.3 (CHCl3, c 1.49). 
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((2S,3S)-3-((E)-7-Methoxy-4-methyl-8,8-diphenyloct-3-enyl)-3-methyloxiran-2-yl)methanol 
(A22) 
A suspension of the activated 4Å molecular sieves 
powder (95 mg) in CH2Cl2 (2.4 mL) was treated with (+)-
diisopropyl tartrate (8.0 μL, 38.0 μmol) and the mixture was cooled to -35 to -30 °C. The mixture 
was stirred for 10 min and Ti(O-i-Pr)4 (9.5 μL, 31.7 μmol) was added and the mixture was stirred 
for 15 min more. After that time, t-butyl hydroperoxide (5.0-6.0 M in decane, 0.19 mL, ~0.951 
mmol) was added dropwise and the mixture was stirred for 30 min. Dienol 1.63 (120.0 mg, 
dissolved in 0.5 mL of CH2Cl2) was added dropwise and the flask formerly containing the dienol 
was rinsed with CH2Cl2 (2 x 0.1 mL). The reaction mixture was stirred at -35 to -30 °C for 40 
min and then water (0.5 mL) was added. The mixture was allowed to warm up to 0 °C and stirred 
for 1 h. A solution of 30% of NaOH saturated with NaCl (0.3 mL) was added and the mixture 
was warmed up to room temperature and stirred for 1.5 h. The suspension was filtered through a 
pad of Celite and the filtrate was dried over MgSO4, filtered and concentrated. The residue was 
purified by flash chromatography (30% - 40% EtOAc in hexanes) to give the monoepoxy alcohol 
A22 (120.0 mg, 95.9%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.39-7.17 (m, 10H), 
5.07 (app t, J = 6.7 Hz, 1H), 4.01 (d, J = 8.3 Hz, 1H), 3.92-3.86 (m, 1H), 3.81-3.75 (m, 1H), 
3.71-3.63 (m, 1H), 3.15 (s, 3H), 2.94 (dd, J = 6.5, 4.5 Hz, 1H), 2.11-2.04 (m, 4H), 1.74-1.43 (m, 
4H), 1.51 (s, 3H), 1.29 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 142.9, 142.5, 135.8, 135.7, 129.0, 
128.6, 128.4, 126.5, 126.4, 123.7, 123.6, 83.3, 83.2, 63.1, 61.6, 61.2, 58.0, 57.8, 56.2, 38.6, 35.2, 
30.7, 30.6, 23.8, 16.9, 16.0; IR (neat) 3424, 3026, 2930, 1598, 1494, 1451, 1384, 1103, 1032, 
862, 746, 704 cm-1; HRMS (ESI): m/z calcd for C26H34O3Na [M+Na]+ 417.2406, found 
417.2436; [α]D = -3.8 (CHCl3, c 1.08). 
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 ((2S,3S)-3-(2-((2R,3R)-3-(3-Methoxy-4,4-diphenylbutyl)-3-methyloxiran-2-yl)ethyl)-3-
methyloxiran-2-yl)methanol (A23) 
To a solution of monoepoxy alcohol A22 (170.0 mg, 
0.431 mmol) in CH3CN/DMM (6.5 mL, 1:2, v/v) were 
added a 0.05 M solution of Na2B4O7 in 4x10-4 M Na2(EDTA) (4.3 mL), Bu4NHSO4 (5.8 mg, 
17.2 μmol) and Shi ketone (55.6 mg, 0.216 mmol) sequentially. The mixture was cooled to 0 °C, 
and the Oxone (366 mg, 0.595 mmol), dissolved in 4x10-4 M Na2(EDTA) (2.8 mL), and K2CO3 
(346 mg, 2.50 mmol), dissolved in water (2.8 mL), were added simultaneously via a syringe 
pump over 2.0 h. After the addition was completed, the blue reaction mixture was stirred further 
for 15 min at 0 °C, then diluted with water (15 mL) and extracted with CH2Cl2 (3 x 30 mL). The 
organic extracts were dried over MgSO4, filtered and concentrated. The residue was purified by 
flash chromatography (50% - 80% EtOAc in hexanes) to give the diepoxy alcohol A23 (160.6 
mg, 90.8%, dr ~ 1:1 regarding the stereochemical outcomes of the homobenzylic center and the 
two epoxide groups): 1H NMR (300 MHz, CDCl3) δ 7.38-7.17 (m, 10H), 3.99-3.95 (m, 1H), 
3.93-3.87 (m, 1H), 3.83-3.73 (m, 1H), 3.71-3.60 (m, 1H), 3.15/3.14 (s, 3H), 2.98-2.90 (m, 1H), 
2.67-2.60 (m, 1H), 2.35-2.28 (m, 1H), 1.91-1.86 (m, 1H), 1.78-1.71 (m, 2H), 1.69-1.55 (m, 3H), 
1.52-1.44 (m, 3H), 1.30 (s, 3H), 1.16/1.14 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 142.6, 142.6, 
142.3, 142.2, 128.9, 128.8, 128.7, 128.6, 128.4, 126.6, 126.5, 83.3, 83.1, 63.6, 63.0, 63.0, 61.4, 
61.2, 61.0, 60.8, 58.2, 57.8, 56.2, 56.0, 36.1, 34.0, 33.7, 27.6, 27.1, 24.7, 16.9, 16.5, 16.4; IR 
(neat) 3438, 3026, 2929, 1495, 1452, 1385, 1100, 1032, 746, 704 cm-1; HRMS (ESI): m/z calcd 
for C26H34O4Na [M+Na]+ 433.2355, found 433.2346; [α]D = +19.3 (CHCl3, c 1.55). 
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tert-Butyl ((2S,3S)-3-(2-((2R,3R)-3-(3-methoxy-4,4-diphenylbutyl)-3-methyloxiran-2-yl)eth-
yl)-3-methyloxiran-2-yl)methyl carbonate (1.52) 
To a solution of diepoxy alcohol A23 (145.1 mg, 
0.353 mmol) in anhydrous toluene (3.5 mL) at 0 
°C were added 1-methylimidazole (28 μL, 0.353 mmol) and Boc2O (154 mg, 0.706 mmol). The 
reaction mixture was stirred overnight, allowing the temperature to warm to room temperature 
slowly. The reaction was quenched with water (15 mL) and extracted with CH2Cl2 (3 x 25 mL). 
The organic extracts were dried over MgSO4, filtered and concentrated. The residue was purified 
by flash chromatography (20% - 25% EtOAc in hexanes containing 0.5% Et3N) to give the tert-
butyl carbonate 1.52 (154.8 mg, 85.8%, dr ~ 1:1 regarding the stereochemical outcomes of the 
homobenzylic center and the two epoxide groups) as a colorless oil: 1H NMR (300 MHz, CDCl3) 
δ 7.41-7.18 (m, 10H), 4.29-4.21 (m, 1H), 4.19-4.11 (m, 1H), 4.02-3.92 (m, 2H), 3.18/3.17 (s, 
3H), 3.04 (dd, J = 6.2, 4.8 Hz, 1H), 2.63-2.59 (m, 1H), 1.82-1.40 (m, 8H), 1.53 (s, 9H), 1.32 (s, 
3H), 1.17/1.15 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 153.5, 142.7, 142.4, 142.2, 129.0, 128.7, 
128.6, 128.4, 126.6, 126.4, 83.3, 82.7, 65.6, 63.1, 62.7, 60.9, 60.3, 59.8, 58.1, 57.8, 56.3, 56.1, 
35.2, 33.9, 33.8, 27.9, 27.6, 27.3, 24.5, 16.9, 16.8, 16.4; IR (neat) 2977, 2932, 1742, 1495, 1453, 
1370, 1279, 1256, 1163, 1097, 858, 704 cm-1; HRMS (ESI): m/z calcd for C31H42O6Na [M+Na]+ 
533.2879, found 533.2857; [α]D = +1.3 (CHCl3, c 2.15). 
O
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(5E,9E)-11-(tert-Butyldimethylsilanyloxy)-5,9-dimethylundeca-5,9-dienal (1.64) 
(Methoxymethyl)triphenylphosphonium chloride (1.656 
g, 4.830 mmol) in a dry flask under high vacuum was 
heated with heat gun for 3 min to remove the moisture. After the flask was cooled to room 
OTBSH
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temperature, THF (8.0 mL) was added in and the suspension was cooled to 0 °C. NaHMDS (1 M 
in THF, 4.83 mL, 4.83 mmol) was added dropwise and the resulting deep orange suspension was 
stirred at 0 °C for 1 h. Dienal 1.62 (0.500 g, 1.61 mmol, dissolved in 2.0 mL of THF) was added 
dropwise and the flask formerly containing the aldehyde was rinsed with THF (2 x 1.0 mL). The 
reaction mixture was stirred at 0 °C for 1 h, then quenched with saturated NaHCO3 (10 mL) and 
poured into water (20 mL). The mixture was extracted with Et2O (3 x 30 mL). The organic 
extracts were dried over MgSO4, filtered and concentrated. The residue was purified by flash 
chromatography (3.5% EtOAc in hexanes) to give the methyl vinyl ether.  
The methyl vinyl ether in THF–H2O (10:1, 16.5 mL) was treated with Hg(OAc)2 (0.558 g, 1.65 
mmol). The reaction mixture was stirred for 30 min and saturated KI (30 mL) was added. The 
resulting yellowish green mixture was stirred for 1 h, then diluted with Et2O (30 mL). The two 
layers were separated and the aqueous layer was extracted with Et2O (2 x 40 mL). The 
combination of the organic extracts were dried over MgSO4, filtered and concentrated. The 
residue was purified by flash chromatography (3% - 5% EtOAc in hexanes) to give the titled 
aldehyde (0.474 g, 90.7%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 9.77 (t, J = 1.7 Hz, 
1H), 5.30 (qt, J = 6.3, 1.1 Hz, 1H), 5.12 (qt, J = 6.9, 1.1 Hz, 1H), 4.20 (d, J = 6.3 Hz, 2H), 2.39 
(dt, J = 7.3, 1.7 Hz, 2H), 2.17-2.08 (m, 2H), 2.01 (app t, J = 7.9 Hz, 4H), 1.74 (pent, J = 7.3 Hz, 
2H), 1.62 (s, 3H), 1.59 (s, 3H), 0.91 (s, 9H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 202.8, 
136.9, 134.2, 125.5, 124.8, 60.5, 43.4, 39.6, 39.0, 26.4, 26.2, 20.4, 18.6, 16.5, 15.9, -4.8; IR 
(neat) 2929, 2856, 2712, 1728, 1472, 1386, 1254, 1110, 1068, 836, 776 cm-1; HRMS (ESI): m/z 
calcd for C19H36O2SiNa [M+Na]+ 347.2382, found 347.2402. 
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(6E,10E)-12-(tert-Butyldimethylsilanyloxy)-6,10-dimethyl-1,1-diphenyldodeca-6,10-dien-2-
ol (A24) 
A solution of diphenylmethane (0.66 mL, 3.93 
mmol) in THF (3.9 mL) was treated with n-BuLi 
(1.6 M in hexanes, 2.46 mL, 3.93 mmol) and the resulting deep-orange solution was refluxed for 
1 h. After cooling to room temperature, the solution was cooled further to 0 °C and the above 
aldehyde 1.64 (0.426 g, 1.31 mmol, dissolved in 1.0 mL of THF) was added dropwise. The flask 
formerly containing the aldehyde was rinsed with THF (2 x 0.5 mL). The deep-orange solution 
was stirred at 0 °C for 2 h, then quenched with saturated NaHCO3 (5 mL). The biphasic mixture 
was poured into water (25 mL) and extracted with Et2O (3 x 25 mL). The combined organic 
extracts were dried over MgSO4, filtered and concentrated. The residue was purified by flash 
chromatography (3% - 9% EtOAc in hexanes) to give the secondary alcohol A24 (0.519 g, 
80.3%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.38-7.13 (m, 10H), 5.28 (qt, J = 6.3, 
1.1 Hz, 1H), 5.03 (qt, J = 6.9, 1.0 Hz, 1H), 4.37-4.29 (m, 1H), 4.18 (d, J = 6.3 Hz, 2H), 3.86 (d, J 
= 8.3 Hz, 1H), 2.08-2.00 (m, 2H), 1.96-1.85 (m, 4H), 1.60 (s, 3H), 1.52 (s, 3H), 1.69-1.30 (m, 
4H), 0.89 (s, 9H), 0.06 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 142.8, 141.7, 137.1, 135.2, 129.0, 
129.0, 128.8, 128.5, 127.0, 126.7, 124.6, 124.3, 73.9, 60.6, 59.0, 39.7, 39.6, 34.8, 26.5, 26.2, 
24.2, 18.6, 16.6, 16.0, -4.8; IR (neat) 3467, 2928, 2856, 1599, 1494, 1451, 1384, 1253, 1107, 
1065, 1005, 835, 775, 702 cm-1; HRMS (ESI): m/z calcd for C32H48O2SiNa [M+Na]+ 515.3321, 
found 515.3317.  
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(2E,6E)-11-Methoxy-3,7-dimethyl-12,12-diphenyldodeca-2,6-dien-1-ol (1.65) 
The secondary alcohol  A24 (0.473 g, 0.960 mmol) in Ph2CH
OMe
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anhydrous DMF (5.0 mL) at 0 °C was treated with NaH (60% dispersion in mineral oil, 96.0 mg, 
2.40 mmol) and the yellow suspension was stirred at 0 °C for 30 min. MeI (0.24 mL, 3.84 mmol) 
was added dropwise and the reaction mixture was stirred for 2.5 h at room temperature. The 
reaction was quenched with water (10 mL) and extracted with Et2O (3 x 30 mL). The organic 
extracts were dried over MgSO4, filtered and concentrated. The residue was dissolved in THF 
(5.0 mL) and TBAF monohydrate (0.301 g, 1.15 mmol) was added in. The yellow solution was 
stirred for 2 h and then concentrated in vacuo. The residue was purified by flash chromatography 
(20% - 30% EtOAc in hexanes) to give the dienol 1.65 (0.368 g, 97.5%) as a colorless oil: 1H 
NMR (300 MHz, CDCl3) δ 7.40-7.16 (m, 10H), 5.40 (qt, J = 6.9, 1.2 Hz, 1H), 5.05 (qt, J = 6.8, 
1.0 Hz, 1H), 4.16 (d, J = 6.8 Hz, 2H), 4.02 (d, J = 8.3 Hz, 1H), 3.94-3.88 (m, 1H), 3.18 (s, 3H), 
2.13-1.98 (m, 4H), 1.93-1.90 (m, 2H), 1.68 (s, 3H), 1.54 (s, 3H), 1.58-1.30 (m, 4H);  13C NMR 
(75 MHz, CDCl3) δ 143.1, 142.6, 139.7, 135.4, 129.1, 128.7, 128.6, 128.4, 126.5, 126.4, 124.2, 
123.7, 83.8, 59.6, 58.0, 56.3, 39.8, 39.7, 31.7, 26.4, 23.4, 16.4, 16.0; IR (neat) 3388, 3026, 2931, 
1667, 1599, 1495, 1451, 1382, 1186, 1102, 1003, 745, 703 cm-1; HRMS (ESI): m/z calcd for 
C27H36O2Na [M+Na]+ 415.2613, found 415.2607.  
 
((2R,3R)-3-(2-((2R,3R)-3-(4-methoxy-5,5-diphenylpentyl)-3-methyloxiran-2-yl)ethyl)-3-
methyloxiran-2-yl)methanol (A25) 
To a solution of monoepoxy alcohol A24 (112 mg, 
0.287 mmol) in CH3CN/DMM (4.3 mL, 1:2, v/v) were 
added a 0.05 M solution of Na2B4O7 in 4x10-4 M Na2(EDTA) (2.9 mL), Bu4NHSO4 (7.8 mg, 
22.9 μmol) and Shi ketone (74 mg, 0.287 mmol) sequentially. The mixture was cooled to 0 °C, 
and the Oxone (486 mg, 0.791 mmol), dissolved in 4x10-4 M Na2(EDTA) (3.7 mL), and K2CO3 
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(460 mg, 3.32 mmol), dissolved in water (3.7 mL), were added simultaneously via a syringe 
pump over 1.5 h. After the addition was completed, the blue reaction mixture was stirred further 
for 15 min at 0 °C, then diluted with water (20 mL) and extracted with CH2Cl2 (3 x 30 mL). The 
organic extracts were dried over MgSO4, filtered and concentrated. The residue was purified by 
flash chromatography (35% - 85% EtOAc in hexanes containing 0.5% Et3N) to give diepoxy 
alcohol A25 (78 mg, 64%, dr ~ 1:1 regarding the stereochemical outcomes of the homobenzylic 
center and the two epoxide groups) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.62-7.16 
(m, 10H), 4.00 (J = 8.4 Hz, 1H), 3.92-3.83 (m, 1H), 3.82-3.79 (m, 1H), 3.75-3.64 (m, 1H), 
3.17/3.16 (s, 3H), 3.01-2.96 (m, 1H), 2.68-2.63 (m, 1H), 1.96-1.70 (m, 2H), 1.64-1.40 (m, 8H), 
1.33 (s, 3H), 1.20/1.19 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 142.8, 142.4, 128.9, 128.9, 128.7, 
128.6, 128.4, 126.6, 126.4, 83.6, 63.0, 62.9, 62.6, 61.4, 61.2, 61.1, 60.7, 58.1, 58.0, 56.2, 38.8, 
38.7, 35.2, 32.1, 24.4, 20.8, 20.7, 17.0, 16.5, 16.5; IR (neat) 3433, 2930, 1599, 1495, 1452, 1386, 
1102, 1032, 734, 704 cm-1. 
 
tert-Butyl ((2R,3R)-3-(2-((2R,3R)-3-(4-methoxy-5,5-diphenylpentyl)-3-methyloxiran-2-yl)et-
hyl)-3-methyloxiran-2-yl)methyl carbonate (1.53) 
The diepoxy alcohol A25 (74 mg, 0.174 mmol) 
was dissolved in dry toluene (1.7 mL) and 
cooled to 0 °C. N-Methylimidazole (18 μL, 0.226 mmol) and Boc2O (152 mg, 0.696 mmol) were 
added sequentially. The reaction mixture was stirred overnight, allowing the temperature to 
warm to room temperature slowly. The reaction was quenched with water (10 mL) and extracted 
with CH2Cl2 (3 x 20 mL). The extracts were dried over MgSO4, filtered and concentrated. The 
residue was purified by column chromatography (20% - 25% EtOAc in hexanes containing 0.5% 
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Et3N) to give the desired product 1.53 (72 mg, 78%, dr ~ 1:1 regarding the stereochemical 
outcomes of the homobenzylic center and the two epoxide groups) as a colorless oil: 1H NMR 
(300 MHz, CDCl3) δ 7.41-7.18 (m, 10H), 4.30-4.14 (m, 2H), 4.02 (d, J = 8.4 Hz, 1H), 3.98-3.85 
(m, 1H), 3.19/3.18 (s, 3H), 3.05 (t, J = 5.7 Hz, 1H), 2.66-2.63 (m, 1H), 1.81-1.39 (m, 8H), 1.52 
(s, 9H), 1.35 (s, 3H), 1.20/1.19 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 153.5, 142.9, 142.5, 142.4, 
129.0, 128.9, 128.7, 128.6, 128.4, 126.6, 126.4, 83.7, 83.6, 82.7, 65.6, 62.9, 62.8, 61.0, 60.3, 
59.3, 58.1, 58.0, 56.3, 38.8, 38.8, 34.8, 32.2, 27.9, 24.4, 20.9, 20.8, 17.1, 16.5, 16.5; IR (neat) 
3026, 2934, 1743, 1495, 1453, 1370, 1279, 1256, 1163, 1098, 859, 747, 705 cm-1; HRMS (ESI): 
m/z calcd for C32H44O6Na [M+Na]+ 547.3036, found 547.3002; [α]D = +11.0 (CHCl3, c 2.01).  
 
((2S,3S)-3-((E)-8-Methoxy-4-methyl-9,9-diphenylnon-3-enyl)-3-methyloxiran-2-yl)methanol 
(A26) 
A suspension of the activated 4Å molecular sieves 
powder (115.0 mg) in CH2Cl2 (3.3 mL) was treated 
with (+)-diisopropyl tartrate (9.6 μL, 45.8 μmol) and the mixture was cooled to -35 to -30 °C. 
The mixture was stirred for 10 min and Ti(O-i-Pr)4 (11.4 μL, 38.2 μmol) was added and the 
mixture was stirred for 15 min more. After that time, t-butyl hydroperoxide (5.0-6.0 M in decane, 
0.23 mL, ~1.15 mmol) was added dropwise and the mixture was stirred for 30 min. Dienol 1.65 
(150.0 mg, 0.382 mmol, dissolved in 1.0 mL of CH2Cl2) was added dropwise and the flask 
formerly containing the allylic alcohol was rinsed with CH2Cl2 (2 x 0.5 mL). The reaction 
mixture was stirred at -35 to -30 °C for 1.5 h and then water (0.6 mL) was added. The mixture 
was allowed to warm up to 0 °C and stirred for 1 h. A solution of 30% of NaOH saturated with 
NaCl (0.2 mL) was added and the mixture was warmed up to room temperature and stirred for 
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1.5 h. The suspension was filtered through a pad of Celite and the filtrate was dried over MgSO4, 
filtered and concentrated. The residue was purified by flash chromatography (30% - 40% EtOAc 
in hexanes) to give the monoepoxy alcohol A26 (156.0 mg, 97.3%) as a colorless oil: 1H NMR 
(300 MHz, CDCl3) δ 7.44-7.23 (m, 10H), 5.09 (t, J = 6.6 Hz, 1H), 4.06 (d, J = 8.3 Hz, 1H), 3.99-
3.93 (m, 1H), 3.86-3.83 (m, 1H), 3.70 (dd, J = 12.0, 6.6 Hz, 1H), 3.22 (s, 3H), 3.02-2.99 (m, 
1H), 2.46 (br s, 1H), 2.10 (q, J = 7.7 Hz, 2H), 1.96-1.91 (m, 2H), 1.72-1.43 (m, 6H), 1.59 (s, 
3H), 1.33 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 143.0, 142.5, 135.7, 128.9, 128.6, 128.3, 126.4, 
126.3, 123.5, 83.6, 63.2, 61.5, 61.2, 57.9, 56.2, 39.6, 38.6, 31.6, 23.6, 23.2, 16.9, 15.9; IR (neat) 
3425, 3027, 2934, 1599, 1495, 1452, 1385, 1103, 1032, 910, 733, 703 cm-1; HRMS (ESI): m/z 
calcd for C27H36O3Na [M+Na]+ 431.2562, found 431.2556; [α]D = -3.8 (CHCl3, c 1.17). 
 
tert-Butyl ((2S,3S)-3-(2-((2R,3R)-3-(4-methoxy-5,5-diphenylpentyl)-3-methyloxiran-2-yl)et-
hyl)-3-methyloxiran-2-yl)methyl carbonate (1.54) 
A solution of monoepoxy alcohol A26 (145.0 
mg, 0.3549 mmol) in CH3CN/DMM (5.3 mL, 
1:2, v/v) was treated a 0.05 M solution of Na2B4O7 in 4x10-4 M Na2(EDTA) (3.5 mL), 
Bu4NHSO4 (4.8 mg, 14.2 μmol) and Shi ketone (45.8 mg, 0.177 mmol) sequentially. The 
mixture was cooled to 0 °C, and the Oxone (301 mg, 0.490 mmol), dissolved in 4x10-4 M 
Na2(EDTA) (2.3 mL), and K2CO3 (284 mg, 2.06 mmol), dissolved in water (2.3 mL), were 
added simultaneously via a syringe pump over 2.0 h. After the addition was completed, the blue 
reaction mixture was stirred further for 15 min at 0 °C, then diluted with water (5 mL) and 
extracted with CH2Cl2 (3 x 25 mL). The organic extracts were dried over MgSO4, filtered and 
concentrated. The residue was dissolved in dry toluene (3.5 mL) and cooled to 0 °C. N-
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Methylimidazole (36.8 μL, 0.4614 mmol) and Boc2O (232 mg, 1.06 mmol) were added 
sequentially. The reaction mixture was stirred overnight, allowing the temperature to warm to 
room temperature slowly. The reaction was quenched with water (5 mL) and extracted with 
CH2Cl2 (3 x 20 mL). The extracts were dried over MgSO4, filtered and concentrated. The residue 
was azeotroped with hexanes (3 x 20 mL) to removed t-BuOH and the residue was purified by 
column chromatography (12% - 24% EtOAc in hexanes containing 0.5% Et3N) to give the 
desired product 1.54 (153.5 mg, 82.4%, dr ~ 1:1 regarding the stereochemical outcomes of the 
homobenzylic center and the two epoxide groups) as a colorless oil: 1H NMR (300 MHz, CDCl3) 
δ 7.43-7.20 (m, 10H), 4.29 (dd, J = 11.9, 4.8 Hz, 1H), 4.17 (dd, J = 11.9, 6.3 Hz, 1H), 4.04 (d, J 
= 8.4 Hz, 1H), 3.99-3.90 (m, 1H), 3.20/3.19 (s, 3H), 3.07 (t, J = 5.3 Hz, 1H), 2.67-2.62 (m, 1H), 
1.77-1.42 (m, 10H), 1.54 (s, 9H), 1.35 (s, 3H), 1.22 (br s, 3H); 13C NMR (75 MHz, CDCl3) δ 
153.4, 142.8, 142.4, 142.4, 128.9, 128.8, 128.6, 128.5, 128.3, 126.5, 126.4, 83.5, 83.5, 82.6, 65.6, 
63.0, 62.9, 60.8, 60.8, 60.3, 59.7, 58.0, 57.9, 56.2, 38.7, 38.7, 35.1, 32.1, 27.8, 24.4, 20.8, 20.6, 
16.8, 16.5, 16.4; IR (neat) 2979, 2935, 1743, 1495, 1453, 1370, 1279, 1163, 1098, 912, 859, 733, 
704 cm-1; HRMS (ESI): m/z calcd for C32H44O6Na [M+Na]+ 547.3036, found 547.3031; [α]D = 
+0.5 (CHCl3, c 1.21). 
 
6,6-Diphenylhexane-1,5-diol (A27) 
In a round-bottomed flask, the δ-valerolactone (1.82 mL, 20.0 mmol) 
in CH2Cl2 (20.0 mL) at -78 °C was treated dropwise with DIBAL-H (1 
M in hexanes, 22.0 mL, 22.0 mmol). The mixture was stirred at -78 °C for 1h, then quenched 
with saturated sodium tartrate (80 mL) and extracted with Et2O (3 x 100 mL). The extracts were 
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dried over MgSO4, filtered and concentrated. The crude lactol was used in the next step without 
further purification. 
In another two-necked round-bottomed flask, diphenylmethane (13.4 mL, 80.0 mmol) in THF 
(50.0 mL) was treated dropwise with n-BuLi (1.6 M in hexanes, 50.0 mL, 80.0 mmol). The 
resulting deep orange solution was refluxed for 1 h and then cooled to 0 °C. The as-prepared 
crude lactol (dissolved in 5 mL THF) was added dropwise and the flask formerly containing the 
lactol was rinsed with THF (2 x 1.5 mL). The deep-orange mixture was stirred at 0 °C for 0.5 h, 
then quenched with saturated NH4Cl (80 mL) and extracted with Et2O (3 x 100 mL). The 
combined extracts were dried over MgSO4 and evaporated. The resulting residue was purified by 
column chromatography (40% - 80% EtOAc in hexanes) to give the diol A27 (4.42 g, 81.8%) as 
a white solid: 1H NMR (300 MHz, CDCl3) δ 7.57-7.18 (m, 10H), 4.38 (app t, J = 8.0 Hz, 1H), 
3.90 (d, J = 8.5 Hz, 1H), 3.59 (t, J = 5.7 Hz, 2H), 1.88 (br s, 1H), 1.81 (br s, 1H), 1.67-1.42 (m, 
6H); 13C NMR (75 MHz, CDCl3) δ 142.6, 141.7, 129.0, 129.0, 128.8, 128.4, 127.0, 126.7, 73.9, 
62.7, 59.0, 34.6, 32.6, 22.0; IR (neat) 3358, 3023, 2948, 1596, 1493, 1450, 1345, 1039, 696 cm-1; 
HRMS (ESI): m/z calcd for C18H22O2Na [M+Na]+ 293.1517, found 293.1537.  
 
6-(1-Phenyl-1H-tetrazol-5-ylthio)-1,1-diphenylhexan-2-ol (A28) 
At 0 °C, to a mixture of diol A27 (1.000 g, 3.699 mmol), 1-
phenyl-1H-tetrazole-5-thiol (0.791 g, 4.44 mmol) and Ph3P 
(1.164 g, 4.44 mmol) in THF (30.0 mL) was added dropwise diisopropyl azodicarboxylate (0.82 
mL, 4.07 mmol). The mixture was warmed to room temperature and stirred for 20 min. The 
reaction was quenched with water (60 mL) and extracted with Et2O (3 x 70 mL). The organic 
extracts were dried over MgSO4 and evaporated. The resulting residue was purified by column 
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chromatography (25% - 40% EtOAc in hexanes) to give the crude product which was further 
purified by column chromatography (3.5% Et2O in CH2Cl2) to give A28 (1.542 g, 96.8%) as a 
colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.60-7.50 (m, 5H), 7.40-7.15 (m, 10H), 4.39-4.33 
(m, 1H), 3.86 (d, J = 8.5 Hz, 1H), 3.35 (t, J = 7.1 Hz, 2H), 1.86-1.38 (m, 6H); 13C NMR (75 
MHz, CDCl3) δ 154.6, 142.4, 141.5, 133.8, 130.2, 129.9, 129.0, 128.9, 128.8, 128.3, 127.0, 
126.8, 124.0, 73.6, 59.1, 34.4, 33.4, 29.1, 25.0; IR (neat) 3439, 3026, 2942, 1597, 1499, 1451, 
1387, 1243, 1088, 1015, 910, 760, 733, 704 cm-1; HRMS (ESI): m/z calcd for C25H26N4OSNa 
[M+Na]+ 453.1725, found 453.1705.  
 
5-(5-Methoxy-6,6-diphenylhexylthio)-1-phenyl-1H-tetrazole (A29) 
The secondary alcohol A28 (1.444 g, 3.354 mmol) in anhydrous 
DMF (17.0 mL) at 0 °C was treated with NaH (60% dispersion 
in mineral oil, 0.335 g, 8.38 mmol) and the yellow suspension was stirred at 0 °C for 30 min. 
MeI (0.84 mL, 13.42 mmol) was added dropwise and the reaction mixture was stirred for 4 h at 
room temperature. The reaction was quenched with water (60 mL) and extracted with Et2O (3 x 
50 mL). The organic extracts were dried over MgSO4, filtered and concentrated. The residue was 
purified by flash chromatography (13% - 20% EtOAc in hexanes) to give the desired product 
A29 (1.268 g, 85.0%) as a pale yellow oil: 1H NMR (300 MHz, CDCl3) δ 7.59-7.56 (m, 5H), 
7.38-7.17 (m, 10H), 3.98 (d, J = 8.4 Hz, 1H), 3.93-3.88 (m, 1H), 3.34 (t, J = 7.2 Hz, 2H), 3.15 (s, 
3H), 1.86-1.70 (m, 2H), 1.65-1.40 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 154.6, 142.8, 142.4, 
133.9, 130.2, 129.9, 128.9, 128.7, 128.6, 128.4, 126.6, 126.4, 124.0, 83.5, 58.1, 56.3, 33.4, 31.7, 
29.3, 24.2; IR (neat) 3026, 2938, 1597, 1498, 1451, 1386, 1242, 1102, 759, 697 cm-1; HRMS 
(ESI): m/z calcd for C26H28N4OSNa [M+Na]+ 467.1882, found 467.1876.  
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 5-(5-Methoxy-6,6-diphenylhexylsulfonyl)-1-phenyl-1H-tetrazole (1.66) 
At 0 °C, NaHCO3 (312 mg, 3.71 mmol) was added to a solution 
of the thioether A29 (330 mg, 0.742 mmol) in CH2Cl2 (10.0 mL) 
and then mCPBA (pure, 435 mg, 2.52 mmol) was added in small portions. The mixture was 
stirred at 0 °C for 15 min, then at room temperature overnight. The reaction was quenched with 
saturated Na2S2O3 solution (20 mL), stirred for 30 min and extracted with CH2Cl2 (3 x 25 mL). 
The extracts were dried over MgSO4, filtered and concentrated. The residue was purified by flash 
chromatography (16% - 24% EtOAc in hexanes) to give the desired sulfone 1.66 (336 mg, 
95.0%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.70-7.60 (m, 5H), 7.38-7.17 (m, 10H), 
3.99 (d, J = 8.5 Hz, 1H), 3.94-3.88 (m, 1H), 3.72-3.64 (m, 2H), 3.15 (s, 3H), 1.96-1.84 (m, 2H), 
1.68-1.53 (m, 3H), 1.49-1.43 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 153.7, 142.6, 142.3, 133.2, 
131.6, 129.9, 128.9, 128.8, 128.6, 128.5, 126.7, 126.6, 125.3, 83.4, 58.2, 56.4, 56.1, 31.7, 23.9, 
22.3; IR (neat) 3027, 2934, 2828, 1597, 1496, 1452, 1342, 1153, 1103, 762, 705 cm-1; HRMS 
(ESI): m/z calcd for C26H28N4O3SNa [M+Na]+ 499.1780, found 499.1787. 
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((2E,6E)-11-Methoxy-3-methyl-12,12-diphenyldodeca-2,6-dienyloxy)(tert-butyl)dimethyl-
silane (A30) 
A solution of sulfone 1.66 (300 mg, 0.630 mmol, 
azeotropically dried with benzene) in anhydrous 1,2-
dimethoxyethane (3.8 mL) at -78 °C was treated dropwise with KHMDS (0.5 M in 1,2-
dimethoxyethane, 1.51 mL, 0.755 mmol) and the resulting yellow mixture was stirred at this 
temperature for 1 h. After that time, aldehyde 1.60 (183 mg, 0.755 mmol, dissolved in 0.5 mL of 
OTBSPh2CH
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1,2-dimethoxyethane) was added dropwise. The reaction mixture was stirred at -78 °C for 1.5 h, 
then at room temperature overnight. The reaction was quenched with saturated NH4Cl solution (5 
mL), poured onto water (10 mL) and extracted with Et2O (3 x 30 mL). The extracts were dried 
over MgSO4, filtered and concentrated. The residue was purified by flash chromatography (2% - 
3% EtOAc in hexanes) to give the desired diene A30 (196.4 mg, 63.3%) as a pale yellow oil: 1H 
NMR (500 MHz, CDCl3) δ 7.38-7.17 (m, 10H), 5.35-5.33 (m, 2H), 5.30 (qt, J = 6.3, 1.0 Hz, 1H), 
4.20 (d, J = 6.3 Hz, 1H), 4.00 (d, J = 8.2 Hz, 1H), 3.91-3.88 (m, 1H), 3.17 (s, 3H), 2.09-2.05 (m, 
2H), 2.20-1.99 (m, 2H), 1.92-1.91 (m, 2H), 1.61 (s, 3H), 1.52-1.48 (m, 2H), 1.45-1.40 (m, 2H), 
0.92 (s, 9H), 0.08 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 143.2, 142.6, 136.9, 130.4, 130.3, 
129.1, 128.7, 128.6, 128.4, 126.5, 126.4, 124.7, 83.8, 60.5, 58.0, 56.3, 39.8, 32.7, 31.7, 31.1, 
26.2, 25.2, 18.6, 16.6, -4.8; IR (neat) 3027, 2928, 2855, 1599, 1495, 1451, 1381, 1254, 1105, 
1062, 836, 775, 701 cm-1; HRMS (EI): m/z calcd for C28H39OSi (M-C4H9) +• 435.2719, found 
435.2706. 
 
(2E,6E)-11-Methoxy-3-methyl-12,12-diphenyldodeca-2,6-dien-1-ol (A31) 
To a solution of silyl ether A30 (196.4 mg, 0.398 
mmol) in THF (4.0 mL) was added TBAF 
monohydrate (125 mg, 0.478 mmol). The yellow solution was stirred for 1.5 h and the 
concentrated. The resulting residue was purified by flash chromatography (20% - 30% EtOAc in 
hexanes) to give the allylic alcohol A31 (143.1 mg, 94.8%) as a colorless oil: 1H NMR (300 
MHz, CDCl3) δ 7.49-7.18 (m, 10H), 5.44-5.36 (m, 3H), 4.15 (d, J = 6.8 Hz, 2H), 4.04 (d, J = 8.3 
Hz, 1H), 3.96-3.91 (m, 1H), 3.19 (s, 3H), 2.14-2.02 (m, 4H), 2.00-1.90 (m, 2H), 1.75 (br s, 1H), 
1.68 (s, 3H), 1.60-1.39 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 143.0, 142.5, 139.1, 130.4, 130.0, 
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129.0, 128.6, 128.3, 126.4, 126.3, 123.8, 83.7, 59.3, 57.9, 56.2, 39.6, 32.6, 31.6, 30.9, 25.0, 16.4; 
IR (neat) 3390, 3026, 2930, 1599, 1495, 1451, 1101, 1003, 969, 745, 703 cm-1; HRMS (ESI): 
m/z calcd for C26H34O2Na [M+Na]+ 401.2457, found 401.2464.  
 
((2R,3R)-3-(2-((2R,3R)-3-(4-Methoxy-5,5-diphenylpentyl)oxiran-2-yl)ethyl)-3-methyloxiran-
2-yl)methanol (A32) 
To a solution of dienol A31(100.0 mg, 0.264 mmol) in 
CH3CN/DMM (7.9 mL, 1:2, v/v) were added a 0.05 M 
solution of Na2B4O7 in 4x10-4 M Na2(EDTA) (5.3 mL), Bu4NHSO4 (7.2 mg, 21.1 μmol) and Shi 
ketone (102  mg, 0.396 mmol) sequentially. The mixture was cooled to -5 °C, and the Oxone 
(672 mg, 1.09 mmol), dissolved in 4x10-4 M Na2(EDTA) (3.4 mL), and K2CO3 (635 mg, 4.59 
mmol), dissolved in water (3.4 mL), were added simultaneously via a syringe pump over 2.0 h. 
After the addition was completed, the slightly blue reaction mixture was stirred further for 15 
min at 0 °C, then diluted with water (10 mL) and extracted with CH2Cl2 (4 x 20 mL). The 
organic extracts were dried over MgSO4, filtered and concentrated. The residue was purified by 
flash chromatography (50% - 70% EtOAc in hexanes) to give the diepoxy alcohol A32 (101.9 
mg, 94.0%, dr ~ 1:1 regarding the stereochemical outcomes of the homobenzylic center and the 
two epoxide groups) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.39-7.15 (m, 10H), 4.01 
(d, J = 8.4 Hz, 1H), 3.94-3.89 (m, 1H), 3.79 (dd, J = 12.1, 4.7 Hz, 1H), 3.69 (dd, J = 12.0, 6.3 Hz, 
1H), 3.17/3.16 (s, 3H), 2.98-2.95 (m, 1H), 2.66-2.60 (m, 2H), 1.86-1.46 (m, 10H), 1.3 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 142.8, 142.4, 128.9, 128.7, 128.6, 128.4, 126.5, 126.4, 83.6, 62.6, 
61.4, 60.7, 58.9, 58.8, 58.3, 58.2, 58.1, 58.0, 56.2, 34.5, 32.1, 32.0, 27.6, 21.6, 17.1; IR (neat) 
OHPh2CH
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3426, 2934, 1495, 1452, 1097, 1032, 732, 704 cm-1; HRMS (EI): m/z calcd for C26H34O4 (M+•) 
410.2457, found 410.2447; [α]D = +14.3 (CHCl3, c 1.20). 
 
tert-Butyl ((2R,3R)-3-(2-((2R,3R)-3-(4-methoxy-5,5-diphenylpentyl)oxiran-2-yl)ethyl)-3-me-
thyloxiran-2-yl)methyl carbonate (1.55) 
A solution of diepoxy alcohol A32 (99.2 mg, 
0.242 mmol) in toluene (2.4 mL) at 0 °C was 
added 1-Methylimidazole (19 μL, 0.24 mmol) and Boc2O (106 mg, 0.484 mmol) sequentially. 
The reaction mixture was stirred overnight, allowing the temperature to warm to room 
temperature slowly. After that time, the reaction was quenched with water (10 mL) and extracted 
with CH2Cl2 (3 x 25 mL). The extracts were dried over MgSO4, filtered and concentrated. The 
residue was azeotroped with hexanes (2 x 20 mL) to remove t-BuOH and the residue was 
purified by column chromatography (16% - 20% EtOAc in hexanes containing 0.5% Et3N) to 
give the desired product 1.55 (102.0 mg, 82.6%, dr ~ 1:1 regarding the stereochemical outcomes 
of the homobenzylic center and the two epoxide groups) as a colorless oil: 1H NMR (300 MHz, 
CDCl3) δ 7.39-7.17 (m, 10H), 4.22 (dd, J = 11.8, 4.7 Hz, 1H), 4.14 (dd, J = 11.9, 6.0 Hz, 1H), 
4.00 (d, J = 8.3 Hz, 1H), 3.93-3.88 (m, 1H), 3.17/3.16 (s, 3H), 3.02 (t, J = 5.4 Hz, 1H), 2.64-2.60 
(m, 2H), 1.75-1.44 (m, 10H), 1.50 (s, 9H), 1.32 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 153.5, 
142.9, 142.4, 129.0, 128.7, 128.6, 128.4, 126.6, 126.4, 83.7, 82.8, 65.6, 60.2, 59.3, 58.8, 58.8, 
58.2, 58.1, 56.3, 34.2, 32.2, 27.9, 27.6, 21.7, 17.1; IR (neat) 2978, 2934, 1743, 1495, 1453, 1370, 
1279, 1256, 1163, 1097, 859, 746, 704 cm-1; HRMS (ESI): m/z calcd for C31H42O6Na [M+Na]+ 
533.2879, found 533.2866; [α]D = +19.1 (CHCl3, c 1.08). 
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(S)-4-((R)-Tetrahydro-5-methoxyfuran-2-yl)-1,3-dioxolan-2-one (1.68) 
To tert-butyl carbonate 1.47 (92.0 mg, 0.223 mmol) in 
dichloroethane/toluene (8.6 mL, 5:1, v/v) in borosilicate flask at room 
temperature were added the activated 4Å molecular sieves (184 mg), anhydrous Na2S2O3 (184 
mg), NaOAc (184 mg) and N-methylquinolinium hexafluorophosphate (6.4 mg, 22.3 μmol). The 
mixture was photoirradiated with gentle air bubbling for 3 h while stirring at room temperature. 
The reaction mixture was filtered through a small plug of silica gel and the residue was washed 
with Et2O (40 mL). The filtrate was concentrated and the resulting residue was purified by flash 
chromatography (45% - 55% EtOAc in hexanes) to give the product  1.68 (24.8 mg, 59.0%) in a 
1.9:1 ratio as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 5.04 (dd, J = 4.5, 1.8 Hz, 66% of 
1H), 5.01-4.99 (m, 34% of 1H), 4.67-4.46 (m, 2.4H), 4.39-4.20 (m, 1.6H), 3.33/3.32 (s, 3H), 
2.26-1.93 (m, 3H), 1.74-1.66 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 155.1 (minor), 154.9 
(major), 105.7 (minor), 105.6 (major), 79.4 (minor), 77.8 (minor), 77.1 (major), 66.8 (major), 
66.4 (minor), 55.1 (major), 32.7 (minor), 31.7 (major), 25.9 (minor), 25.5 (major); IR (neat) 
2920, 1807, 1464, 1376, 1170, 1088, 1031, 955 cm-1; HRMS (EI): m/z calcd for C7H9O4 (M-
CH3O)+• 157.0501, found 157.0499. 
O O
O
MeO O
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(S)-4-((R)-Tetrahydro-5-oxofuran-2-yl)-1,3-dioxolan-2-one (1.69) 
At 0 °C, the acetal 1.68 (6.4 mg, 34.0 μmol) in acetone (1.0 mL) was 
treated with Jones reagent (2.67M, 60 μL, 0.160 mmol). The mixture was 
stirred at 0 °C for 1 h, and Jones reagent (2.67M, 60 μL, 0.160 mmol) was added. The mixture 
was stirred at 0 °C fro 30 min, then at room temperature for 2 h. After that time, the mixture was 
purified by column chromatography (10% - 20% EtOAc in CH2Cl2) to give the lactone 1.69 (4.3 
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mg, 74.1%) as a pale yellow solid: 1H NMR (300 MHz, CDCl3) δ 4.74 (ddd, J = 8.0, 6.7, 5.8 Hz, 
1H), 4.64 (t, J = 8.9 Hz, 1H), 4.65-4.58 (m, 1H), 4.40 (dd, J = 8.9, 5.6 Hz, 1H), 2.68-2.62 (m, 
2H), 2.60-2.50 (m, 1H), 2.20-2.10 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 175.2, 154.0, 78.1, 
76.2, 66.7, 27.5, 24.0; IR (neat) 2919, 1778, 1462, 1401, 1328, 1173, 1087, 1048 cm-1; HRMS 
(EI): m/z calcd for C7H8O5 [M+H]+ 173.0450, found 173.0455. 
 
To monoepoxide 1.48 (102.0 mg, 0.239 mmol) in dichloroethane/toluene (9.2 mL, 5:1, v/v) in 
borosilicate flask at room temperature were added the activated 4Å molecular sieves (204 mg), 
anhydrous Na2S2O3 (204 mg), NaOAc (204 mg) and N-methylquinolinium hexafluorophosphate 
(6.9 mg, 23.9 μmol). The mixture was photoirradiated with gentle air bubbling for 3 h while 
stirring at room temperature. The reaction mixture was filtered through a small plug of silica gel 
and the residue was washed with Et2O (50 mL). The filtrate was concentrated and the resulting 
yellowish-green residue was dissolved in CH2Cl2 (2.0 mL). To this solution were added Et3N 
(0.22 mL, 1.6 mmol), Ac2O (57 μL, 0.6 mmol) and DMAP (2.4 mg, 20 μmol) sequentially. The 
mixture was stirred at room temperature for 3 h, then concentrated and purified by column 
chromatography (20% - 50% EtOAc in hexanes) to provide the cyclization products, which were 
further purified by column chromatography (4% - 10% EtOAc in CH2Cl2) to give exo-product 
1.71 (14.6 mg, 30%, dr = 2:1) and endo-product 1.72 (10.6 mg, 22%, dr = 3.4:1) as colorless oils. 
 
(S)-4-((R)-Tetrahydro-6-methoxy-2H-pyran-2-yl)-1,3-dioxolan-2-one (1.71) 
1H NMR (300 MHz, CDCl3) δ 4.74 (app d, J = 2.5 Hz, 67% of 1H), 
4.62-4.45 (m, 3H), 4.37 (dd, J = 9.3, 2.2 Hz, 33% of 1H), 3.96 (ddd, J 
= 11.8, 4.4, 1.9 Hz, 67% of 1H), 3.66 (ddd, J = 11.2, 5.6, 2.2 Hz, 33% of 1H), 3.46 (s, 33% of 
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3H), 3.36 (s, 67% of 3H), 1.98-1.16 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 155.1 (major), 155.0 
(minor), 103.4 (minor), 98.4 (major), 78.0 (major), 77.4 (minor), 75.3 (minor), 68.2 (major), 66.4 
(minor), 66.1 (major), 56.4 (minor), 55.0 (major), 30.9 (minor), 29.5 (major), 26.6 (minor), 26.5 
(major), 21.2 (minor), 17.2 (major); IR (neat) 2952, 2851, 1799, 1389, 1174, 1078, 1031 cm-1; 
HRMS (EI): m/z calcd for C8H11O4 (M+•) 171.0657, found 171.0650. 
 
(4aR,9aS)-Hexahydro-6-methoxy-4H-[1,3]dioxino[5,4-b]oxepin-2-one (1.72) 
1H NMR (300 MHz, CDCl3) δ 4.74 (t, J = 4.2 Hz, 23% of 1H), 4.66 (dd, J 
= 8.6, 5.7 Hz, 77% of 1H), 4.42 (dd, J = 10.6, 5.8 Hz, 23% of 1H), 4.36-
4.29 (m, 77% of 1H), 4.22-4.06 (m, 2.8H), 3.79 (dt, J = 9.7, 5.8 Hz, 23% 
of 1H), 3.42 (s, 23% of 3H), 3.36 (s, 77% of 3H), 2.37-2.14 (m, 3H), 1.96-1.93 (m, 23% of 1H), 
1.77-1.42 (m, 5H); 13C NMR (75 MHz, CDCl3) δ 148.5 (minor), 148.1 (major), 104.9 (minor), 
102.8 (major), 81.2 (minor), 80.8 (major), 69.3 (major), 69.2 (minor), 68.2 (minor), 61.5 (major), 
56.4 (minor), 55.8 (major), 35.5 (major), 34.2 (major), 33.5 (minor), 27.9 (minor), 17.7 (major), 
16.6 (minor); IR (neat) 2943, 1760, 1403, 1382, 1224, 1140, 1057 cm-1; HRMS (EI): m/z calcd 
for C8H11O4 (M+•) 171.0657, found 171.0651; an analytical sample of the major diastereomer 
was obtained through purifying the above mixture by column chromatography (35% - 45% 
EtOAc in hexanes): 1H NMR (300 MHz, C6D6) δ 4.02 (dd, J = 8.9, 5.8 Hz, 1H), 3.60 (dd, J = 
10.1, 5.5 Hz, 1H), 3.42 (t, J = 10.2 Hz, 1H), 3.34-3.27 (m, 2H), 2.85 (s, 3H), 1.76-1.67 (m, 1H), 
1.57-1.47 (m, 1H), 1.10 (dddd, J = 15.3, 11.6, 8.9, 1.0 Hz, 1H),  0.95-0.85 (m, 2H), 0.82-0.71 
(m, 1H).  
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(R)-Tetrahydro-6-((S)-2-oxo-1,3-dioxolan-4-yl)pyran-2-one (1.73) 
A solution of acetal 1.71 (6.0 mg, 29.7 μmol) in CH2Cl2 (0.6 mL) at 0 °C 
was treated with mCPBA (pure, 6.7 mg, 38.6 μmol) and BF3•OEt2 (4.5 
μL, 35.6 μmol) sequentially. After stirred at 0 °C for 10 min and then at room temperature for 
1.5 h, the mixture was cooled to 0 °C and Et3N (20.7 μL, 148 μmol) was added dropwise. The 
mixture was stirred at 0 °C for 1 h, then concentrated, and the resulting residue was purified by 
column chromatography (15% - 25% EtOAc in CH2Cl2) to give the desired lactone 1.73 (4.6 mg, 
83.6%) as a colorless liquid: 1H NMR (300 MHz, CDCl3) δ 4.69-4.59 (m, 2H), 4.56-4.41 (m, 
2H), 2.69 (dddd, J = 18.0, 6.8, 4.8, 1.1 Hz, 1H), 2.54 (ddd, J = 17.9, 9.3, 7.0 Hz, 1H), 2.24-2.16 
(m, 1H), 2.08-1.90 (m, 2H), 1.64 (dtd, J = 13.8, 11.0, 5.2 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 
169.3, 154.2, 79.0, 76.3, 66.9, 29.8, 24.6, 18.2; IR (neat) 2919, 1790, 1732, 1376, 1239, 1166, 
1056 cm-1; HRMS (EI): m/z calcd for C8H10O5 (M+•) 186.0528, found 186.0536. 
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4-(Tetrahydro-5-methoxy-2-methylfuran-2-yl)-1,3-dioxolan-2-one (1.76), Hexahydro-6-
methoxy-8a-methylpyrano[3,2-d][1,3]dioxin-2-one (1.77) and (4aR,6S,8aR)-Hexahydro-6-
methoxy-8a-methylpyrano[3,2-d][1,3]dioxin-2-one (1.78) 
To tert-
butyl 
carbonate 1.49 (125.2 mg, 0.294 mmol) in dichloroethane/toluene (11.3 mL, 5:1, v/v) in 
borosilicate flask at room temperature were added the activated 4Å molecular sieves (250 mg), 
anhydrous Na2S2O3 (250 mg), NaOAc (250 mg) and N-methylquinolinium hexafluorophosphate 
(8.5 mg, 29.4 μmol). The mixture was photoirradiated with gentle air bubbling for 2.5 h while 
stirring at room temperature. The reaction mixture was filtered through a small plug of silica gel 
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and the residue was washed with EtOAc (30 mL). The filtrate was concentrated and the resulting 
residue was purified by flash chromatography (30% - 45% EtOAc in hexanes) to provide a 
mixture of 1.76 and 1.77 (19.7 mg, 33.2%, a pale yellow oil) with a molar ratio of 4.8:1 and cis-
fused endo-product 1.78 (3.8 mg, 8.0%) as a white solid. For the mixture of 1.76 and 1.77: IR 
(neat) 2928, 2835, 1791, 1755, 1463, 1375, 1170, 1084, 1034, 951 cm-1. For cis-fused endo-
product 1.78: 1H NMR (300 MHz, CDCl3) δ 4.78 (app d, J = 2.0 Hz, 1H), 4.66 (dd, J = 12.1, 2.7 
Hz, 1H), 4.34 (dd, J =12.1, 0.4 Hz, 1H), 3.86 (app d, J = 2.0 Hz, 1H), 3.41 (s, 3H), 2.12-2.00 (m, 
1H), 1.94 (dd, J = 12.8, 4.0 Hz, 1H), 1.87-1.81 (m, 1H), 1.67-1.61 (m, 1H), 1.45 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 148.5, 98.3, 78.6, 69.3, 63.2, 55.4, 29.4, 25.3, 25.1; IR (neat) 2932, 
1748, 1212, 1178, 1130, 1060, 1024 cm-1; HRMS (EI): m/z calcd for C9H15O5 [M+H]+ 203.0919, 
found 203.0929. 
 
(S)-4-((R)-Tetrahydro-2-methyl-5-oxofuran-2-yl)-1,3-dioxolan-2-one (1.79) 
To a solution of the mixture of 1.76 and 1.77 (18.9 mg, 93.5 μmol) in 
acetone (3.0 mL) at 0 °C was added Jones reagent (0.3 mL). The mixture 
was stirred at 0 °C for 15 min and then at room temperature for 3 h. After that time, the reaction 
was quenched with isopropyl alcohol (1 drop), concentrated and purified by column 
chromatography (2% - 20% EtOAc in CH2Cl2) to give the unreacted acetal 1.77 (2.9 mg, 15.3%) 
as a white solid and the  title lactone 1.79 (11.0 mg, ~74.8% based on unreacted acetal): 1H NMR 
(300 MHz, CDCl3) δ 4.72 (dd, J = 8.4, 6.2 Hz, 1H), 4.57 (t, J = 9.0 Hz, 1H), 4.36 (dd, J = 9.2, 
6.1 Hz, 1H), 2.70 (t. J = 8.8 Hz, 2H), 2.34-2.24 (m, 1H), 2.19-2.09 (m, 1H), 1.47 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 175.0, 154.1, 83.9, 78.7, 65.4, 30.0, 28.2, 20.8; IR (neat) 2920, 1789, 
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1463, 1267, 1167, 1082 cm-1; HRMS (EI): m/z calcd for C8H11O5 [M+H]+ 187.0606, found 
187.0612. 
 
(4aR,6S,8aS)-Hexahydro-6-meth
δ 4.75-4.71 (app d, J = 2.4 Hz, 1H), 4.37 (dd, 
aR,9aS)-Hexahydro-6-methoxy-9a-methyl-4H-[1,3]dioxino[5,4-b]oxepin-2-one (1.81) 
in 
anhydrous Na2S2O3 (1
oxy-8a-methylpyrano[3,2-d][1,3]dioxin-2-one (1.77) 
1H NMR (300 MHz, CDCl3) 
J = 8.0, 4.4 Hz, 1H), 4.18 (d, J = 8.2 Hz, 1H), 4.16 (d, J = 4.7 Hz, 1H), 
3.38 (s, 3H), 2.13-2.04 (m, 1H), 1.95-1.76 (m, 3H), 1.50 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
148.1, 98.3, 77.5, 67.0, 62.7, 55.3, 31.1, 27.8, 17.5; IR (neat) 2917, 1757, 1464, 1196, 1111, 
1068 cm-1; HRMS (EI): m/z calcd for C9H15O5 [M+H]+ 203.0919, found 203.0930. 
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To tert-butyl carbonate 1.50 (65.8 mg, 149 μmol) 
dichloroethane/toluene (5.7 mL, 5:1, v/v) in borosilicate flask at room 
temperature were added the activated 4Å molecular sieves (132 mg), 
32 mg), NaOAc (132 mg) and N-methylquinolinium hexafluorophosphate 
(4.3 mg, 14.9 μmol). The mixture was photoirradiated with gentle air bubbling for 2 h while 
stirring at room temperature. The reaction mixture was filtered through a small plug of silica gel 
and the residue was washed with EtOAc (20 mL). The filtrate was concentrated and the resulting 
residue was purified by flash chromatography (5% - 15% EtOAc in CH2Cl2) to provide the 
desired compound 1.81 (23.7 mg, 73.4%) as a mixture of two diastereomers in a 1.2:1 ratio: 1H 
NMR (300 MHz, CDCl3) δ 4.76 (t, J = 3.8 Hz, 46% of 1H), 4.66 (dd, J = 8.8, 5.8 Hz, 54% of 
1H), 4.34 (dd, J = 10.8, 6.4 Hz, 46% of 1H), 4.29-4.18 (m, 54% of 2H), 4.19 (t, J = 10.8 Hz, 
46% of 1H ), 3.88 (dd, J = 10.6, 6.4 Hz, 46% of 1H), 3.42 (s, 46% of 3H), 3.35 (s, 54% of 3H), 
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2.23-2.01 (m, ~1.5H), 1.96-1.92 (m, 46% of 1H), 1.75-1.58 (m, ~3.5H), 1.51 (s, 46% of 3H), 
1.48 (s, 54% of 3H), 1.45-1.35 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 148.2, 148.0, 104.3, 
102.8, 84.2, 83.0, 68.1, 66. 7, 66.3, 62.7, 56.3, 55.7, 43.2, 41.6, 34.5, 34.4, 19.5, 19.3, 18.3, 16.7; 
IR (neat) 2941, 1755, 1464, 1384, 1252, 1199, 1128, 1091, 1050, 969 cm-1; HRMS (EI): m/z 
calcd for C9H13O4Na (M-CH3O)+• 185.0814, found 185.0811. An analytical sample of the 
slightly major diastereomer was obtained through purifying the  above mixture by column 
chromatography (35% - 40% EtOAc in hexanes): 1H NMR (300 MHz, C6D6) δ 4.00 (dd, J = 8.8, 
5.9 Hz, 1H), 3.60 (d, J = 10.4 Hz, 1H), 3.58 (d, J = 6.8 Hz, 1H), 3.44 (dd, J = 10.4, 6.8 Hz, 1H), 
2.85 (s, 3H), 1.56-1.48 (m, 2H), 1.19-1.10 (m, 2H), 0.98-0.88 (m, 1H), 0.94 (s, 3H), 0.75-0.66 (m, 
1H). 
 
(S)-4-((2R,5S)-Tetrahydro-5-((R)-tetrahydro-5-methoxy-2-methylfuran-2-yl)-2-
oxy-5a,11a-
de 1.51 (129.1 mg, 
e
O
methylfuran-2-yl)-1,3-dioxolan-2-one (1.85) and (4aR,5aS,9aR,11aS)-8-Meth
dimethyldecahydro-1,3,5,9-tetraoxadibenzo[a,d]cyclohepten-2-one (1.86) 
To diepoxi
0.253 mmol) in 
dichloroethane/toluene (9.7 
d the activated 4Å molecular 
sieves (258 mg), anhydrous Na2S2O3 (258 mg), NaOAc (258 mg) and N-methylquinolinium 
hexafluorophosphate (7.3 mg, 25.3 μmol). The mixture was photoirradiated with gentle air 
bubbling for 4.5 h while stirring at room temperature. The reaction mixture was filtered through 
a small plug of silica gel and the residue was washed with EtOAc (40 mL). The filtrate was 
concentrated and the resulting residue was purified by flash chromatography (35% - 50% EtOAc 
mL, 5:1, v/v) in borosilicate flask at room temperature were add
O
O
OHH
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O
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in hexanes) to provide a mixture of the above two products (28.7 mg, 39.6%) as a colorless oil: 
IR (neat) 2926, 1796, 1754, 1460, 1374, 1166, 1085, 1036, 1006, 952 cm-1.  
 
(S)-4-((2R,5S)-Tetrahydro-5-((R)-tetrahydro-2-methyl-5-oxofuran-2-yl)-2-methylfuran-2-
ixture of acetals 1.85 and 1.86 (20.8 mg, 72.6 μmol) in 
ti
aR,5aS,9aR,11aS)-5a,11a-Dimethyloctahydro-1,3,5,9-tetraoxadibenzo[a,d]cycloheptene-
A solution of acetal 1.86 (2.9 mg, 11.2 μmol) in CH2Cl2 (0.5 mL) at 0 
e
O
yl)-1,3-dioxolan-2-one (A33) 
A mO
acetone (2.1 mL) at 0 °C was treated dropwise with Jones reagent 
rred at 0 °C for 10 min, then at room temperature for 1.5 h and 
purified without workup by column chromatography (50% - 90% EtOAc in hexanes) to give the 
unreacted acetal 1.86 (3.2 mg, 15.4%, nearly pure) and lactone A33 (13.8 mg, ~80%). For 
lactone A33: 1H NMR (300 MHz, CDCl3) δ 4.60 (dd, J = 8.4, 6.2 Hz, 1H), 4.50 (t, J = 8.6 Hz, 
1H), 4.38 (dd, J = 8.7, 6.2 Hz, 1H), 4.08 (dd, J = 8.6, 6.3 Hz, 1H), 2.64-2.58 (m, 2H), 2.31-2.19 
(m, 1H), 2.10-2.04 (m, 2H), 1.94-1.73 (m, 3H), 1.39 (s, 3H), 1.27 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 176.7, 155.1, 86.9, 83.5, 83.2, 79.5, 66.0, 34.1, 29.3, 29.2, 26.7, 23.8, 21.0; IR (neat) 
2958, 2924, 2853, 1790, 1770, 1456, 1382, 1248, 1166, 1085, 1020, 944, 770, 728 cm-1; HRMS 
(EI): m/z calcd for C13H18O6 (M+•) 270.1103, found 270.1094; [α]D = +4.5 (CHCl3, c 0.24). 
 
(0.2 mL). The mixture was s
(4
2,8-dione (A34) 
°C was treated with mCPBA (pure, 2.5 mg, 14.6 μmol) and BF3•OEt2 
(1.9 μL, 13.4 μmol) sequentially. After stirred at 0 °C for 10 min and 
 for 30 min, the mixture was cooled to 0 °C and Et3N (7.8 μL, 56.0 then at room temperatur
O OHH
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μmol) was added dropwise. The mixture was stirred at 0 °C for 30 min, and purified by column 
chromatography (10% - 20% EtOAc in CH2Cl2) to give the desired lactone A34 (1.8 mg, 66.7%) 
as colorless needles: 1H NMR (300 MHz, CDCl3) δ 4.28 (dd, J = 8.6, 5.1 Hz, 1H), 4.21-4.14 (m, 
1H), 4.09 (dd, J = 10.1, 8.6 Hz, 1H), 4.06 (dd, J = 11.0, 2.9 Hz, 1H), 2.80 (ddd, J = 18.3, 9.4, 5.5 
Hz, 1H), 2.64 (ddd, J = 18.3, 8.7, 7.4 Hz, 1H), 2.35-2.28 (m, 1H), 2.17-1.88 (m, 5H), 1.50 (s, 
3H), 1.38 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 170.4, 148.2, 83.1, 82.7, 77.4, 75.7, 66.5, 65.2, 
37.2, 34.3, 27.5, 24.8, 22.4, 16.0; IR (neat) 2923, 1747, 1463, 1408, 1229, 1124, 1068 cm-1; 1H 
NMR (300 MHz, C6D6) δ 3.44 (d, J = 7.7 Hz, 1H), 3.43 (d, J = 9.6 Hz, 1H), 3.18 (dd, J = 9.6, 7.7 
Hz, 1H), 2.93 (dd, J = 10.9, 3.0 Hz, 1H), 2.02-1.97 (m, 2H), 1.65 (td, J = 15.3, 4.8 Hz, 1H), 1.43-
1.26 (m, 3H), 1.17-1.04 (m, 2H), 0.81 (s, 3H), 0.48 (s, 3H); HRMS (ESI): m/z calcd for 
C13H18O6Na [M+Na]+ 293.1001, found 293.1020; [α]D = +101 (CHCl3, c 0.15). 
 
(R)-4-((2S,5S)-tetrahydro-5-((R)-tetrahydro-5-methoxy-2-methylfuran-2-yl)-2-
hoxy-5a,11a-
de 1.52 (150 mg, 
d
O
methylfuran-2-yl)-1,3-dioxolan-2-one (1.87) and (4aS,5aS,9aR,11aR)-8-Met
dimethyldecahydro-1,3,5,9-tetraoxadibenzo[a,d]cyclohepten-2-one (1.88) 
To diepoxi
0.294 mmol) in 
dichloroethane/toluene (11.3 
ed the activated 4Å molecular 
sieves (300 mg), anhydrous Na2S2O3 (300 mg), NaOAc (300 mg) and N-methylquinolinium 
hexafluorophosphate (8.5 mg, 29.4 μmol). The mixture was photoirradiated with gentle air 
bubbling for 4.5 h while stirring at room temperature. The reaction mixture was filtered through 
a small plug of silica gel and the residue was washed with EtOAc (40 mL). The filtrate was 
mL, 5:1, v/v) in borosilicate flask at room temperature were ad
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concentrated and the resulting residue was purified by flash chromatography (35% - 50% EtOAc 
in hexanes) to provide a mixture of the above two products (51.2 mg, 60.9%): IR (neat) 2925, 
1797, 1750, 1462, 1384, 1259, 1167, 1120 cm-1.  
 
(R)-4-((2S,5S)-tetrahydro-5-((R)-tetrahydro-2-methyl-5-oxofuran-2-yl)-2-methylfuran-2-
ixture of acetals 1.87 and 1.88 (34.9 mg, 122 μmol) in 
t
aS,5aS,9aR,11aR)-5a,11a-Dimethyloctahydro-1,3,5,9-tetraoxadibenzo[a,d]cycloheptene-
A solution of acetal 1.88 (4.5 mg, 15.7 μmol) in CH2Cl2 (0.5 mL) at 0 
O
yl)-1,3-dioxolan-2-one (A35) 
A mO
acetone (1.8 mL) at 0 °C was treated dropwise with Jones reagent 
irred at 0 °C for10 min, then at room temperature for 1.5 h and 
purified without workup by column chromatography (50% - 90% EtOAc in hexanes) to give the 
unreacted acetal 1.88 (4.9 mg, nearly pure) and lactone A35 (22.1 mg, ~81%). For lactone A35: 
1H NMR (300 MHz, CDCl3) δ 4.58 (dd, J = 8.3, 6.1 Hz, 1H), 4.48 (t, J = 8.4 Hz, 1H), 4.32 (dd, J 
= 8.8, 6.1 Hz, 1H), 4.08 (dd, J = 8.8, 5.6 Hz, 1H), 2.65-2.59 (m, 2H), 2.24 (ddd, J = 12.9, 9.6, 6.9 
Hz, 1H), 2.07-1.81 (m, 5H), 1.38 (s, 3H), 1.27 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 176.7, 
155.0, 86.9, 85.1, 83.1, 80.3, 66.2, 34.5, 29.4, 29.1, 27.0, 23.4, 21.3; IR (neat) 2979, 2880, 1790, 
1767, 1454, 1382, 1170, 1111, 1085, 944 cm-1; HRMS (EI): m/z calcd for C13H18O6 (M+•) 
270.1103, found 270.1095; [α]D = -11.3 (CHCl3, c 1.03). 
 
(0.3 mL). The mixture was s
(4
2,8-dione (A36) 
°C was treated with mCPBA (pure, 3.5 mg, 20.4 μmol) and BF3•OEt2 
(2.7 μL, 18.8 μmol) sequentially. After stirred at 0 °C for 10 min and 
O OHH
OO
OO
O
O
O
O
H
H
 119 
at room temperature for 20 min, the mixture was cooled to 0 °C and Et3N (10.9 μL, 78.5 μmol) 
was added dropwise. The mixture was stirred at 0 °C for 30 min and purified by column 
chromatography (15% - 25% EtOAc in CH2Cl2) to give the desired lactone A36 (3.0 mg, 71.4%) 
as colorless needles: 1H NMR (300 MHz, CDCl3) δ 4.40 (app dd, J = 10.0, 2.2 Hz, 1H), 4.23 (dd, 
J = 10.5, 6.1 Hz, 1H), 4.09 (t, J = 10.2, Hz, 1H), 4.00 (dd, J = 10.1, 6.1 Hz, 1H), 2.88 (ddd, J = 
18.3, 11.2, 4.7 Hz, 1H), 2.72 (ddd, J = 18.3, 9.6, 5.5 Hz, 1H); 2.21-1.76 (m, 6H), 1.49 (s, 3H), 
1.24 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 170.7, 147.4, 83.8, 81.4, 77.4, 66.6, 64.9, 39.1, 30.8, 
28.1, 24.4, 20.5, 19.5; IR (neat) 2924, 1748, 1463, 1408, 1229, 1124, 1068 cm-1; HRMS (ESI): 
m/z calcd for C13H18O6Na [M+Na]+ 293.1001, found 293.0988; [α]D = +48.7 (CHCl3, c 0.23). 
 
(4aR,5aS,10aR,12aS)-9-Methoxy-5a,12a-dimethyldecahydro-1,3,5,10-tetraoxabenzo[b]-
To diepoxide 1.53 (145 mg, 276 μmol) in dichloroethane/toluene 
Na2S2O3 (290 mg), NaOAc (
heptalen-2-one (1.91) 
(10.6 mL, 5:1, v/v) in borosilicate flask at room temperature were 
added the activated 4Å molecular sieves (290 mg), anhydrous 
290 mg) and N-methylquinolinium hexafluorophosphate (8.0 mg, 
27.6 μmol). The mixture was photoirradiated with gentle air bubbling for 2 h while stirring at 
room temperature. The reaction mixture was filtered through a small plug of silica gel and the 
residue was washed with EtOAc (40 mL). The filtrate was concentrated and the resulting residue 
was purified by flash chromatography (25% - 35% EtOAc in hexanes) to provide the product 
1.91 (44.8 mg, 54.0%, pale yellow liquid) as two diastereomers in about 1:1 ratio: 1H NMR (300 
MHz, CDCl3) δ 4.54-4.48 (m, 1H), 4.25-3.98 (m, 3H), 3.92-3.85 (m, 0.5H), 3.56 (dd, J = 11.2, 
2.4 Hz, 0.5H), 3.40/3.37 (s, 3H), 3.24 (dd, J = 10.8, 3.8 Hz, 0.5H), 2.26-1.94 (m, 2.5H), 1.91-
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1.72 (m, 3.5H), 1.65-1.52 (m, 3.5H), 1.47/1.44 (s, 3H), 1.33/1.29 (s, 3H), 1.21-1.18 (m, 0.5H); 
13C NMR (75 MHz, CDCl3) δ 149.0, 148.6, 105.2, 102.6, 83.3, 83.2, 81.4, 80.3, 79.7, 75.6, 67.0, 
67.0, 65.2, 63.8, 56.1, 55.9, 44.6, 43.3, 37.5, 37.0, 35.3, 33.6, 27.6, 26.2, 22.3, 21.6, 19.2, 17.7, 
17.0, 16.7; IR (neat) 2940, 1759, 1454, 1384, 1209, 1111, 1053, 1008, 921 cm-1; HRMS (ESI): 
m/z calcd for C15H24O6Na [M+Na]+ 323.1471, found 323.1500; [α]D = +31.5 (CHCl3, c 1.45). 
 
(4aR,5aS,10aR,12aS)-5a,12a-Dimethyldecahydro-1,3,5,10-tetraoxabenzo[b]heptalene-2,9-
A solution of acetal 1.91 (15.6 mg, 51.9 μmol) in CH2Cl2 (0.5 mL) at 
min, then at room temper
(CHCl3, c 0.42). 
dione (1.92) 
0 °C was treated with mCPBA (pure, 11.6 mg, 67.5 μmol) and 
BF3•OEt2 (7.2 μL, 57.1 μmol) sequentially. After stirred at 0 °C for 10 
ature for 1 h, the mixture was cooled to 0 °C and Et3N (36.2 μL, 256 
μmol) was added dropwise. The mixture was stirred at 0 °C for 1.5 h, the quenched with a 
mixture of saturated NaHCO3/saturated Na2S2O3 (4 mL, 1:1, v/v). The mixture was poured onto 
water (5 mL) and extracted with Et2O (3 x 25 mL). The extracts were dried over MgSO4, filtered 
and concentrated, and the resulting residue was purified by column chromatography (10% - 20% 
EtOAc in CH2Cl2) to give the desired lactone 1.92 (9.9 mg, 66.9%) as a white crystalline solid: 
1H NMR (300 MHz, CDCl3) δ 4.26-4.20 (m, 2H), 4.14-4.06 (m, 2H), 2.70-2.55 (m, 2H), 2.35-
2.23 (m, 2H), 1.99-1.81 (m, 4H), 1.77-1.68 (m, 2H), 1.46 (s, 3H), 1.31 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 173.3, 148.6, 84.3, 82.2, 78.9, 66.8, 64.3, 43.2, 36.2, 33.6, 26.6, 22.0, 20.0, 15.8; 
IR (neat) 2989, 2941, 2871, 1748, 1727, 1501, 1454, 1365, 1328, 1272, 1212, 1098, 1040 cm-1; 
HRMS (ESI): m/z calcd for C14H20O6Na [M+Na]+ 307.1158, found 307.1158. [α]D = +50.4 
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 (4aS,5aS,10aR,12aR)-9-Methoxy-5a,12a-dimethyldecahydro-1,3,5,10-tetraoxabenzo[b]-
eptalen-2-one (1.93) 
ene 
(3.5 mL, 5:1, v/v) in borosilicate flask at room temperature were 
9
μmol). The mixture was phot
O
h
To diepoxide 1.54 (48.2 mg, 91.9 μmol) in dichloroethane/tolu
added the activated 4Å molecular sieves (96 mg), anhydrous 
6 mg) and N-methylquinolinium hexafluorophosphate (2.6 mg, 9.2 
oirradiated with gentle air bubbling for 3 h while stirring at room 
temperature. The reaction mixture was filtered through a small plug of silica gel and the residue 
was washed with EtOAc (30 mL). The filtrate was concentrated and the resulting residue was 
purified by flash chromatography (25% - 35% EtOAc in hexanes) to provide the product 1.93 
(21.7 mg, 78.6%, pale yellow solid) as two diastereomers in about 1:1 ratio: 1H NMR (300 MHz, 
CDCl3) δ 4.69 (dd, J = 3.8, 2.2 Hz, 0.5H), 4.54 (dd, J = 8.9, 5.7 Hz, 0.5H), 4.17 (dd, J = 10.7, 6.6 
Hz, 1H), 4.02 (t, J = 10.7 Hz, 1H), 3.90 (dd, J = 10.7, 6.6 Hz, 1H), 3.90-3.85 (m, 0.5H), 3.52 (dd, 
J = 10.1, 0.8 Hz, 0.5H), 3.40/3.37 (s, 3H), 2.08-2.00 (m, 2H), 1.89-1.53 (m, 8H), 1.44 (s, 3H), 
1.21/1.17 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 151.6, 148.0, 102.7, 102.4, 83.6, 83.6, 81.3, 
80.6, 78.8, 74.1, 67.0 (2C), 64.0, 63.9, 56.0, 55.8, 40.5, 40.2, 39.8, 39.5, 33.7, 33.4, 27.3 (2C), 
20.8, 20.3, 19.4, 19.3, 19.3, 17.5; IR (neat) 2940, 1755, 1461, 1382, 1246, 1223, 1116, 1051, 913 
cm-1; HRMS (ESI): m/z calcd for C15H24O6Na [M+Na]+ 323.1471, found 323.1462; [α]D = +26.6 
(CHCl3, c 0.55). 
 
 
Na2S2O3 (96 mg), NaOAc (
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(4aS,5aS,10aR,12aR)-5a,12a-Dimethyldecahydro-1,3,5,10-tetraoxabenzo[b]heptalene-2,9-
ione (1.94) 
at 
0 °C was treated with mCPBA (pure, 14.2 mg, 82.2 μmol) and 
 
0 °C and Et3N (44.0 μL, 3
d
A solution of acetal 1.93 (19.0 mg, 63.2 μmol) in CH2Cl2 (2.0 mL) 
BF3•OEt2 (9.5 μL, 75.8 μmol) sequentially. The mixture was stirred at 
at room temperature for 1 h. After that time, the mixture was cooled to 
16 μmol) was added dropwise. The mixture was stirred at 0 °C for 30 
min, then concentrated, and the resulting residue was purified by column chromatography (15% - 
25% EtOAc in CH2Cl2) to give the desired lactone 1.94 (14.4 mg, 80.0%) as a white solid: 1H 
NMR (600 MHz, CDCl3) δ 4.47 (dd, J = 10.4 Hz, 1H), 4.20 (dd, J = 10.7, 6.4 Hz, 1H), 4.05 (t, J 
= 10.7 Hz, 1H), 3.98 (dd, J = 10.5, 6.4 Hz, 1H), 2.70 (dt, J = 14.1, 2.2 Hz, 1H), 2.64 (ddd, J = 
14.1, 5.8, 1.3 Hz, 1H), 2.12 (ddd, J = 13.6, 5.9, 2.0 Hz, 1H), 2.07-1.98 (m, 3H), 1.90 (dddd, J = 
14.7, 5.8, 2.6, 1.0 Hz, 1H), 1.84 (app dt, J = 13.6, 1.7 Hz, 1H), 1.78-1.70 (m, 2H), 1.48 (s, 3H), 
1.14 (s, 3H); 13C NMR (151 MHz, CDCl3) δ 173.4, 147.8, 83.6, 82.7, 79.0, 66.8, 64.6, 39.3, 
38.3, 33.4, 26.4, 20.4, 19.14, 19.10; IR (neat) 2984, 2941, 1747, 1732, 1444, 1388, 1274, 1252, 
1200, 1116, 1100, 1070, 1049 cm-1; HRMS (EI): m/z calcd for C14H20O6 (M+•) 284.1260, found 
284.1254; [α]D = +17.2 (CHCl3, c 0.52). 
Key NOESY enhancements observed in lactone 1.94:  
0 °C for 10 min, and then
O
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(S)-4-((2R,5S)-tetrahydro-5-((R)-tetrahydro-6-methoxy-2H-pyran-2-yl)-2-methylfuran-2-
yl)-1,3-dioxolan-2-one (1.97) and (4aR,5aS,10aR,12aS)-9-Methoxy-12a-methyldecahydro-
1,3,5,10-tetraoxabenzo[b]heptalen-2-one (1.98) 
To diepoxide .55 (52.8 mg, 
103 μmol) in 
.0 
 NaOAc (106 mg) and N-methylquinolinium 
 
bubbling for 4 h while stirring at room temperature. The reaction
small plug of silica gel and the residue was washed with EtO
O
1
dichloroethane/toluene (4
mL, 5:1, v/v) in borosilicate flask at room temperature were added the activated 4Å molecular 
sieves (106 mg), anhydrous Na2S2O3 (106 mg,),
hexafluorophosphate (3.0 mg, 10.3 μmol). The mixture was photoirradiated with gentle air 
 mixture was filtered through a 
Ac (20 mL). The filtrate was 
concentrated and the resulting residue was purified by flash chromatography (5% - 20% EtOAc 
in CH2Cl2) to provide the exo, exo-product 1.97 (7.3 mg, 24.7%) as a white solid and endo, endo-
product 1.98 (8.8 mg, 29.7%) as a colorless oil. For exo, exo-product 1.97 (dr = 2:1): 1H NMR 
(600 MHz, CDCl3) δ 4.71 (br s, 67% of 1H), 4.61-4.56 (m, 1H), 4.54-4.50 (m, 1H), 4.44-4.41 (m, 
1H), 4.32 (dd, J = 9.5, 2.0 Hz, 33% of 1H), 4.02 (dd, J = 7.1, 4.9 Hz, 33% of 1H), 3.98 (dd, J = 
7.4, 4.4 Hz, 67% of 1H), 3.72 (ddd, J = 11.6, 4.2, 2.0 Hz, 67% of 1H), 3.48 (s, 33% of 3H), 3.40 
(ddd, J = 11.3, 4.7, 1.9 Hz, 33% of 1H), 3.33 (s, 67% of 3H), 2.05-1.95 (m, 4H), 1.90-1.78 (m, 
3H), 1.73-1.65 (m, 1H), 1.60 (s, 3H), 1.55-1.48 (m, 1H), 1.31-1.22 (m, 1H), 1.28 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 155.3 (major), 151.1 (minor), 103.7 (minor), 98.7 (major), 82.2 (major, 
2C), 81.9 (minor), 79.6 (minor), 79.2 (major), 69.7 (major), 66.0 (major), 56.3 (minor), 54.7 
(major), 35.1 (major), 34.7 (minor), 31.3 (minor), 29.9 (major), 27.6 (minor), 27.3 (major), 26.7 
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(minor), 26.3 (major), 22.0 (minor), 20.9 (minor), 20.5 (major), 17.8 (major); IR (neat) 2943, 
1798, 1455, 1374, 1166, 1033, 949 cm-1; HRMS (EI): m/z calcd for C14H22O6 (M+•) 286.1416, 
found 286.1419; [α]D = -24.1 (CHCl3, c 0.71). For endo, endo-product 1.98 (dr = 2.3:1): 1H 
NMR (600 MHz, CDCl3) δ 4.56 (dd, J = 8.8, 5.8 Hz, 70% of 1H), 4.49-4.46 (m, 30% of 1H), 
4.39-4.34 (m, 1H), 4.11 (t, J = 10.6 Hz, 70% of 1H), 4.10 (t, J = 10.6 Hz, 30% of 1H), 3.94 (dd, 
J = 11.3, 6.5 Hz, 70% of 1H), 3.84 (dd, J = 11.0, 6.3 Hz, 30% of 1H), 3.68 (dt, J = 8.5, 4.5 Hz, 
70% of 1H), 3.62-3.59 (m, 30% of 1H), 3.49-3.47 (m, 30% of 1H), 3.42 (s, 30% of 3H), 3.38 (s, 
70% of 3H), 3.37-3.33 (70% of 1H), 2.22-1.97 (m, 4H), 1.92-1.78 (m, 2H), 1.65-1.59 (m, 2H), 
1.46 (s, 30% of 3H), 1.43 (s, 70% of 3H), 1.38-1.33 (m, 1H), 1.28-1.25 (m, 1H); 13C NMR (151 
MHz, CDCl3) δ 149.0 (minor), 148.9 (major), 106.9 (minor), 102.6 (major), 86.4 (major), 83.3 
(minor), 82.6 (minor), 82.4 (major), 79.5 (minor), 75.2 (minor), 74.0 (major), 73.2 (minor), 73.1 
(major), 66.5 (major), 56.1 (minor), 55.9 (major), 39.5 (minor), 36.7 (major), 35.9 (minor), 35.6 
(major), 34.9 (minor), 33.5 (major), 29.7 (major), 28.6 (minor), 28.0 (minor), 21.0 (major), 18.9 
(major),17.9 (minor); IR (neat) 2939, 1755, 1455, 1384, 1255, 1205, 1109, 1042, 999 cm-1; 
HRMS (EI): m/z calcd for C14H22O6 (M+•) 286.1416, found 286.1414; [α]D = +11.8 (CHCl3, c 
0.85). 
 
(4aR,5aS,10aR,12aS)-12a-Methyldecahydro-1,3,5,10-tetraoxa-benzo[b]heptalene-2,9-dione 
(1.99) 
To a solution of acetal 1.98 (8.0 mg, 27.9 μmol) in CH2Cl2 (0.5 mL) at 
0 °C were added mCPBA (pure, 6.2 mg, 36.3 μmol) and BF3•OEt2 
(4.2 μL, 33.5 μmol) sequentially. After stirred at room temperature for 
30 min, the mixture was cooled to 0 °C and Et3N (19.4 μL, 140 μmol) was added dropwise. The 
O
O
O
O
O
H H
HO
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mixture was stirred at 0 °C for 30 min, then concentrated, and the resulting residue was purified
by colu
 
mn chromatography (10% - 20% EtOAc in CH2Cl2) to give lactone 1.99 (5.3 mg, 70.2%) 
as a white crystalline solid
6.5 Hz, 1H), 4.13 (dd, J = 
8.0, 3.4 Hz, 1H), 2.70-2.6
 min, the 
ixture was cooled to 0 °C and Et3N (16.5 μL, 118 μmol) was added dropwise. The mixture was 
 
 - 25% EtOAc in CH2Cl2) to give the desired lactone A37 (5.2 mg, 81.2%) 
as a white solid: 1H NMR  (500 MHz, CDCl3) δ 4.64 (dd, J = 8.4, 6.0 Hz, 1H), 4.52 (t, J = 8.8 
: 1H NMR (600 MHz, CDCl3) δ 4.43-4.39 (m, 1H), 4.40 (dd, J = 10.4, 
11.2, 10.5 Hz, 1H), 3.86 (dd, J = 11.3, 6.5 Hz, 1H), 3.53 (ddd, J = 10.6, 
1 (m, 2H), 2.22-2.17 (m, 3H), 2.07-2.01 (m, 2H), 1.92 (ddd, J = 15.4, 
9.6, 2.2 Hz, 1H),1.77-1.73 (m, 2H), 1.48 (s, 3H); 13C NMR (151 MHz, CDCl3) δ 173.9, 148.2, 
85.5, 81.9, 81.2, 78.4, 66.5, 35.7, 34.5, 33.6, 27.5, 21.0, 19.2; 1H NMR (500 MHz, C6D6) δ 3.58 
(dd, J = 10.0, 6.6 Hz, 1H), 3.46 (dd, J = 11.2, 10.2 Hz, 1H), 3.38-3.34 (m, 1H), 2.66 (dd, J = 
11.2, 6.6 Hz, 1H), 2.58 (ddd, J = 11.2, 7.8, 3.3 Hz, 1H), 2.22-2.18 (m, 1H), 1.73-1.65 (m, 2H), 
1.52 (dddd, J = 15.8, 8.8, 3.8, 1.4 Hz, 1H), 1.42-1.38 (m, 1H), 1.30 (ddd, J = 14.4, 8.8, 1.4 Hz, 
1H), 1.22 (dddd, J = 17.1, 11.6, 5.2, 1.5 Hz, 1H), 1.16-1.11 (m, 2H), 0.92-0.84 (m, 1H), 0.80 (s, 
3H); IR (neat) 2922, 2850, 1747, 1453, 1387, 1273, 1204, 1106, 1058, 1015 cm-1; HRMS (EI): 
m/z calcd for C13H18O6 (M+•) 270.1103, found 270.1111; [α]D = +12.7 (CHCl3, c 0.26). 
 
(R)-Tetrahydro-6-((2S,5R)-tetrahydro-5-methyl-5-((S)-2-oxo-1,3-dioxolan-4-yl)furan-2-yl)-
pyran-2-one (A37) 
To a solution of acetal 1.97 (6.8 mg, 23.7 μmol) in CH2Cl2 (0.5 
mL) at 0 °C were added mCPBA acid (pure, 5.3 mg, 30.8 μmol) 
and BF3•OEt2 (4.0 μL, 28.4 μmol) sequentially. After stirred at room temperature for 30
O O O
O
O O
HHH
m
stirred at 0 °C for 30 min, then concentrated, and the resulting residue was purified by column
chromatography (15%
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Hz, 1H), 4.45 (dd, J = 8.8, 6.0
Hz, 1H), 2.62 (dddd, J = 17.8,
 Hz, 1H), 4.30 (dd, J = 11.4, 4.6, 3.0 Hz, 1H), 4.10 (dt, J = 7.2, 4.6 
 6.6, 4.8, 1.4 Hz, 1H), 2.46 (ddd, J = 17.8, 9.3, 7.0 Hz, 1H), 2.19-
2.12 (m, 1H), 2.07-2.02 (m, 1H), 2.01-1.93 (m, 3H), 1.90-1.85 (m, 1H), 1.84-1.79 (m, 1H), 1.50-
1.44 (m, 1H), 1.28 (s, 3H); 13C NMR (125 MHz, CDCl3) δ171.1, 155.2, 83.0, 81.1, 80.7, 79.0, 
66.1, 34.5, 29.9, 26.4, 24.8, 20.7, 18.5; IR (neat) 2957, 2929, 1789, 1731, 1242, 1173, 1084, 
1049, 1018, 771 cm-1; HRMS (EI): m/z calcd for C13H18O6 (M+•) 270.1103, found 270.1104; [α]D 
= -42.8 (CHCl3, c 0.50). 
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APPENDIX B 
EFFORTS TOWARDS THE TOTAL SYNTHESIS OF (+)-
LACTODEHYDROTHYRSIFEROL AND ITS ANALOGS (SUPPORTING 
INFORMATION) 
General Experimental Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded at ambient temperature on Bruker Avance 300 spectrometer at 300 MHz 
and 75 MHz or Bruker Avance 500 spectrometer at 500 MHz and 125 MHz if specified. The 
chemical shifts are given in parts per million (ppm) on the delta (δ) scale. The solvent peak was 
used as a reference value, for 1H NMR: CDCl3 = 7.27 ppm, for 13C NMR: CDCl3 = 77.23. Data 
are reported as follows: (s = singlet; d = doublet; t = triplet; q = quartet; dd = doublet of doublets; 
ddd = doublet of doublet of doublets; dt = doublet of triplets; td = triplet of doublets; br = broad). 
High resolution mass spectra were recorded on a MICROMASS AUTOSPEC (for EI) or 
WATERS Q-TOF API-US (for ESI) spectrometer. Infrared (IR) spectra were collected on a 
Mattson Cygnus 100 spectrometer. Samples for IR were prepared as a thin film on a NaCl plate 
by dissolving the compound in CH2Cl2 and then evaporating the CH2Cl2. Tetrahydrofuran was 
distilled from sodium and benzophenone. Activated 4 Å molecular sieves were obtained through 
drying in oven at 150 °C overnight. Boc2O and N-methylimidole were purchased from Acros and 
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used without further purification. Anhydrous Na2S2O3 was purchased from Aldrich and used as 
received. Toluene and 1,2-dichloroethane were purchased from Fisher Scientific and dried with 4 
Å molecular sieves overnight prior to use. Anhydrous DMF and MeI were purchased from 
Acros. NiCl2, CrCl3, Mn, and anhydrous LiCl were purchased from Aldrich and used without 
further purification. TMSCl (purchased from Aldrich) was distilled from anhydrous K2CO3 
before use. Analytical TLC was performed on E. Merck pre-coated (25 mm) silica gel 60F-254 
plates. Visualization was done under UV (254 nm). Flash chromatography was done using ICN 
SiliTech 32-63 60 Å silica gel. Reagent grade ethyl acetate, diethyl ether and hexanes 
(commercial mixture) were purchased from EM Science and used as is for chromatography. All 
reactions were performed in flame-dried glassware under nitrogen with magnetic stirring unless 
otherwise noted.  
 
1-Hydroxy-5-methoxy-6,6-diphenylhexan-2-one (2.11) 
To a solution of terminal olefin 2.10 (407 mg, 1.53 mmol) in 
acetone/H2O (15 mL, 4.5:1, v/v) and AcOH (0.58 mL) was added 
dropwise a solution of KMnO4 (435 mg, 2.75 mmol) in acetone/H2O 
(6.9 mL). The mixture was stirred for 5 min and EtOH (0.8 mL) was added. After 20 min, the 
mixture was filtered through Celite and the residue was washed with acetone (50 mL). The 
filtrate was concentrated and the residue was azeotroped with acetone (3 x) and purified by 
column chromatography (35% - 40% EtOAc in hexanes) to give hydroxyl ketone 2.11 (258 mg, 
57%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.38-7.18 (m, 10H), 4.29-4.14 (m, 2H), 
4.02-3.95 (m, 2H), 3.10 (s, 3H), 3.08-3.06 (m, 1H), 2.58-2.38 (m, 2H), 2.07-1.95 (m, 1H), 1.73-
1.64 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 209.7, 142.2, 128.9, 128.8, 128.6, 126.9, 126.7, 82.6, 
Ph2CH
OMe
O
OH
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68.2, 58.1, 56.4, 33.9, 26.3; IR (neat) 3435, 2931, 1718, 1494, 1451, 1102, 748; HRMS (ESI): 
m/z calcd for C19H22O3K [M+K]+ 337.1206, found 337.1176. 
 
5-Methoxy-2-methylene-6,6-diphenylhexan-1-ol (2.12) 
To a solution of hydroxyl ketone 2.11 (235 mg, 0.788 mmol) in THF 
(7 mL) were added PPh3 (227 mg, 0.867 mmol), (Ph3P)3RhCl (18.2 
mg, 19.7 μmol) and iPrOH (0.6 mL, 7.88 mmol) sequentially. After 5 min, TMSCHN2 (0.63 mL, 
1.26 mmol) was added. The yellow mixture was stirred for 18 h, PPh3 (200 mg, 0.788 mmol) 
was added followed by TMSCHN2 (0.63 mL, 1.26 mmol). The reaction was stirred for another 
18 h and TBAF (1 M in THF, 3.0 mL, 3.0 mmol) was added. The mixture was stirred for 30 min, 
then treated with saturated NH4Cl (15 mL) and extracted with Et2O (4 x 20 mL). The extract was 
dried (MgSO4), filtered and concentrated. The residue was purified column chromatography 
(20% - 45% EtOAc in hexanes) to give allylic alcohol 2.12 (168 mg, 72%) and unreacted starting 
material 2.11 (23 mg, 10%). For allylic alcohol 2.12: 1H NMR (300 MHz, CDCl3) δ 7.40-7.18 
(m, 10H), 5.00 (br s, 1H), 4.82 (d, J = 0.9 Hz, 1H), 4.04 (d, J = 8.4 Hz, 1H), 4.00 (br s, 2H), 
3.97-3.90 (m, 1H), 3.16 (s, 3H), 2.27-2.09 (m, 2H), 1.78-1.52 (m, 3H); 13C NMR (75 MHz, 
CDCl3) δ 149.0, 142.8, 142.4, 129.0, 128.8, 128.7, 128.5, 126.7, 126.5, 109.8, 83.4, 66.1, 58.1, 
56.4, 30.6, 28.7; IR (neat) 3397, 2928, 1599, 1494, 1451, 1103, 1030, 898, 745; HRMS (ESI): 
m/z calcd for C20H24O2K [M+K]+ 335.1413, found 335.1404. 
Ph2CH
OMe
OH
 
(2-(3-Methoxy-4,4-diphenylbutyl)oxiran-2-yl)methanol (2.13) 
To a solution of allylic alcohol 2.12 (157 mg, 0.530 mmol) in benzene 
(3.0 mL) was added VO(acac)2 (2.8 mg, 10.6 μmol) followed by Ph2CH
OMe
OH
O
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dropwise addition of tBuOOH (5-6 M in decane, 0.12 mL, ~0.65 mmol). The mixture was heated 
to 80 °C for 20 min, then cooled to room temperature and saturated Na2SO3 (2 mL) was added. 
The mixture was stirred for 10 min, the treated with saturated NaHCO3 (10 mL) and extracted 
with Et2O (4 x 20 mL). The extract was dried (MgSO4), filtered and concentrated. The residue 
was purified column chromatography (30% - 60% EtOAc in hexanes containing 0.5% Et3N) to 
give epoxy alcohol 2.13 (148 mg, 90%, dr ~ 1:1) as a colorless oil: 1H NMR (300 MHz, CDCl3) 
δ 7.39-7.19 (m, 10H), 3.98 (d, J = 8.5 Hz, 1H), 3.96-3.90 (m, 1H), 3.65 (ddd, J = 12.3, 6.6, 4.4 
Hz, 1H), 3.53 (dd, J = 12.2, 8.4 Hz, 1H), 3.16/3.15 (s, 3H), 2.81 (dd, J = 4.6, 2.2 Hz, 1H), 2.56 
(dd, J = 4.6, 1.4 Hz, 1H), 1.98-1.56 (m, 4H), 1.56-1.38 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 
142.6, 142.3, 128.9, 128.8, 128.6, 128.5, 126.8, 126.6, 83.4, 83.3, 63.2, 62.9, 59.8, 59.7, 58.2, 
58.1, 56.3, 56.3, 50.2, 49.7, 27.5, 27.2, 27.0, 26.8; IR (neat) 3432, 2929, 1642, 1600, 1494, 1452, 
1101, 747; HRMS (ESI): m/z calcd for C20H24O3Na [M+Na]+ 335.1623, found 335.1607. 
 
tert-Butyl 2-(3-methoxy-4,4-diphenylbutyl)oxiranylmethyl carbonate (2.14) 
To a solution of epoxy alcohol 2.13 (135 mg, 0.432 mmol) in dry 
toluene (4.3 mL) at 0 °C were added 1-methylimidazole (34 μL, 
0.432 mmol) and di-tert-butyl dicarbonate (188 mg, 0.864 mmol). 
The reaction mixture was stirred overnight, allowing the temperature to warm to room 
temperature slowly. After that time, water (2 drops) was added. After 10 min, the mixture was 
concentrated and the residue was azeotroped with acetone (5 mL), then hexanes (2 x 5 mL) and 
purified by flash chromatography (10% - 20% EtOAc in hexanes containing 0.5% Et3N) to give 
the tert-butyl carbonate 2.14 (162 mg, 91%, dr ~ 1:1) as a colorless oil: 1H NMR (300 MHz, 
CDCl3) δ 7.41-7.19 (m, 10H), 4.12-3.94 (m, 4H), 3.18/3.17 (s, 3H), 2.72 (t, J = 4.2 Hz, 1H), 2.58 
Ph2CH
OMe
OCO2tBu
O
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(dd, J = 4.5, 2.0 Hz, 1H), 1.97-1.58 (m, 4H), 1.51 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 153.4, 
153.4, 142.6, 142.3, 142.3, 129.0, 128.9, 128.8, 128.8, 128.6, 128.5, 126.7, 126.7, 126.5, 83.2, 
82.6, 68.5, 68.1, 58.0, 58.0, 57.3, 57.2, 56.2, 56.2, 50.8, 50.3, 27.9, 27.4, 26.9, 26.8, 26.6; IR 
(neat) 2979, 2933, 1742, 1494, 1453, 1279, 1161, 1102, 743; HRMS (ESI): m/z calcd for 
C25H32O5Na [M+Na]+ 435.2147, found 435.2150. 
 
(5S)-8-Methoxy-1,3,7-trioxaspiro[4.5]decan-2-one (2.17) 
To epoxide 2.14 (70 mg, 0.17 mmol) in dichloroethane/toluene (5.6 mL, 
5:1, v/v) in borosilicate flask at room temperature were added the 
activated 4Å molecular sieves (140 mg), anhydrous Na2S2O3 (140 mg), 
NaOAc (140 mg) and N-methylquinolinium hexafluorophosphate (24.6 mg, 85 μmol). The 
mixture was photoirradiated with gentle air bubbling for 8 h while stirring at room temperature. 
The reaction mixture was filtered through a small plug of silica gel and the residue was washed 
with Et2O (30 mL). The filtrate was concentrated and the resulting residue was purified by flash 
chromatography (30% - 60% EtOAc in hexanes) to produce the bicycle 2.17 (25.2 mg, 79%, dr 
1.1:1) as a pale yellow oil: 1H NMR (300 MHz, CDCl3) δ 4.70 (t, J = 2.3 Hz, 0.5H), 4.60 (app dd, 
J = 3.0, 2.3 Hz, 0.5H), 4.50 (d, J = 8.6 Hz, 0.5H), 4.20 (dd, J = 8.6, 1.4 Hz, 0.5H), 4.10 (d, J = 
8.8 Hz, 0.5H), 4.06 (d, J = 8.8 Hz, 0.5H), 3.88 (dd, J = 11.0, 1.0 Hz, 0.5H), 3.72 (d, J = 12.4 Hz, 
0.5H), 3.66 (dd, J = 12.4, 2.2 Hz, 0.5H), 3.52 (dd, J = 11.1, 2.4 Hz, 0.5H), 3.39 (s, 1.5H), 3.38 (s, 
1.5H), 2.33 (dt, J = 12.8, 4.5 Hz, 0.5H), 2.15-2.00 (m, 1H), 1.99-1.90 (m, 1H), 1.84 (dtd, J = 
12.4, 4.1, 2.4 Hz, 0.5H), 1.76-1.57 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 154.2, 154.2, 97.6, 
96.9, 79.4, 78.6, 72.8, 71.7, 64.5, 63.3, 55.5, 55.3, 28.2, 28.1, 27.4, 26.1; IR (neat) 2921, 1804, 
O
O
O
MeO
O
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1389, 1183, 1125, 1050, 772; HRMS (EI): m/z calcd for C8H11O5 (M+•) 187.0606, found 
187.0606. 
 
6-(tert-Butyldiphenylsilanyloxy)-2-(tert-butyldiphenylsilanyloxymethyl)hex-1-en-3-ol (2.25) 
To a mixture of (2-bromoallyloxy)(tert-butyl)diphenylsilane 2.23 
(2.764 g, 7.36 mmol), aldehyde 2.24 (1.200 g, 3.68 mmol), CrCl3 (116 
mg, 0.736 mmol), NiCl2 (95 mg, 0.736 mmol) and Mn (1.011 g, 18.4 
mmol) in anhydrous DMF (6 mL, degassed with argon prior to use) was added TMSCl (1.12 mL, 
8.83 mmol). After stirring overnight, the reaction was quenched with water (15 mL) and 
transferred to a beaker. HCl (1 N) was added until all the manganese metal was completely 
consumed. The mixture was extracted with Et2O (4 x 40 mL), and the extract was dried 
(MgSO4) and concentrated. The residue was purified by column chromatography (2% - 10% 
EtOAc in hexanes) to give allylic alcohol 2.25 (1.948 g, 85%) as a colorless oil: 1H NMR (300 
MHz, CDCl3) δ 7.71-7.64 (m, 8H), 7.46-7.34 (m, 12H), 5.20 (q, J = 1.5 Hz, 1H), 5.12 (s, 1H), 
4.30 (d, J = 13.6 Hz, 1H), 4.23-4.19 (m, 2H), 3.65 (app t, J = 6.0 Hz, 2H), 2.63 (d, J = 4.9 Hz, 
1H), 1.70-1.51 (m, 4H), 1.07 (s, 9H), 1.04 (s, 9H). 
OTBDPS
OTBDPS
OH
 
Ethyl (Z)-8-(tert-butyldiphenylsilanyloxy)-4-(tert-butyldiphenylsilanyloxymethyl)oct-4-eno-
ate (2.26) 
A mixture of allylic alcohol 2.25 (1.868 g, 3.00), triethyl 
orthoacetate (2.2 mL, 12.0 mmol) and propionic acid (11 
μL, 0.15 mmol) was heated to 100 °C for 4 h and the 
unreacted triethyl orthoacetate was distilled out under reduced pressure. The residue was purified 
OTBDPS
OTBDPS
EtO
O
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by column chromatography (1% - 3% EtOAc in hexanes) to give the ethyl ester 2.26 (1.724 g, 
83%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.69-7.60 (m, 8H), 7.43-7.32 (m, 12H), 
5.19 (t, J =7.3 Hz, 1H), 4.20 (s, 2H), 4.12 (q, J = 7.1 Hz, 2H), 3.53 (t, J = 6.4 Hz, 2H), 2.51-2.41 
(m, 4H), 1.86 (q, J = 7.3 Hz, 2H), 1.52-1.43 (m, 2H), 1.23 (t, J = 7.4 Hz, 3H), 1.04 (s, 9H), 1.00 
(s, 9H). 
 
(Z)-10-(tert-Butyldiphenylsilanyloxy)-6-(tert-butyldiphenylsilanyloxymethyl)-2-methyldeca-
1,6-dien-3-ol (2.27) 
A solution of ethyl ester 2.26 (1.700 g, 2.45 mmol) in 
CH2Cl2 (3 mL) at -78 °C was treated with DIBAL-H (1 M in 
hexanes, 2.6 mL, 2.6 mmol) over 15 min. After 30 min, 
DIBAL-H (0.36 mL, 0.36 mmol) was added over 2 min. The mixture was stirred for 15 min and 
isopropenylmagnesium bromide (0.5 M in THF, 9.8 mL, 4.9 mmol) was added dropwise. The 
reaction was stirred at -78 °C for 1 h, then warmed to room temperature and quenched with 
saturated NH4Cl solution (10 mL) and saturated sodium tartrate solution (25 mL). The mixture 
was stirred vigorously for 1 h and extracted with Et2O (3 x 30 mL). The organic extract was 
dried (MgSO4) and concentrated. The residue was purified by column chromatography (3% - 
12% EtOAc in hexanes) to give secondary alcohol 2.27 (1.333 g, 79%) as a colorless oil: 1H 
NMR (300 MHz, CDCl3) δ 7.70-7.63 (m, 8H), 7.45-7.34 (m, 12H), 5.23 (t, J = 7.3 Hz, 1H), 
4.97-4.96 (m, 1H), 4.87-4.86 (m, 1H), 4.22 (d, J = 2.5 Hz, 2H), 4.08-4.05 (m, 1H), 3.56 (t, J = 
6.5 Hz, 2H), 2.28-2.21 (m, 2H), 1.91 (q, J = 7.2 Hz, 2H), 1.78-1.67 (m, 5H), 1.56-1.49 (m, 2H), 
1.06 (s, 9H), 1.02 (s, 9H). 
OTBDPS
OTBDPS
OH
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Ethyl (4E,8Z)-12-(tert-butyldiphenylsilanyloxy)-8-(tert-butyldiphenylsilanyloxymethyl)-4-
methyldodeca-4,8-dienoate (2.28) 
A mixture of allylic alcohol 2.27 (1.333 g, 1.93 
mmol), triethyl orthoacetate (1.4 mL, 7.72 mmol) 
and propionic acid (7 μL, 96 μmol) was heated to 
115 °C for 2 h and the unreacted triethyl orthoacetate was distilled out under reduced pressure. 
The residue was purified by column chromatography (2% - 4% EtOAc in hexanes) to give the 
ethyl ester 2.28 (1.216 g, 83%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.69-7.60 (m, 
8H), 7.41-7.32 (m, 12H), 5.16 (t, J = 6.8 Hz, 2H), 4.18 (s, 2H), 4.12 (q, J = 7.1 Hz, 2H), 3.55 (t, 
J = 6.4 Hz, 2H), 2.42-2.37 (m, 2H), 2.32-2.28 (m, 2H), 2.19-2.06 (m, 4H), 1.89 (q, J = 7.4 Hz, 
2H), 1.60 (br s, 3H), 1.54-1.47 (m, 2H), 1.25 (t, J = 7.1 Hz, 3H), 1.04 (s, 9H), 1.00 (s, 9H). 
OTBDPS
OTBDPS
EtO
O
 
(5E,9Z)-13-(tert-Butyldiphenylsilanyloxy)-9-(tert-butyldiphenylsilanyloxymethyl)-5-methyl-
1-phenyltrideca-5,9-dien-2-ol (2.29) 
A solution of ethyl ester 2.28 (600 mg, 0.788 
mmol) in CH2Cl2 (4 mL) at -78 °C was treated 
with DIBAL-H (1 M in hexanes, 0.83 mL, 0.83 
mmol) over 10 min. After 30 min, DIBAL-H (0.12 mL, 0.12 mmol) was added and the mixture 
was stirred for 30 min.  
OTBDPS
OTBDPS
Bn
OH
In a separate round-bottom flask, a mixture of CuCN (282 mg, 3.15 mmol) and LiCl (294 mg, 
6.93 mmol) in THF (10 mL) at -78 °C was treated with BnMgCl (2 M in THF, 1.6 mmol, 3.2 
mmol) dropwise. After 1 h, BF3•OEt2 (0.28 mL, 2.26 mmol) was added and the mixture was 
stirred for 5 min. The reaction mixture from the first reaction was cannulated into the second 
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flask followed by rinse (2 x 0.5 mL THF). The mixture was stirred at -78 °C for 1 h and then at 
room temperature for 1 h. After that time, the reaction was quenched with saturated NH4Cl 
solution (10 mL) /saturated sodium tartrate solution (5 mL) and stirred vigorously for 1 h. The 
mixture was extracted with Et2O (4 x 20 mL) and the organic extract was dried (MgSO4) and 
concentrated. The residue was purified by column chromatography (3% - 12% EtOAc in 
hexanes) to give secondary alcohol 2.29 (496 mg, 78%) as a colorless oil: 1H NMR (300 MHz, 
CDCl3) δ 7.70-7.62 (m, 8H), 7.44-7.30 (m, 12H), 7.30-7.20 (m, 5H), 5.21-5.15 (m, 2H), 4.19 (s, 
2H), 3.86-3.76 (m, 1H), 3.55 (t, J = 6.5 Hz, 2H), 2.84 (dd, J = 13.6, 4.4 Hz, 1H), 2.67 (dd, J = 
13.5, 8.3 Hz, 1H), 2.23-1.98 (m, 2H), 1.60 (s, 3H), 1.66-1.47 (m, 6H), 1.05 (s, 9H), 1.01 (s, 9H). 
 
(Z)-6-((E)-7-Methoxy-4-methyl-8-phenyloct-3-enyl)-2,2-13,13-tetramethyl-3,3,12,12-
tetraphenyl-4,11-dioxa-3,12-disilatetradec-6-ene (B1) 
A solution of alcohol 2.29 (486 mg, 0.600 mmol) 
in DMF (5 mL) at 0 °C was treated with NaH 
(60% weight in mineral oil, 60 mg, 1.50 mmol). 
After 20 min, MeI (0.15 mL, 2.4 mmol) was added and the mixture was stirred overnight at room 
temperature. After that time, the reaction was quenched with water (20 mL) cautiously and 
extracted with Et2O (3 x 20 mL). The organic extract was dried (MgSO4) and concentrated. The 
residue was purified by column chromatography (2% - 5% EtOAc in hexanes) to give methyl 
ether B1 (431 mg, 87%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.69-7.61 (m, 8H), 
7.43-7.30 (m, 12H), 7.29-7.26 (m, 2H), 7.22-7.18 (m, 3H), 5.20-5.10 (m, 2H), 4.19 (s, 2H), 3.55 
(t, J = 6.5 Hz, 2H), 3.36-3.30 (m, 1H), 3.31 (s, 3H), 2.84 (dd, J = 13.7, 6.2 Hz, 1H), 2.72 (dd, J = 
OTBDPS
OTBDPS
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13.8, 6.2 Hz, 1H), 2.22-1.96 (m, 6H), 1.89 (q, J = 7.3 Hz, 2H), 1.58-1.48 (m, 7H), 1.04 (s, 9H), 
1.00 (s, 9H). 
 
(2Z)-2-((E)-7-Methoxy-4-methyl-8-phenyloct-3-enyl)hex-2-ene-1,6-diol (2.30) 
To a solution of silyl ether B1 (409 mg, 0.497 mmol) in 
THF (5 mL) was added TBAF·H2O (312 mg, 1.19 
mmol). The reaction was stirred for 4 h, then 
concentrated and the residue was purified by column chromatography (50% - 60% EtOAc in 
hexanes) to give the diol 2.30 (144 mg, 84%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 
7.32-7.19 (m, 5H), 5.28 (t, J = 7.8 Hz, 1H), 5.16-4.99 (m, 1H), 4.17 (s, 2H), 3.63 (t, J = 5.9 Hz, 
2H), 3.39-3.35 (m, 1H), 3.32 (s, 3H), 2.86 (dd, J = 13.7, 6.2 Hz, 1H), 2.71 (dd, J = 13.7, 6.3 Hz, 
1H), 2.24 (q, J = 7.1 Hz, 2H), 2.15-1.97 (m, 8H), 1.68-1.60 (m, 2H), 1.58-1.49 (m, 5H). 
OH
OH
Bn
OMe
 
3-((2S,3R)-3-(Hydroxymethyl)-3-((E)-7-methoxy-4-methyl-8-phenyloct-3-enyl)oxiran-2-
yl)propan-1-ol (B2) 
To a mixture of diol 2.30 (138 mg, 0.398 mmol) and 
activated 4 Å molecular sieves (120 mg) in CH2Cl2 (4 
mL) at -20 °C was added D--diisopropyl tartrate (8 μL, 
48 μmol). After 10 min, Ti(OiPr)4 (12 μL, 40μmol) was introduced. The mixture was stirred for 
30 min, and tBuOOH (5-6 M in decane, 0.22 mL, ~1.2 mmol) was added dropwise. The reaction 
was stirred for 5 h at -20 °C, and then stored in at -20 °C overnight. Water (0.5 mL) was added 
the mixture was stirred at 0 °C for 1 h. After that time, 30% NaOH saturated with NaCl (0.5 mL) 
was added and the mixture was stirred at room temperature for 2.5 h. The mixture was filtered 
OH
OH
Bn
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through a 1:1 mixture of MgSO4/Celite and the residue was washed with CH2Cl2 (20 mL). The 
combined filtrates were concentrated and the residue was purified by column chromatography 
(60% - 80% EtOAc in hexanes containing 1% Et3N) to give monoepoxy diol B2 (47 mg, 33%) as 
a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.32-7.19 (m, 5H), 5.11 (t, J = 6.8 Hz, 1H), 3.78-
3.65 (m, 4H), 3.39-3.34 (m, 1H), 3.32 (s, 3H), 2.90-2.83 (m, 2H), 2.70 (ddd, J =13.8, 6.3, 2.5 Hz, 
1H), 2.38 (br s, 1H), 2.16-1.95 (m, 6H), 1.86-1.49 (m, 10H). 
 
3-((2S,3R)-3-(Hydroxymethyl)-3-(2-((2R,3R)-3-(3-methoxy-4-phenylbutyl)-3-methyloxiran-
2-yl)ethyl)oxiran-2-yl)propan-1-ol (B3) 
A solution of monoepoxide B2 (45 mg, 0.124 mmol) in 
CH3CN/DMM (1.8 mL, 1:2, v/v) was treated with 0.05 
M solution of Na2B4O7 in 4x10-4 M Na2(EDTA) (1.2 
mL), Bu4NHSO4 (1.7 mg, 4.5 μmol) and Shi ketone (16.0 mg, 62 μmol) sequentially. The 
mixture was cooled to -5 °C. Oxone (122 mg, 0.198 mmol), dissolved in 4x10-4 M Na2(EDTA) 
(0.8 mL), and K2CO3 (115 mg, 0.831 mmol), dissolved in water (0.8 mL), were added 
simultaneously via a syringe pump over 2.0 h. After the addition was completed, the blue 
mixture was stirred further for 10 min, and anhydrous Na2SO4 was added in portions until all the 
water disappeared. The mixture was filtered and the residues was washed with CH2Cl2 (30 mL). 
The combined filtrates were concentrated and the residue was purified by flash chromatography 
(80% - 100% EtOAc in hexanes containing 1% Et3N) to give diepoxide B3 (42 mg, 89%) as a 
colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.30-7.18 (m, 5H), 3.90-3.49 (m, 4H), 3.38-3.34 (m, 
1H), 3.32 (s, 3H), 2.91-2.82 (m, 2H), 2.76-2.64 (m, 2H), 2.20-1.41 (m, 14H), 1.22/1.22/1.21 (s, 
3H). 
OH
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 tert-Butyl 3-((2S,3R)-3-tert-butoxycarbonyloxymethyl-3-(2-[3-(3-methoxy-4-phenylbutyl)-
(2R,3R)-3-methyloxiranyl]ethyl)oxiranyl)propyl carbonate (ent-2.21) 
A solution of the diepoxide B3 (39 mg, 0.103 mmol) 
in dry toluene (1.0 mL) at 0 °C was treated with N-
methylimidazole (16 μL, 0.206 mmol) followed by di-
tert-butyl dicarbonate (90 mg, 0.412 mmol). The reaction mixture was stirred overnight, 
allowing the temperature to warm to room temperature slowly. After that time, the reaction was 
quenched with water (5 mL) and extracted with CH2Cl2 (3 x 15 mL). The organic extracts were 
dried (MgSO4), filtered and concentrated. The residue was purified by flash chromatography 
(15% - 25% EtOAc in hexanes containing 1% Et3N) to give the tert-butyl carbonate ent-2.21 (31 
mg, 52%, dr ~ 2:1 regarding the stereochemical outcomes of the two epoxide groups) as a 
colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.32-7.18 (m, 5H), 4.20-4.05 (m, 4H), 3.36-3.34 (m, 
1H), 3.31 (s, 3H), 2.90-2.81 (m, 2H), 2.72-2.63 (m,, 2H), 1.90-1.70 (m, 6H), 1.66-1.56 (m, 5H), 
1.54-1.43 (m, 1H), 1.49 (s, 9H), 1.20/1.20/1.19 (s, 3H). 
OBoc
OBoc
Bn
OMe
OO
 
tert-Butyl 3-[8-((R)-2-methyl-5-oxotetrahydrofuran-2-yl)-(5S,6S,8S)-2-oxo-1,3,7-trioxaspi-
ro[4.5]dec-6-yl]propyl carbonate (2.32) 
Diepoxide ent-2.21 (30 mg, 51.8 μmol) in 
dichloroethane/toluene (1.7 mL, 5:1, v/v) in borosilicate flask 
at room temperature was treated with the activated 4Å 
molecular sieves (60 mg), anhydrous Na2S2O3 (60 mg), NaOAc (60 mg) and N-
methylquinolinium hexafluorophosphate (7.5 mg, 26 μmol). The mixture was photoirradiated 
OO
H HO
OBoc
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with gentle air bubbling for 3.5 h while stirring at room temperature. The reaction mixture was 
filtered through a small plug of silica gel and the residue was washed with Et2O (25 mL). The 
filtrate was concentrated and the resulting residue was purified by column chromatography (25% 
- 40% EtOAc in hexanes) to provide a pale yellow oil 2.31 (9.5 mg, 43%, containing small 
amounts of unknown materials) and another pale yellow oil (3.0 mg, 13%). For the major 
product 2.31: IR (neat) 2976, 1809, 1739, 1280, 1163, 1067. 
The acetal 2.31 (3.2 mg) was dissolved in acetone (0.3 mL) at 0 °C and Jones reagent (16 μL) 
was added. The mixture was stirred for 1 h, then purified by column chromatography (50% - 
80% EtOAc in hexanes) to give title lactone 2.33 (2.6 mg, 84%) as a colorless oil: 1H NMR (500 
MHz, CDCl3) δ 4.54 (d, J = 8.9 Hz, 1H), 3.41 (d, J = 9.0 Hz, 1H), 4.08 (t, J = 5.8 Hz, 2H), 3.50 
(dd, J = 10.6, 1.4 Hz, 1H), 3.46 (dd, J = 11.6, 2.0 Hz, 1H), 2.62-2.58 (m, 2H), 2.24 (ddd, J = 13.1, 
9.6, 6.9Hz, 1H), 2.18 (td, J = 12.8, 3.8 Hz, 1H), 2.10 (dt, J = 13.4, 4.4 Hz, 1H), 1,96-1.91 (m, 
2H), 1.90-1.86 (m, 1H), 1.74-1.70 (m, 2H), 1.53-1.46 (m, 1H), 1.49 (s, 9H), 1.39-1.33 (m, 1H), 
1.35 (s, 3H). 
 
(5S,6S,8S)-6-(3-Hydroxypropyl)-8-((R)-2-methyl-5-oxotetrahydrofuran-2-yl)-1,3,7-
trioxaspiro[4.5]decan-2-one (2.35) 
A solution of lactone 2.33 (7.2 mg, 17.4 μmol) in CH2Cl2 (0.8 
mL) at 0 °C was treated with 2,6-lutidine (7.1 μL, 61 μmol) 
followed by TMSOTf (10 μL, 52 μmol). The reaction was stirred 
at 0 °C for 1 h, and then quenched with saturated NaHCO3 (0.5 mL). Anhydrous Na2SO4 was 
added and the mixture was filtered. The residue was washed with EtOAc (40 mL) and the filtrate 
was concentrated. The resulting residue was purified by column chromatography (70% - 100% 
OO
H HO
OH
O
O
O
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EtOAc in hexanes) to give the alcohol 2.35 (5.4 mg, 98%) as a white solid: 1H NMR (500 MHz, 
CDCl3) δ 4.54 (d, J = 8.8 Hz, 1H), 4.11 (d, J = 8.8Hz, 1H), 3.67 (br s, 2H), 3.54 (dd, J = 11.9, 
1.8 Hz, 1H), 3.50 (dd, J = 11.8, 2.2 Hz, 1H), 2.68-2.54 (m, 2H), 2.24 (ddd, J = 13.1, 10.2, 5.5 Hz, 
1H), 2.19 (ddd, J = 3.0, 4.2, 3.0 Hz, 1H), 2.11 (dt, J = 13.4, 4.6 Hz, 1H), 1.94-1.88 (m, 2H), 
1.78-1.69 (m, 2H), 1.66-1.60 (m, 2H), 1.66-1.60 (m, 1H), 1.53-1.48 (m, 1H), 1.40-1.32 (m, 1H), 
1.37 (s, 3H). 
 
3-(5S,6S,8S)-[8-((R)-2-Methyl-5-oxotetrahydrofuran-2-yl)-2-oxo-1,3,7-trioxaspiro[4.5]dec-
6-yl]propionaldehyde (ent-2.19) 
A solution of alcohol 2.35 (5.2 mg, 16 μmol) in CH2Cl2 (0.5 mL) 
was treated with NaHCO3 (5.5 mg, 66 μmol) and Dess-Martin 
periodinane (10.5 mg, 25 μmol) sequentially. The mixture was 
stirred for 30 min, then loaded onto column and purified (60% - 
80% EtOAc in hexanes) to give the aldehyde ent-2.19 (3.2 mg, 61%) as a colorless oil: 1H NMR 
(500 MHz, CDCl3) δ 9.77 (s, 1H), 4.57 (d, J = 8.9 Hz, 1H), 4.13 (d, J = 9.0 Hz, 1H), 3.52 (dd, J 
= 11.1, 2.4 Hz, 1H), 3.47 (dd, J = 11.8, 2.2 Hz, 1H), 2.67-2.54 (m, 4H), 2.23-2.17 (m, 2H), 2.10 
(dt, J = 8.6, 4.6 Hz, 1H), 1.99-1.86 (m, 3H), 1.84-1.76 (m, 1H), 1.39-1.32 (m, 2H), 1.34 (s, 3H). 
OO
H HO
O
O
O
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2-(tert-Butyldiphenylsilanyloxymethyl)hepta-1,6-dien-3-ol (2.38) 
A solution of methyl ester 2.37 (2.050 g, 12.0 mmol) in Et2O (24 mL) at 0 °C 
was treated with LiAlH4 (1 M in Et2O, 12.0 mL) dropwise over 20 min. The 
reaction was stirred at 0 °C for 1 h and then quenched with saturated NH4Cl 
(20 mL) cautiously. Saturated sodium tartrate solution (40 mL) was added and the mixture was 
OTBDPS
OH
 205 
stirred vigorously for 2 h. The mixture was extracted with EtOAc (3 x 60 mL) and the organic 
extract was dried (MgSO4), filtered and concentrated. The crude product was purified by column 
chromatography (40% - 60% EtOAc in hexanes) to give a colorless oil (1.033 g). This oil was 
separated into two parts (325 mg and 708 mg). The first part (325 mg) was dissolved in CH2Cl2 
(10 mL) and treated with TBDPSCl (0.47 mL, 1.83 mmol) and imidazole (155 mg, 2.28 mmol) 
at 0 °C. The mixture was stirred at 0 °C for 15 min, then quenched with water (20 mL) and 
extracted with CH2Cl2 (3 x 25 mL). The organic extract was dried (MgSO4) and concentrated. 
The crude product was purified by column chromatography (5% - 10% EtOAc in hexanes) to 
give desired silyl ether. The second part (708 mg) was treated in a similar manner with 
TBDPSCl (1.15 mL, 4.48 mmol) and imidazole (373 mg, 5.48 mmol) in CH2Cl2 (10 mL). The 
combined silyl ether 2.38 (1.180g, 26%, two steps) was obtained as a colorless oil: 1H NMR (300 
MHz, CDCl3) δ 7.71-7.69 (m, 4H), 7.48-7.38 (m, 6H), 5.89-5.75 (m, 1H), 5.18 (q, J = 1.4 Hz, 
1H), 5.12 (s, 1H), 5.06-4.96 (m, 2H), 4.32 (d, J = 13.5 Hz, 1H), 4.24-4.18 (m, 2H), 2.25 (d, J = 
4.9 Hz, 1H), 2.20-2.01 (m, 2H), 1.71-1.63 (m, 2H), 1.08 (s, 9H). 
 
Ethyl (Z)-4-(tert-butyldiphenylsilanyloxymethyl)nona-4,8-dienoate (B4) 
A mixture of allylic alcohol 2.38 (1.180 g, 3.10 mmol), triethyl 
orthoacetate (2.3 mL, 12.4 mmol) and propionic acid (11 μL, 0.16 
mmol) was heated to 100 °C for 6 h and the unreacted triethyl 
orthoacetate was removed by distillation under reduced pressure. The residue was purified by 
column chromatography (1% - 4% EtOAc in hexanes) to give ethyl ester B4 (0.903 g, 65%) as a 
colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.71-7.68 (m, 4H), 7.47-7.36 (m, 6H), 5.76-5.63 (m, 
EtO
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1H), 5.24 (t, J = 7.1 Hz, 1H), 4.97-4.89 (m, 2H), 4.21 (s, 2H), 4.14 (q, J = 7.1 Hz, 2H), 2.56-2.45 
(m, 4H), 2.01-1.85 (m, 4H), 1.26 (t, J = 7.1 Hz, 3H), 1.05 (s, 9H). 
 
(Z)-6-(tert-Butyldiphenylsilanyloxymethyl)-2-methylundeca-1,6,10-trien-3-ol (2.39) 
A solution of the ethyl ester B4 (897 mg, 1.99 mmol) in CH2Cl2 (6 
mL) at -78 °C was treated with DIBAL-H (1 M in hexanes, 2.10 
mL, 2.1 mmol) over 30 min. After 40 min, DIBAL-H (0.30 mL, 
0.30 mmol) was added over 5 min. The mixture was stirred for 15 min and 
isopropenylmagnesium bromide (0.5 M in THF, 6.0 mL, 3.0 mmol) was added dropwise. The 
reaction was stirred at -78 °C for 15 min, then warmed to room temperature and quenched with 
saturated NH4Cl solution (10 mL) and saturated sodium tartrate solution (8 mL). The mixture 
was stirred vigorously for 1 h and extracted with Et2O (3 x 30 mL). The organic extract was 
dried (MgSO4) and concentrated. The residue was purified by column chromatography (3% - 
10% EtOAc in hexanes) to give secondary alcohol 2.39 (678 mg, 76%) as a colorless oil: 1H 
NMR (300 MHz, CDCl3) δ 7.71-7.68 (m, 4H), 7.47-7.36 (m, 6H), 5.76-5.65 (m, 1H), 5.26 (t, J = 
7.0 Hz, 1H), 4.99-4.90 (m, 3H), 4.87-4.85 (m, 1H), 4.24-4.16 (m, 2H), 4.11-4.06 (m, 1H), 2.29-
2.22 (m, 2H), 2.04-1.89 (m, 4H), 1.79-1.66 (m, 2H), 1.74 (s, 3H), 1.62 (d, J = 3.9 Hz, 1H), 1.06 
(s, 9H). 
OTBDPS
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Ethyl (4E,8Z)-8-(tert-butyldiphenylsilanyloxymethyl)-4-methyltrideca-4,8,12-trienoate (B5) 
A mixture of allylic alcohol 2.39 (670 mg, 1.49 mmol), 
triethyl orthoacetate (1.1 mL, 6.0 mmol) and propionic 
acid (5.5 μL, 74 μmol) was heated to 135 °C for 2 h and 
OTBDPS
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then purified by column chromatography (1% - 3% EtOAc in hexanes) to give ethyl ester B5 
(594 mg, 77%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.71-7.68 (m, 4H), 7.46-7.36 
(m, 6H), 5.76-5.65 (m, 1H), 5.23-5.15 (m, 2H), 5.01-4.91 (m, 2H), 4.19 (s, 2H), 4.13 (q, J = 7.2 
Hz, 2H), 2.43-2.37 (m, 2H), 2.35-2.28 (m, 2H), 2.22-2.10 (m, 4H), 2.03-1.88 (m, 4H), 1.61 (s, 
3H), 1.26 (t, J = 7.1 Hz, 3H), 1.05 (s, 9H). 
 
(5E,9Z)-9-(tert-Butyldiphenylsilanyloxymethyl)-5-methyl-1-phenyltetradeca-5,9,13-trien-2-
ol (B6) 
A solution of the ethyl ester B5 (588 mg, 1.13 mmol) in 
CH2Cl2 (5.6 mL) at - 78 °C was added DIBAL-H (1 M in 
hexanes, 1.2 mL, 1.2 mmol) over 15 min. After 30 min, 
DIBAL-H (0.20 mL, 0.20 mmol) was added over 5 min. The mixture was stirred for 20 min.  
OTBDPS
Bn
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In a separate round-bottom flask, to a mixture of CuCN (405 mg, 4.52 mmol) and LiCl (422 mg, 
9.94 mmol) in THF (14 mL) at -78 °C was added BnMgCl (2 M in THF, 2.3 mmol, 4.6 mmol) 
dropwise over 15 min. After 1 h, BF3•OEt2 (0.28 mL, 2.26 mmol) was added and the mixture 
was stirred for 5 min. The reaction mixture from the first reaction was cannulated to the second 
flask followed by rinse (2 x 1 mL THF). The mixture was stirred at -78 °C for 1 h and then at 
room temperature for 2 h. After that time, the reaction was quenched with saturated NH4Cl 
solution (10 mL)/saturated sodium tartrate solution (8 mL) and stirred vigorously for 1 h. The 
mixture was extracted with Et2O (3 x 30 mL) and the organic extract was dried (MgSO4) and 
concentrated. The residue was purified by column chromatography (3% - 12% EtOAc in 
hexanes) to give secondary alcohol B6 (520 mg, 81%) as a colorless oil: 1H NMR (300 MHz, 
CDCl3) δ 7.73-7.70 (m, 4H), 7.48-7.37 (m, 6H), 7.35-7.22 (m, 5H), 5.77-5.66 (m, 1H), 5.24-5.19 
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(m, 2H), 4.99-4.91 (m, 2H), 4.20 (s, 2H), 3.87-3.78 (m, 1H), 2.84 (dd, J = 13.5, 4.4 Hz, 1H), 
2.68 (dd, J = 13.5, 8.3 Hz, 1H), 2.24-2.08 (m, 6H), 2.06-1.88 (m, 4H), 1.62 (s, 3H), 1.66-1.58 
(m, 2H), 1.07 (s, 9H).  
 
((2Z,5E)-9-Methoxy-6-methyl-2-(pent-4-enylidene)-10-phenyldec-5-enyloxy)(tert-
butyl)diphenylsilane (B7) 
A solution of the secondary alcohol B6 (510 mg, 0.900 
mmol) in DMF (8 mL) at 0 °C was treated with NaH (60% 
weight in mineral oil, 90 mg, 2.25 mmol). After 30 min, 
MeI (0.22 mL, 3.60 mmol) was added and the mixture was stirred overnight at room 
temperature. After that time, the reaction was quenched with water (20 mL) cautiously and 
extracted with Et2O (3 x 30 mL) and the organic extract was dried (MgSO4) and concentrated. 
The residue was purified by column chromatography (1% - 4% EtOAc in hexanes) to give the 
methyl ether B7 (474 mg, 91%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 7.72-7.66 (m, 
4H), 7.47-7.36 (m, 6H), 7.32-7.25 (m, 2H), 7.23-7.18 (m, 3H), 5.79-5.66 (m, 1H), 5.21 (app t, J 
= 7.0 Hz, 1H), 5.14 (app qt, J = 6.8, 1.0 Hz, 1H), 4.99-4.91 (m, 2H), 4.20 (s, 2H), 3.39-3.32 (m, 
1H), 3.32 (s, 3H), 2.86 (dd, J = 13.7, 6.1 Hz, 1H), 2.72 (dd, J = 13.7, 6.2 Hz, 1H), 2.25-2.07 (m, 
5H), 2.04-1.88 (m, 5H), 1.59-1.51 (m, 2H), 1.54 (br s, 3H), 1.06 (s, 9H). 
OTBDPS
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(2Z,5E)-9-Methoxy-6-methyl-2-(pent-4-enylidene)-10-phenyldec-5-en-1-ol (2.40) 
A solution of the silyl ether B7 (464 mg, 0.799 mmol) in 
THF (5 mL) was treated with TBAF (1 M in THF, 1.9 mL, 
1.9 mmol). The reaction was stirred for 4 h, then 
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concentrated and the residue was purified by column chromatography (10% - 22% EtOAc in 
hexanes) to give the trienol 2.40 (230 mg, 84%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 
7.32-7.28 (m, 2H), 7.23-7.18 (m, 3H), 5.82 (tdd, J = 16.8, 10.2, 6.5 Hz, 1H), 5.31 (t, J = 6.8 Hz, 
1H), 5.14-5.10 (m, 1H), 5.06-4.98 (m, 2H), 4.12 (d, J = 5.6 Hz, 2H), 3.38-3.30 (m, 1H), 3.32 (s, 
3H), 2.86 (dd, J = 13.7, 6.1 Hz, 1H), 2.72 (dd, J =13.7, 6.2 Hz, 1H), 2.23-1.96 (m, 10H), 1.57-
1.50 (m, 2H), 1.55 (s, 3H), 1.15 (t, J = 5.7 Hz, 1H). 
 
((2S,3R)-3-(But-3-enyl)-2-((E)-7-methoxy-4-methyl-8-phenyloct-3-enyl)oxiran-2-
yl)methanol (B8) 
A mixture of trienol 2.40 (223 mg, 0.651 mmol) and 
activated 4 Å molecular sieves (195 mg) in CH2Cl2 (6 mL) 
at -20 °C was treated with L-diisopropyl tartrate (16 μL, 
78 μmol). After 15 min, Ti(OiPr)4 (20 μL, 65μmol) was introduced. The mixture was stirred for 
30 min, and tBuOOH (5-6 M in decane, 0.36 mL, ~1.9 mmol) was added dropwise. The reaction 
was stirred for 40 min at -20 °C, and then water (0.3 mL) was added. The mixture was stirred at 
0 °C for 1 h. After that time, 30% NaOH saturated with NaCl (0.3 mL) was added and the 
mixture was stirred at room temperature for 4 h. The mixture was filtered through a 1:1 mixture 
of MgSO4/Celite and the residue was washed with CH2Cl2 (30 mL). The combined filtrates were 
concentrated and the residue was purified by column chromatography (20% - 25% EtOAc in 
hexanes containing 0.5% Et3N) to give a colorless oil (150 mg, containing 7 mol% (+)-DIPT) 
which was treated with a mixture of 30% NaOH saturated with NaCl (0.3 mL) and CH2Cl2 (3 
mL) for 5 h. The mixture was concentrated and the residue was purified by column 
chromatography (20% - 25% EtOAc in hexanes containing 0.5% Et3N) to give the monoepoxide 
OH
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B8 (134 mg, 58%) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.31-7.20 (m, 5H), 5.84 (tdd, 
J = 16.9, 10.2, 6.6 Hz, 1H), 5.10-5.02 (m, 3H), 3.76 (dd, J = 11.8, 6.8 Hz, 1H), 3.67 (dd, J = 11.8, 
5.3 Hz, 1H), 3.36-3.34 (m, 1H), 3.32 (s, 3H), 2.90-2.84 (m, 2H), 2.71 (dd, J = 13.7, 6.2 Hz, 1H), 
2.28-1.99 (m, 6H), 1.94-1.90 (m, 1H), 1.78-1.45 (m, 6H), 1.55 (s, 3H). 
 
((2S,3R)-3-(But-3-enyl)-2-(2-((2S,3S)-3-(3-methoxy-4-phenylbutyl)-3-methyloxiran-2-
yl)ethyl)oxiran-2-yl)methanol (B9) 
A solution of B8 (125 mg, 0.349 mmol) in CH3CN/DMM 
(5.2 mL, 1:2, v/v) was treated with a 0.05 M solution of 
Na2B4O7 in 4x10-4 M Na2(EDTA) (3.5 mL), Bu4NHSO4 
(4.7 mg, 14.0 μmol) and ent-Shi ketone (27.0 mg, 0.105 mmol) sequentially. The mixture was 
cooled to - 5 °C. Oxone (268 mg, 0.436 mmol), dissolved in 4x10-4 M Na2(EDTA) (2.0 mL), and 
K2CO3 (253 mg, 1.83 mmol), dissolved in water (2.0 mL), were added simultaneously via a 
syringe pump over 2.0 h. After the addition was completed, the slightly blue reaction mixture 
was stirred further for 15 min, then diluted with water (10 mL) and extracted with CH2Cl2 (4 x 
15 mL). The organic extracts were dried (MgSO4), filtered and concentrated. The residue was 
purified by flash chromatography (25% - 38% EtOAc in hexanes) to give unreacted starting 
material B8 (37.4 mg, 30%)  and the diepoxide B9 (79.7 mg, 61%) as a colorless oil: 1H NMR 
(300 MHz, CDCl3) δ 7.32-7.19 (m, 5H), 5.91-5.78 (m, 1H), 5.11-5.01 (m, 2H), 3.73-3.71 (m, 
2H), 3.38-3.34 (m, 1H), 3.32 (s, 3H), 2.92-2.83 (m, 2H), 2.71-2.65 (m, 1H), 2.32-2.18 (m, 2H), 
2.03-1.91 (m, 1H), 1.87 (dt, J = 5.9, 2.2 Hz, 1H), 1.81-1.41 (m, 8H), 1.22 (s, 3H).  
OH
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tert-Butyl ((2S,3R)-3-(but-3-enyl)-2-(2-((2S,3S)-3-(3-methoxy-4-phenylbutyl)-3-methyloxira-
n-2-yl)ethyl)oxiran-2-yl)methyl carbonate (2.36) 
A solution of the diepoxy alcohol B9 (78 mg, 0.208 
mmol) in dry toluene (2.0 mL) at 0 °C was treated with di-
tert-butyl dicarbonate (91 mg, 0.416 mmol) and 1-
methylimidazole (16 μL, 0.208 mmol). The reaction mixture was stirred overnight, allowing the 
temperature to warm to room temperature slowly. After that time, the reaction was quenched 
with water (10 mL) and extracted with CH2Cl2 (3 x 15 mL). The organic extracts were dried 
(MgSO4), filtered and concentrated. The residue was purified by flash chromatography (15% - 
20% EtOAc in hexanes containing 0.5% Et3N) to give the tert-butyl carbonate 2.36 (90 mg, 
91%, dr ~ 4.6:1 regarding the stereochemical outcomes of the two epoxide groups) as a colorless 
oil: 1H NMR (500 MHz, CDCl3) δ 7.31-7.28 (m, 2H), 7.23-7.19 (m, 3H), 5.85-5.80 (m, 1H), 
5.08 (td, J = 17.1, 1.6 Hz, 1H), 5.02 (dd, J = 10.4, 1.2 Hz, 1H), 4.21-4.12 (m, 2H), 3.38-3.33 (m, 
1H), 3.31 (s, 3H), 2.89-2.83 (m, 2H), 2.70-2.65 (m, 2H), 2.29-2.21 (m, 2H), 1.85-1.81 (m, 1H), 
1.78-1.60 (m, 7H), 1.54-1.42 (m, 2H), 1.45 (s, 9H), 1.21/1.20 (s, 3H). 
OBoc
Bn
OMe
OO
 
(5R,6R,8R)-6-But-3-enyl-8-((S)-2-methyl-5-oxo-tetrahydrofuran-2-yl)-1,3,7-
trioxaspiro[4.5]decan-2-one (B10) 
Diepoxide 2.36 (44 mg, 92.7 μmol) in dichloroethane/toluene (3.1 
mL, 5:1, v/v) in borosilicate flask at room temperature was treated 
with activated 4Å molecular sieves (88 mg), anhydrous Na2S2O3 
(88 mg), NaOAc (88 mg) and N-methylquinolinium hexafluorophosphate (13.4 mg, 46.4 μmol). 
The mixture was photoirradiated with gentle air bubbling for 6.5 h while stirring at room 
OO
H HO
O
O
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temperature. The reaction mixture was filtered through a small plug of silica gel and the residue 
was washed with EtOAc (20 mL). The filtrate was concentrated and the resulting residue was 
purified by flash chromatography (25% - 35% EtOAc in hexanes) to provide a pale yellow oil 
(10.5 mg), which was dissolved in acetone (1.0 mL) at 0 °C. Jones reagent (2.67 M, 6 drops) was 
added dropwise (1 drop/5 min). After completion of addition, the mixture was stirred for 1 h and 
then concentrated. The residues was purified by column chromatography (50% - 70% EtOAc in 
hexanes) to give the lactone B10 (4.6 mg, 17%, two steps) as a colorless oil: 1H NMR (300 MHz, 
CDCl3) δ 5.83-5.69 (m, 1H), 5.11-5.01 (m, 2H), 4.54 (d, J = 8.8 Hz, 1H), 4.12 (d, J = 9.0 Hz, 
1H), 3.50 (dd, J = 10.8, 2.0 Hz, 1H), 3.46 (dd, J = 11.7, 2.3 Hz, 1H), 2.64-2.57 (m, 2H), 2.32-
2.05 (m, 5H), 1.97-1.87 (m, 2H), 1.69 (dtd, J = 13.6, 8.1, 2.2 Hz, 1H), 1.49 (dtd, J = 13.6, 5.7, 
2.9 Hz, 1H), 1.40-1.32 (m, 1H), 1.36 (s, 3H).  
 
3-((5R,6R,8R)-[8-((S)-2-Methyl-5-oxotetrahydrofuran-2-yl)-2-oxo-1,3,7-trioxaspiro[4.5]dec-
6-yl])propionaldehyde (2.19) 
A solution of the lactone B10 (3.3 mg, 10.6 μmol) in CH2Cl2 (0.8 
mL) at - 78 °C was treated dropwise with a saturated solution of 
O3 in CH2Cl2 at -78 °C until all the starting material disappeared. 
PPh3 (a crystal) was added and the cold bath was removed. The reaction was stirred for 10 h, 
then concentrated and the residues was purified by column chromatography (60% - 80% EtOAc 
in hexanes) to give the aldehyde 2.19 (3.6 mg (containing ~17% Ph3P=O, 83%) as a colorless oil, 
which has identical spectral data to ent-2.19.  
OO
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H
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(S)-1-((2R,5R)-Tetrahydro-5-(2-hydroxypropan-2-yl)-2-methylfuran-2-yl)ethane-1,2-diol 
(2.42) 
A mixture of AD-mix-β (12.35 g) in tBuOH/H2O (88 mL, 1:1, v/v) at 0 
°C was treated with CH3SO2NH2 (0.839 g, 8.82 mmol). After 15 min, 
the epoxy alcohol (1.50 g, 8.82 mmol, prepared from geraniol through Sharpless asymmetric 
epoxidation) was added dropwise and the flask formerly containing the epoxy alcohol was rinsed 
with tBuOH/H2O (2 x 2 mL, 1:1, v/v). The mixture was stirred at 0 °C for 2 days, then 
concentrated to ~50 mL and extracted with EtOAc (25 x 30 mL). The combined organic extracts 
were dried (Na2SO4), filtered and concentrated. The residue was purified by column 
chromatography (90% - 100% EtOAc in hexanes followed by 5% - 15% MeOH in EtOAc) to 
give a mixture of 2.22 and 2.42 (1.720 g). This mixture was dissolved in PhMe (200 mL) at 0 °C 
and CSA·pyridine (262 mg, 0.842 mmol) was added. The reaction was stirred for 1.5 h, and Et3N 
(1 mL) was added. The solvent was removed under reduced pressure and the residue was 
purified by column chromatography (90% - 100% EtOAc in hexanes followed by 5% - 15% 
MeOH in EtOAc) to give triol 2.42 (1.627 g, 90%, two steps) as a colorless oil: 1H NMR (300 
MHz, CDCl3) δ 3.79 (t, J = 8.2 Hz, 1H), 3.75-3.70 (m, 2H), 3.58-3.52 (m, 1H), 2.88 (br s, 1H), 
2.53-2.51 (m, 1H), 2.18 (s, 1H), 2.10 (td, J = 11.3, 10.2 Hz, 1H), 1.90-1.81 (m, 2H), 1.65-1.57 
(m, 1H), 1.22 (s, 3H), 1.18 (s, 3H), 1.14 (s, 3H); HRMS (ESI): m/z calcd for C10H20O4Na (M + 
Na+) 227.1259, found 227.1246. 
O OHHO
OH
H
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(R)-2-Hydroxy-2-[(5R)-5-(1-hydroxy-1-methylethyl)-(2R)-2-methyltetrahydrofuran-2-
te (B11) yl]ethyl toluene-4-sulfona
A solution of triol 2.42 (1.627 g, 7.96 mmol) in CH2Cl2 (20 mL) was 
treated with pyridine (1.3 mL, 15.9 mmol), TsCl (1.670 g, 8.76 mmol) 
and DMAP (49 mg, 0.40 mmol) sequentially. The reaction was stirred overnight, then 
concentrated and the residue was purified by column chromatography (30% - 60% EtOAc in 
hexanes) to give the tosylate B11 (1.284 g, 45%) as a colorless oil: 1H NMR (300 MHz, CDCl3) 
δ 7.82 (td, J = 8.4, 1.9 Hz, 2H), 7.38-7.35 (m, 2H), 4.26 (dd, J = 10.4, 2.6 Hz, 1H), 4.02 (dd, J = 
10.5, 7.8 Hz, 1H), 3.78 (td, J = 7.6, 2.9 Hz, 1H), 3.72 (dd, J = 8.9, 6.8 Hz, 1H), 2.52 (d, J = 3.2 
Hz, 1H), 2.46 (s, 3H), 2.06 (td, J = 11.9, 9.2 Hz, 1H), 1.96 (s, 1H), 1.89-1.81 (m, 2H), 1.66 (ddd, 
J = 11.9, 6.2, 3.5 Hz, 1H), 1.18 (s, 3H), 1.13 (s, 3H), 1.11 (s, 3H); HRMS (ESI): m/z calcd for 
C17H26O6NaS [M+Na]+ 381.1348, found 381.1340. 
O OHTsO
OH
H
 
2-((2R,5R)-Tetrahydro-5-methyl-5-((S)-oxiran-2-yl)furan-2-yl)propan-2-ol (B12) 
A solution of the tosylate B11 (270 mg, 0.753 mmol) in dry MeOH (21 
mL) was treated with anhydrous K2CO3 (104 mg, 0.753 mmol). The 
mixture was stirred for 1.5 h, then concentrated and the residue was purified by column 
chromatography (50% EtOAc in hexanes containing 0.5% Et3N) to give the epoxide B12 (134 
mg, 96%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 3.81-3.76 (m, 1H), 3.04 (dd, J = 4.1, 
2.8 Hz, 1H), 2.74 (dd, J = 5.0, 4.2 Hz, 1H), 2.58 (dd, J = 5.0, 2.8 Hz, 1H), 2.11 (s, 1H), 1.90-1.78 
(m, 2H), 1.68-1.58 (m, 1H), 1.28 (s, 3H), 1.23 (s, 3H), 1.13 (s, 3H); 13C NMR (75 MHz, CDCl3) 
δ 86.8, 81.4, 70.7, 57.2, 43.9, 32.8, 27.5, 26.3, 24.3, 24.3. 
O OHHO
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(2-((2R,5R)-Tetrahydro-5-methyl-5-((S)-oxiran-2-yl)furan-2-yl)propan-2-yloxy)triethyl-
silane (2.43) 
A solution of the tertiary alcohol B12 (178 mg, 0.956 mmol) in DMF 
(5.8 mL) at 0 °C were treated with imidazole (130 mg, 1.91 mmol), 
TESCl (0.24 mL, 1.43 mmol) and DMAP sequentially. The mixture was stirred at 0 °C for 2 h 
and then at room temperature overnight. After that time, the reaction was quenched with water 
(15 mL) at 0 °C and extracted with Et2O (3 x 20 mL). The organic extract was dried (MgSO4), 
filtered and concentrated. The residue was purified by column chromatography (2% - 8% Et2O in 
hexanes containing 0.5% Et3N) to give the silyl ether 2.43 (261 mg, 91%) as a colorless oil: 1H 
NMR (300 MHz, CDCl3) δ 3.72 (t, J = 7.0 Hz, 1H), 2.99 (dd, J = 4.1, 2.8 Hz, 1H), 2.73 (dd, J = 
4.9, 4.2 Hz, 1H), 2.58 (dd, J = 5.1, 2.8 Hz, 1H), 1.98-1.73 (m, 3H), 1.58 (ddd, J = 13.7, 8.2, 5.2 
Hz, 1H), 1.24 (s, 3H), 1.20 (s, 3H), 1.19 (s, 3H), 0.95 (t, J = 8.1 Hz, 9H), 0.58 (q, J = 7.8 Hz, 
6H); 13C NMR (75 MHz, CDCl3) δ 87.7, 81.6, 74.3, 57.4, 44.2, 33.1, 28.1, 26.6, 25.5, 24.0, 7.3, 
6.9; IR (neat) 2958, 2876, 1240, 1174, 1044, 726. HRMS (ESI): m/z calcd for C16H32O3NaSi 
[M+Na]+ 323.2018, found 323.1993. 
O OSiEt3HO
 
(R)-2-Methyl-(5R)-5-(1-methyl-1-triethylsilanyloxyethyl)-2-((S)-1-triethylsilanyloxypent-4-
ynyl)tetrahydrofuran (B13) 
A mixture of n-BuLi (1.6 M in hexanes, 23.2 mL, 37.2 mmol) in 
Et2O (8 mL) at -78 °C was treated with 
tetramethylethylenediamine (1.4 mL, 9.3 mmol) followed by dropwise addition of propargyl 
bromide (80% weight in PhMe, 2.1 mL, 18.6 mmol). The resulting yellow suspension was stirred 
at -78 °C for 20 min, then transferred to a solution of epoxide 2.43 (180 mg, 0.6 mmol) in 
O OSiEt3
OH
H
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anhydrous Et2O (1.0 mL) at -78 °C quickly via syringe. The mixture was stirred at -78 °C for 1 
h, then quenched with saturated NH4Cl (20 mL)/water (10 mL) and extracted with Et2O (3 x 20 
mL). The ether solution was dried (MgSO4), filtered and concentrated. The residue was purified 
by column chromatography (4% - 12% Et2O in hexanes) to give starting material 2.43 (65 mg, 
36%) and the terminal alkyne B13 (128 mg, 63%) as a colorless oil: 1H NMR (300 MHz, CDCl3) 
δ 3.71-3.61 (m, 2H), 2.49-2.40 (m, 2H), 2.33 (ddd, J = 16.8, 8.0, 2.6 Hz, 1H), 2.04 (td, J = 11.2, 
8.2 Hz, 1H), 1.97 (t, J = 2.7 Hz, 1H), 1.96-1.83 (m, 2H), 1.74-1.65 (m, 1H), 1.56-1.44 (m, 2H), 
1.22 (s, 3H), 1.18 (s, 3H), 1.13 (s, 3H), 0.96 (t, J = 7.7 Hz, 9H), 0.59 (q, J = 8.0 Hz, 6H); 13C 
NMR (75 MHz, CDCl3) δ 88.9, 85.9, 84.7, 75.6, 74.1, 68.6, 31.1, 30.9, 27.7, 26.9, 26.1, 24.0, 
16.1, 7.3, 7.0. 
 
(S)-1-[(2R)-2-Methyl-(5R)-5-(1-methyl-1-triethylsilanyloxy-ethyl)-tetrahydro-furan-2-yl]-
pent-4-yn-1-ol (2.44) 
A solution of the secondary alcohol B13 (120 mg, 0.352 mmol) 
in CH2Cl2 (3.5 mL) at 0 °C was treated with imidazole (27 mg, 
0.396 mmol), TESCl (65 μL, 0.387 mmol) and DMAP (2.1 mg, 17 μmol) sequentially, and the 
cold bath was removed. After 1 h, the reaction mixture was concentrated and the residue was 
purified by column chromatography (1% - 3% Et2O in hexanes) to give the bis-silyl ether 2.44 
(145 mg, 91%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ 3.67-3.63 (m, 2H), 2.38-2.29 (m, 
1H), 2.23 (ddd, J = 16.9, 7.9, 2.6 Hz, 1H), 1.99-1.74 (m, 5H), 1.59-1.47 (m, 2H), 1.19 (s, 3H), 
1.17 (s, 3H), 1.09 (s, 3H), 1.00-0.93 (m, 18H), 0.68-0.55 (m, 12H); 13C NMR (75 MHz, CDCl3) δ 
87.4, 85.8, 85.2, 76.3, 74.3, 68.4, 34.6, 32.8, 28.1, 26.5, 25.7, 22.7, 15.9, 7.3, 7.3, 7.0, 5.7. 
O OSiEt3
OSiEt3
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(2R)-2-Methyl-(5R)-5-(1-methyl-1-triethylsilanyloxyethyl)-2-((1S)-4-tributylstannanyl-1-
triethylsilanyloxypent-4-enyl)tetrahydrofuran (B14) 
A solution of iPr2NH (0.57 mL, 4.05 mmol) in THF (3.5 
mL) at 0 °C was treated with n-BuLi (1.6 M in hexanes, 2.3 
mL, 3.6 mmol). After 30 min, the flask was cooled to -30 °C and a solution of n-Bu3SnH (0.97 
mL, 3.6 mmol) in THF (2.1 mL) was added dropwise. The pale yellow solution was stirred for 1 
h and Et2AlCl (1 M in heptane, 3.0 mL, 3.0 mmol) was added. The mixture was stirred at -30 °C 
for 5 h to form an n-Bu3SnAlEt2 solution (~0.244 M).  
O OSiEt3
OSiEt3
H
Bu3Sn
A solution of terminal alkyne 2.44 (140 mg, 0.308 mmol) in THF (11 mL) at -30 °C was treated 
with n-Bu3SnAlEt2 solution (6.2 mL, ~1.5 mmol) followed by CuCN (8.3 mg, 92.4 μmol). After 
1 h, the n-Bu3SnAlEt2 solution (2.0 mL, ~0.5 mmol) and CuCN (8.0 mg, 89 μmol) were added. 
The mixture was stirred at -30 °C for 5 h, and then stored at -20 °C overnight. The reaction was 
quenched with saturated NH4Cl (20 mL) and extracted with Et2O (3 x 20 mL). The ether solution 
was dried (MgSO4), filtered and concentrated. The residue was purified by column 
chromatography (2% - 2.5% Et2O in hexanes) to give the desired vinyl stannane B14 (67.8 mg, 
29%) and unreacted starting material 2.44 (71.9 mg, 51%). For vinyl stannane: 1H NMR (500 
MHz, CDCl3) δ 5.70 (J = 84.6, 0.8 Hz, 1H), 5.10 (J = 38.7, 1.5 Hz, 1H), 3.64 (dd, J = 5.5, 3.7 Hz, 
1H), 3.52 (dd, J = 5.0, 1.9 Hz, 1H), 2.42 (dt, J = 8.2, 2.8 Hz, 1H), 2.22 (dt, J = 7.5, 2.8 Hz, 1H), 
1.97 (dt, J = 6.5, 4.8 Hz, 1H), 1.92-1.84 (m, 1H), 1.82-1.76 (m, 1H), 1.66 (tt, J = 8.0, 2.0 Hz, 1H), 
1.57-1.29 (m, 14H), 1.19 (s, 3H), 1.17 (s, 3H), 1.08 (s, 3H), 0.99-0.88 (m, 33H), 0.66-0.56 (m, 
12H). 
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2-((1S)-4-Iodo-1-triethylsilanyloxypent-4-enyl)-(2R)-2-methyl-(5R)-5-(1-methyl-1-
triethylsilanyloxy-ethyl)tetrahydrofuran (2.45) 
A solution of the vinyl stannane B14 (62 mg, 83 μmol) in 
CH2Cl2 (1.6 mL) was treated with I2 (23 mg, 91μmol). The 
slightly purple solution was stirred for 10 min, then quenched with saturated Na2S2O3 solution (5 
mL) and extracted with CH2Cl2 (3 x 15 mL). The organic extract was dried (Na2SO4), filtered 
and concentrated. The residue was purified by column chromatography (2% Et2O in hexanes 
containing 0.5% Et3N) to give the vinyl iodide 2.45 (41.7 mg, 86%) as a colorless oil: 1H NMR 
(300 MHz, CDCl3) δ 6.04 (q, J = 1.4 Hz, 1H), 5.69 (d, J = 0.8 Hz, 1H), 3.66-3.61 (m, 1H), 3.54 
(dd, J = 7.5, 4.1 Hz, 1H), 2.60-2.41 (m, 2H), 1.99-1.73 (m, 4H), 1.60-1.50 (m, 2H), 1.19 (s, 3H), 
1.17 (s, 3H), 1.10 (s, 3H), 1.00-0.93 (m, 18H), 0.67-0.54 (m, 12H); 13C NMR (75 MHz, CDCl3) 
δ 125.2, 113.1, 87.4, 85.9, 76.8, 74.2, 42.9, 34.9, 33.9, 28.0, 26.5, 25.8, 22.6, 7.4, 7.0, 5.7; IR 
(neat) 2956, 2876, 1459, 1238, 1173, 1099, 1068. HRMS (ESI): m/z calcd for C25H51IO3NaSi 
[M+Na]+ 605.2319, found 605.2341. 
O OSiEt3
OSiEt3
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APPENDIX C 
MULTICOMPONENT APPROACH TO THE SYNTHESIS OF OXIDIZED AMIDES 
THROUGH NITRILE HYDROZIRCONATION (SUPPORTING INFORMATION) 
General Experimental Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded at ambient temperature on Bruker Avance 300 spectrometer at 300 MHz 
and 75 MHz or Bruker Avance 500 spectrometer at 500 MHz and 125 MHz if specified. The 
chemical shifts are given in parts per million (ppm) on the delta (δ) scale. The solvent peak was 
used as a reference value, for 1H NMR: CDCl3 = 7.27 ppm, CD3OD = 3.31, for 13C NMR: CDCl3 
= 77.23, CD3OD = 49.00. Data are reported as follows: (s = singlet; d = doublet; t = triplet; q = 
quartet; sept = septet; sext = sextet; dd = doublet of doublets; ddd = doublet of doublet of 
doublets; dt = doublet of triplets; td = triplet of doublets; dtd = doublet of triplet of doublets; br = 
broad; app = apparently). High resolution mass spectra were recorded on a MICROMASS 
AUTOSPEC (for EI) or WATERS Q-TOF API-US (for ESI) spectrometer. Infrared (IR) spectra 
were collected on a Mattson Cygnus 100 spectrometer. Samples for IR were prepared as a thin 
film on a NaCl plate by dissolving the compound in CH2Cl2 and then evaporating the CH2Cl2. 
Optical rotations were measured on a Perkin-Elmer 241 polarimeter at ambient temperature. 
Tetrahydrofuran and diethyl ether were distilled from sodium and benzophenone. Methylene 
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chloride and benzene was distilled under N2 from CaH2. Anhydrous CH2Cl2 was obtained 
through distillation from CaH2. PhOCOCl, iPrCOCl, MeOCH2COCl, CbzCl, PhSH, Et3N, and 
BF3•OEt2 were distilled prior to use. MeOH and tBuOH were distilled from Mg and stored over 
4 Å molecular sieves prior to use. PhOH was azeotroped with toluene and dried under high 
vacuum before use. Methanesulfonic anhydride was purchased from Aldrich and used without 
further purification. Anhydrous Mg(ClO4)2 and Zn(OTf)2 were purchased from Aldrich and 
Fluka, respectively, stored in dessicator, and used as received. Analytical TLC was performed on 
E. Merck pre-coated (25 mm) silica gel 60F-254 plates. Visualization was done under UV (254 
nm). Flash chromatography was done using ICN SiliTech 32-63 60 Å silica gel. Reagent grade 
ethyl acetate, diethyl ether and hexanes (commercial mixture) were purchased from EM Science 
and used as is for chromatography. All reactions were performed in oven or flame-dried 
glassware under Ar with magnetic stirring unless otherwise noted. Schwartz’ reagent, though 
commercially available, was prepared according to the literature.112 All the compounds in this 
work were prepared in their racemic form unless otherwise noted.  
 
Phenyl (1R,2R)-1,2-dimethoxyoctylcarbamate (3.2) and phenyl (1S,2R)-1,2-dimethoxy-
octylcarbamate (3.3) 
A solution of 2-methoxyoctanenitrile 3.1 
(70.0 mg, 0.451 mmol) in CH2Cl2 (43.5 
mL) was treated with Cp2Zr(H)Cl (140 mg, 0.541 mmol). The reaction was stirred for 15 min, 
then cooled to 0 °C and phenyl chloroformate (79 μL, 0.631 mmol) was added dropwise. The 
cold bath was removed and the mixture was stirred for 10 min. After that time, the flask was 
cooled to 0 °C and phenyl chloroformate (56 μL, 0.451 mmol) was added. The mixture was 
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stirred at room temperature for 15 min and then cooled to 0 °C. A solution of MeOH (0.36 ml, 
9.02 mmol) in CH2Cl2 (0.6 mL) was added dropwise. The reaction was stirred for 15 min at 0 °C 
and then quenched with saturated NaHCO3 (25 mL). The mixture was extracted with CH2Cl2 (4 
x 20 mL) and the combined organic extracts were dried (Na2SO4) and concentrated. The residue 
was purified by column chromatography (6% - 120% EtOAc in hexanes containing 0.5% Et3N) 
to give the desired product (77.2 mg, 55.3%) as a colorless oil in a 2.4:1.0 diastereomeric ratio. 
Further purification by column chromatography (8% - 14% EtOAc in hexanes containing 0.5% 
Et3N) yielded analytically pure samples. For faster eluting anti-product 3.2: 1H NMR (300 MHz, 
CDCl3) 7.38 (app t, J = 7.7 Hz, 2H), 7.24-7.12 (m, 3H), 5.90 (d, J = 9.8 Hz, 1H), 4.88 (d, J = 
10.0 Hz, 1H), 3.59-3.49 (m, 1H), 3.52 (s, 3H), 3.44 (s, 3H), 1.55-1.27 (m, 10H), 0.90 (t, J = 6.9 
Hz, 3H); 13C NMR (75 MHz, CDCl3) 155.2, 151.0, 129.5, 125.6, 121.7, 85.6, 82.4, 59.7, 56.0, 
31.9, 31.4, 29.5, 25.6, 22.8, 14.3; IR (neat) 3322, 2930, 2857, 1747, 1515, 1487, 1334, 1206, 
1103, 1025, 952, 738; HRMS (ESI): m/z calcd for C17H27NO4Na [M+Na]+ 332.1838, found 
332.1830. For slower eluting syn-product 3.3: 1H NMR (300 MHz, CDCl3) 7.40-7.34 (m, 2H), 
7.29-7.22 (m, 3H), 5.82 (d, J = 9.7 Hz, 1H), 5.00 (dd, J = 10.0, 2.9 Hz, 1H), 3.41 (s, 3H), 3.40 (s, 
3H), 3.18 (dt, J = 6.8, 2.9 Hz, 1H), 1.62-1.55 (m, 2H), 1.40-1.24 (m, 8H), 0.90 (t, J = 6.8 Hz, 
3H); 13C NMR (75 MHz, CDCl3) 154.9, 151.0, 129.5, 125.7, 121.7, 82.9, 82.6, 58.4, 56.5, 31.9, 
29.7, 29.0, 25.6, 22.8, 14.3; IR (neat) 3324, 2928, 2857, 1747, 1523, 1488, 1356, 1209, 1086, 
954; HRMS (ESI): m/z calcd for C17H27NO4Na [M+Na]+ 332.1838, found 332.1841. 
 
(E)-Ethyl non-2-enoate (3.7) 
1H NMR (300 MHz, CDCl3) 6.97 (td, J = 15.6, 7.0 Hz, 1H), 5.81 (td, J = 
15.7, 1.5 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 2.20 (qd, J = 7.0, 1.5 Hz, 2H), 4
EtO
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1.50-1.41 (m, 2H), 1.36-1.27 (m, 9H), 0.89 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
167.0, 149.7, 121.4, 60.3, 32.4, 31.8, 29.0, 28.2, 22.8, 14.5, 14.3. 
 
(2S,3R)-Ethyl 2,3-dihydroxynonanoate (C1) 
A mixture of AD-mix-β in tBuOH/H2O (20 mL, 1:1, v/v) at 0 °C was 
treated with CH3SO2NH2 (0.190 g, 2.00 mmol) followed by a solution of 
enoate 3.7 (0.368 g, 2.00 mmol) in tBuOH (0.5 mL). The mixture was stirred at 0 °C for 6 h and 
then at room temperature for 10 h. The reaction was cooled to 0 °C and quenched with Na2SO3 
solution (10%, 30 mL). After stirred at 0 °C for 1 h, the mixture was extracted with CH2Cl2 (3 x 
30 mL). The organic extracts were dried (MgSO4) and concentrated. The residue was purified by 
column chromatography (30% - 40% EtOAc in hexanes) to give the diol C1 (0.402 g, 92.0%) as 
a white solid: 1H NMR (300 MHz, CDCl3) 4.29 (q, J = 7.1 Hz, 2H), 4.08 (dd, J = 5.3, 2.0 Hz, 
1H), 3.88 (dtd, J = 8.9, 6.9, 2.1 Hz, 1H), 3.12 (d, J = 5.3 Hz, 1H), 1.98 (d, J = 9.2 Hz, 1H), 1.64-
1.58 (m, 2H), 1.52-1.44 (m, 1H), 1.39-1.25 (m, 10H), 0.89 (t, J = 6.9 Hz, 3H); 13C NMR (75 
MHz, CDCl3) 173.9, 73.2, 72.7, 62.3, 34.0, 32.0, 29.4, 25.9, 22.8, 14.4, 14.3; IR (neat) 3377, 
2925, 2854, 1737, 1462, 1294, 1136, 1099, 1072; HRMS (ESI): m/z calcd for C11H22O4Na 
[M+Na]+ 241.1416, found 241.1420; [α]D = +12.6 (CHCl3, c 0.98). 
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(2S,3R)-Ethyl 2,3-dimethoxynonanoate (C2) 
A solution of the diol C1 (170.0 mg, 0.779 mmol) in CH2Cl2 (4.0 mL) were 
treated with Ag2O (271 mg, 1.17 mmol) and MeI (0.22 mL, 3.50 mmol). 
The reaction was refluxed for 10 h, and Ag2O (271 mg, 1.17 mmol) and MeI (0.22 mL, 3.50 
mmol) were added sequentially. After 12 h, Ag2O (271 mg, 1.17 mmol) and MeI (0.22 mL, 3.50 
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mmol) were added. The mixture was refluxed for another 6 h, then filter through Celite and the 
residue was washed with CH2Cl2 (30 mL). The combined filtrate was concentrated and the 
resulting residue was purified by column chromatography (5% - 15% EtOAc in hexanes) to give 
the desired product C2 (59.4 mg, 31.0%) as a colorless oil: 1H NMR (300 MHz, CDCl3) 4.32-
4.21 (m, 2H), 3.78 (d, J = 4.1 Hz, 1H), 3.51 (dt, J = 6.5, 4.1 Hz, 1H), 3.44 (s, 3H), 3.39 (s, 3H), 
1.61-1.54 (m, 2H), 1.34-1.26 (m, 11H), 0.89 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
171.4, 82.7, 82.0, 61.1, 59.2, 58.6, 32.0, 30.1, 29.6, 25.8, 22.8, 14.5, 14.3; IR (neat) 2927, 1747, 
1464, 1261, 1190, 1143, 1105, 1031; HRMS (ESI): m/z calcd for C13H26O4Na [M+Na]+ 
269.1729, found 269.1713; [α]D = -29.7 (CHCl3, c 0.63). 
 
(2S,3R)-2,3-Dimethoxynonanoic acid (3.8) 
A solution of the ethyl ester C2 (40.0 mg, 0.162 mmol) in 1,2-
dimethoxyethane/H2O (2.8 mL, 4:1, v/v) was treated with LiOH·H2O (13.6 
mg, 0.324 mmol). After 3 and 4 h, LiOH·H2O (6.8 mg, 0.162 mmol) was 
added, respectively. The reaction was stirred for another 3 h, then quenched with HCl (0.5 N, 
~1.0 mL) to pH~1.5 and extracted with Et2O (5 x 10 mL). The combined organic extracts were 
dried (Na2SO4) and concentrated. The residue was purified by column chromatography (30% 
EtOAc in hexanes followed by 50% MeOH in EtOAc) to give the unreacted ester (7.6 mg, 
19.0%) and carboxylic acid 3.8 (28.1 mg, 79.4%) as a white sticky solid: 1H NMR (300 MHz, 
CD3OD) 3.66 (d, J = 3.0 Hz, 1H), 3.54 (dt, J = 6.7, 3.1 Hz, 1H), 3.42 (s, 3H), 3.41 (s, 3H), 1.69-
1.57 (m, 2H), 1.46-1.29 (m, 8H), 0.91 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CD3OD) 178.2, 
84.9, 83.9, 59.4, 58.9, 32.9, 31.2, 30.5, 26.8, 23.7, 14.4; IR (neat) 3401, 2926, 2856, 1618, 1418, 
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1194, 1091; HRMS (ESI): m/z calcd for C11H22O4Na [M+Na]+ 241.1416, found 241.1407; [α]D = 
-26.0 (CH3OH, c 0.77). 
 
Phenyl (1S,2R)-1,2-dimethoxyoctylcarbamate ((-)-3.3) 
A stirred solution of the carboxylic acid 3.8 (15.4 mg, 70.5 μmol) in 
benzene (2.0 mL) was treated with Et3N (0.12 ml, 0.846 mmol) and 
diphenyl phosphoryl azide (61 μL, 0.282 mmol). After 2 h, diphenylphosphoryl azide (30 μL, 
0.140 mmol) was added. The reaction was stirred for 2 h, then quenched with water (10 mL) and 
extracted with Et2O (3 x 20 mL). The organic extracts were dried (Na2SO4) and concentrated. 
The residue was purified by column chromatography (5% - 15% EtOAc in hexanes) to give the 
carbamate (-)-3.3 (11.4 mg, 52.3%) as a colorless oil: [α]D = -3.8 (CHCl3, c 0.52). No other 
diastereomer was observed. 
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2-Ethoxyoctanenitrile (3.11) 
A mixture of heptanal (4.00 g, 35.0 mmol), absolute EtOH (80 ml), (EtO)3CH 
(5.8 mL, 35.0 mmol) and the activated 4Å molecular sieves (4.00 g) at 0 °C was 
treated dropwise with concentrated H2SO4 (2.0 ml) and the mixture was stirred at room 
temperature overnight. After that time, the reaction mixture was concentrated to ~30 mL and 
slowly poured onto a cold saturated NaHCO3 solution (80 mL) at 0 °C. The resulting mixture 
was filtered through Celite. The filtrate was extracted with CH2Cl2 (3 x 80mL) and the extracts 
were dried (Na2SO4) and concentrated. The resulting residue was dissolved in CH2Cl2 (70 mL), 
and BiBr3 (1.57 g, 3.50 mmol) and TMSCN (5.60 ml, 42.0 mmol) were added sequentially. The 
reaction was stirred overnight, then quenched with saturated NaHCO3 solution (50 mL)/water 
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(20 mL) and extracted with CH2Cl2 (3 x 100mL). The combined extracts were dried (Na2SO4) 
and concentrated. The residue was purified by column chromatography (2% - 5% EtOAc in 
hexanes) to give the ethoxy nitrile 3.11 (4.51 g, 76.0%) as a colorless liquid. 1H NMR (300 
MHz, CDCl3) 4.11 (t, J = 6.6 Hz, 1H), 3.82 (qd, J = 8.8, 6.9 Hz, 1H), 3.51 (qd, J = 8.9, 7.0 Hz, 
1H), 1.87-1.80 (m, 2H), 1.52-1.44 (m, 2H), 1.38-1.30 (m, 6H), 1.26 (t, J = 7.0 Hz, 3H), 0.89 (t, J 
= 6.7 Hz, 3H); 13C NMR (75 MHz, CDCl3) 118.9, 69.0, 66.4, 33.8, 31.7, 28.9, 24.9, 22.7, 15.0, 
14.2; IR (neat) 2957, 2930, 2860, 1468, 1335, 1126, 1108, 735; HRMS (EI): m/z calcd for 
C10H19NO (M+•) 169.1467, found 169.1474. 
 
Representative procedure for the preparation of acyl aminals: 
N-((1R,2R)-2-Ethoxy-1-methoxyoctyl)isobutyramide (3.12) and N-((1S,2R)-2-ethoxy-1-
methoxyoctyl)isobutyramide (3.13) 
A solution of ethoxynitrile 3.11 (100.0 
mg, 0.591 mmol) in CH2Cl2 (4.5 mL) 
was treated with Cp2Zr(H)Cl (229 mg, 
0.886 mmol). The reaction was stirred for 15 min, then cooled to 0 °C and isobutyryl chloride 
(94 μL, 0.886 mmol) was added dropwise. The mixture was stirred for 15 min at 0 °C and 
MeOH (1.0 mL, 23.6 mmol) was added dropwise. The reaction was stirred for 15 min at 0 °C 
and quenched with AcOH (2.0 mL)/water (20 mL). The mixture was extracted with CH2Cl2 (3 x 
25 mL) and the combined organic extracts were washed with saturated NaHCO3 (15 mL), dried 
(Na2SO4) and concentrated. The residue was purified by column chromatography (15% - 30% 
EtOAc in hexanes) to give the desired product (121.3 mg, 75.1%) as a white solid in a 2.3:1.0 
diastereomeric ratio. Further purification (15% - 30% EtOAc in hexanes) yielded analytically 
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pure samples. For faster eluting anti-product 3.12: 1H NMR (300 MHz, CDCl3) 6.20 (d, J = 9.5 
Hz, 1H), 5.01 (dd, J = 9.7, 1.4 Hz, 1H), 3.74 (qd, J = 9.4, 7.0 Hz, 1H), 3.54 (qd, 9.4, 7.1 Hz, 1H), 
3.47-3.43 (m, 1H), 3.29 (s, 3H), 2.40 (sept, J = 6.9 Hz, 1H), 1.37-1.23 (m, 10H), 1.18-1.14 (m, 
9H), 0.84 (app t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 177.9, 82.6, 80.6, 67.3, 55.8, 36.1, 
31.9, 31.8, 29.4, 25.6, 22.7, 19.8, 19.7, 15.8, 14.2; IR (neat) 3271, 2965, 2920, 1653, 1540, 1467, 
1233, 1113, 1101; HRMS (EI): m/z calcd for C14H28NO2 (M-CH3O)+• 242.2120, found 242.2123. 
For slower eluting syn-product 3.13: 1H NMR (300 MHz, CDCl3) 6.20 (d, J = 9.7 Hz, 1H), 5.17 
(dd, J = 9.8, 2.9 Hz, 1H), 3.66 (qd, J = 9.4, 7.0 Hz, 1H), 3.46 (qd, J = 9.3, 7.0 Hz, 1H), 3.36 (s, 
3H), 3.24 (dt, J = 6.8, 2.9 Hz, 1H), 2.42 (sept, J = 6.9 Hz, 1H), 1.63-1.55 (m, 2H), 1.40-1.25 (m, 
10H), 1.23-1.17 (m, 9H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 177.5, 81.0, 80.0, 
66.1, 56.4, 36.2, 31.9, 29.8, 29.7, 25.6, 22.8, 19.9, 19.7, 15.8, 14.2; IR (neat) 3273, 2971, 2921, 
1651, 1538, 1467, 1154, 1103, 1072; HRMS (EI): m/z calcd for C14H28NO2 (M-CH3O)+• 
242.2120, found 242.2119. 
 
N-((1R,2R)-2-Ethoxy-1-methoxyoctyl)-2-methoxyacetamide (3.14) and N-((1S,2R)-2-ethoxy-
1-methoxyoctyl)-2-methoxyacetamide (3.15) 
The title compounds were 
prepared by following the 
representative procedure with the following amounts of reagents: ethoxynitrile 3.11 (100.0 mg, 
0.591 mmol), CH2Cl2 (4.5 mL), Cp2Zr(H)Cl (168 mg, 0.650 mmol), methoxyacetyl chloride (65 
μL, 0.709 mmol) MeOH (1.0 ml, 23.6 mmol). The reaction was quenched with 1 N HCl (2.0 
mL)/water (15 mL) and extracted with CH2Cl2 (3 x 25 mL). The combined organic extracts were 
washed with saturated NaHCO3 (15 mL), dried (Na2SO4) and concentrated. The residue was 
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purified by column chromatography (20% - 40% EtOAc in hexanes) to give the desired product 
(111.8 mg, 68.7%) as a colorless oil in a 1.7:1.0 diastereomeric ratio. Further purification (20% - 
40% EtOAc in hexanes) yielded analytically pure samples. For the faster eluting anti-product 
3.14: 1H NMR (300 MHz, CDCl3) 7.18 (d, J = 9.8 Hz, 1H), 5.06 (dd, J = 10.0, 1.5 Hz, 1H), 3.98 
(d, J = 15.2 Hz, 1H), 3.90 (d, J = 15.2 Hz, 1H), 3.76 (qd, J = 9.4, 7.0 Hz, 1H), 3.56 (qd, J = 9.3, 
7.0 Hz, 1H), 3.49-3.45 (m, 1H), 3.43 (s, 3H), 3.33 (s, 3H), 1.45-1.25 (m, 10H), 1.18 (t, J = 7.0 
Hz, 3H), 0.86 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) 170.8, 82.4, 80.5, 72.0, 67.3, 59.4, 
56.1, 31.9, 31.8, 29.4, 25.7, 22.8, 15.8, 14.2; IR (neat) 3413, 2930, 2858, 1695, 1506, 1113; 
HRMS (EI): m/z calcd for C13H26NO3 (M-CH3O)+• 244.1913, found 244.1925. For the slower 
eluting syn-product 3.15: 1H NMR (300 MHz, CDCl3) 7.22 (d, J = 10.0 Hz, 1H), 5.18 (dd, J = 
10.1, 3.0 Hz, 1H), 3.98 (d, J = 15.3 Hz, 1H), 3.92 (d, J = 15.3 Hz, 1H), 3.66 (qd, J = 9.2, 7.0 Hz, 
1H), 3.50 (qd, J = 9.2, 7.0 Hz, 1H), 3.43 (s, 3H), 3.36 (s, 3H), 3.26 (dt, J = 6.8, 3.0 Hz, 1H), 
1.63-1.55 (m, 2H), 1.41-1.29 (m, 8H), 1.21 (t, J = 7.0 Hz, 3H), 0.88 (t, J = 6.8 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) 170.4, 81.0, 79.8, 72.0, 66.5, 59.4, 56.5, 31.9, 29.9, 29.6, 25.7, 22.8, 
15.7, 14.3; IR (neat) 3417, 2928, 2858, 1686, 1510, 1112, 1078; HRMS (EI): m/z calcd for 
C13H26NO3 (M-CH3O)+• 244.1913, found 244.1917. 
 
Benzyl (1R,2R)-2-ethoxy-1-methoxyoctylcarbamate (3.16) and benzyl (1S,2R)-2-ethoxy-1-
methoxyoctylcarbamate (3.17) 
The title compounds were prepared 
by following the representative 
procedure with the following amounts of reagents: ethoxynitrile 3.11 (60.0 mg, 0.354 mmol), 
CH2Cl2 (3.5 mL), Cp2Zr(H)Cl (110.0 mg, 0.425 mmol). After completion of hydrozirconation, 
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the reaction mixture was cooled to 0 °C and benzyl chloroformate (71 μL, 0.500 mmol) was 
added dropwise. The cold bath was removed and the mixture was stirred for 10 min. After that 
time, the flask was cooled to 0 °C and benzyl chloroformate (50 μL, 0.354 mmol) was added. 
The mixture was stirred at room temperature for 30 min and then cooled to 0 °C. A solution of 
MeOH (0.28 ml, 7.08 mmol) in CH2Cl2 (0.5 mL) was added dropwise. The reaction was stirred 
for 10 min at 0 °C and then quenched with saturated NaHCO3 (20 mL). The mixture was 
extracted with CH2Cl2 (3 x 20 mL) and the combined organic extracts were dried (Na2SO4) and 
concentrated. The residue was purified by column chromatography (5% - 20% EtOAc in hexanes 
containing 0.5% Et3N) to give the desired product (76.3 mg, 63.8%) as a colorless oil in a 1.5:1.0 
diastereomeric ratio. Further purification (10% - 13% EtOAc in hexanes containing 0.5% Et3N) 
yielded analytically pure materials. For faster eluting anti-product 3.16: 1H NMR (300 MHz, 
CDCl3) 7.39-7.30 (m, 5H), 5.66 (d, J = 9.8 Hz, 1H), 5.14 (s, 2H), 4.82 (dd, J = 9.9, 1.0 Hz, 1H), 
3.74 (qd, J = 9.3, 7.0 Hz, 1H), 3.56 (qd, J = 9.2, 7.0 Hz, 1H), 3.48-3.44 (m, 1H), 3.37 (s, 3H), 
1.46-1.28 (m, 10H), 1.17 (t, J = 7.0 Hz, 3H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) 156.8, 136.6, 128.7, 128.4, 128.2, 85.6, 80.6, 67.4, 67.1, 55.7, 31.9, 29.5, 25.7, 22.8, 
15.9, 14.3; IR (neat) 3337, 2929, 2858, 1731, 1497, 1456, 1326, 1216, 1107, 966, 735; HRMS 
(ESI): m/z calcd for C19H31NO4Na [M+Na]+ 360.2151, found 360.2148. For slower eluting syn-
product 3.17: 1H NMR (300 MHz, CDCl3) 7.40-7.31 (m, 5H), 5.54 (d, J = 10.0 Hz, 1H), 
5.15/5.14 (two s, 2H), 4.94 (dd, J = 10.1, 2.9 Hz, 1H), 3.64 (qd, J = 9.2, 7.0 Hz, 1H), 3.48 (qd, J 
= 9.2, 7.0 Hz, 1H), 3.38 (s, 3H), 3.28 (dt, J = 6.8, 2.9 Hz, 1H), 1.63-1.52 (m, 2H), 1.41-1.26 (m, 
8H), 1.20 (t, J = 7.0 Hz, 3H), 0.89 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 156.6, 136.5, 
128.8, 128.5, 128.4, 82.9, 81.1, 77.4, 67.2, 66.2, 56.3, 31.9, 29.7, 29.6, 25.7, 22.8, 15.8, 14.3; IR 
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(neat) 3334, 2928, 2858, 1729, 1501, 1455, 1232, 1097, 737; HRMS (ESI): m/z calcd for 
C19H31NO4Na [M+Na]+ 360.2151, found 360.2149. 
 
N-(2-Ethoxy-1-methoxyoctyl)methanesulfonamide (3.18 and 3.19) 
The title compounds were prepared by 
following the representative procedure with 
the following amounts of reagents: ethoxynitrile 3.11 (100.0 mg, 0.591 mmol), CH2Cl2 (4.5 mL), 
Cp2Zr(H)Cl (228 mg, 0.886 mmol). After addition of methanesulfonic anhydride (144 mg, 0.827 
mmol), The mixture was stirred for 2 min at 0 °C and MeOH (1.0 mL, 23.6 mmol) was added 
dropwise. The reaction was stirred for 10 min at 0 °C and quenched with saturated NaHCO3 (15 
mL). The mixture was extracted with CH2Cl2 (3 x 20 mL) and the combined organic extracts 
were dried (Na2SO4) and concentrated. The residue was purified by column chromatography 
(20% - 30% EtOAc in hexanes) to give the desired product (40.8 mg, 24.5%) as a colorless oil in 
a 2.4:1.0 diastereomeric ratio: 1H NMR (300 MHz, CDCl3) 5.42 (d, J = 9.4 Hz, 71% of 1H), 5.22 
(d, J = 9.5 Hz, 29% of 1H), 4.64 (dd, J = 9.5, 3.1 Hz, 29% of 1H), 4.48 (dd, J = 9.4, 2.4 Hz, 71% 
of 1H), 3.72-3.52 (m, 2H), 3.45 (s, 29% of 3H), 3.46-3.42 (m, 71% of 1H), 3.40 (s, 71% of 3H), 
3.32 (ddd, J = 7.2, 5.6, 3.1 Hz, 29% of 1H), 3.06 (s, 29% of 3H), 3.05 (s, 71% of 3H), 1.56-1.25 
(m, 10H), 1.21 (t, J = 6.9 Hz, 29% of 3H), 1.18 (t, J = 7.0 Hz, 71% of 3H), 0.88 (app t, J = 6.8 
Hz, 3H); 13C NMR (75 MHz, CDCl3) 88.1 (major), 86.0 (minor), 81.2 (minor), 79.5 (major), 
67.2 (major), 66.4 (minor), 56.5, (minor), 55.7 (major), 43.3 (major), 43.2 (minor), 31.9, 31.6 
(major), 29.6 (minor), 29.5 (major), 29.3 (minor), 25.8 (minor), 25.4 (major), 22.8, 15.8 (major), 
15.7 (minor), 14.2; IR (neat) 3286, 2926, 2858, 1458, 1328, 1161, 1110, 978, 766; HRMS (EI): 
m/z calcd for C11H24NO3S (M-CH3O)+• 250.1477, found 250.1466. 
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 N-((1R,2R)-2-Ethoxy-1-tert-butoxyoctyl)isobutyramide (3.21) and N-((1S,2R)-2-ethoxy-1-
tert-butoxyoctyl)isobutyramide (3.22) 
The title compounds were prepared 
by following the representative 
procedure with the following amounts of reagents: ethoxynitrile 3.11 (60.0 mg, 0.354 mmol), 
CH2Cl2 (3.5 mL), Cp2Zr(H)Cl (110.0 mg, 0.425 mmol). After addition of isobutyryl chloride (52 
μL, 0.500 mmol), the cold bath was removed and the mixture was stirred for 10 min. After that 
time, the flask was cooled to 0 °C and a solution of tBuOH (0.67 ml, 7.08 mmol) in CH2Cl2 (0.5 
mL) was added dropwise to the reaction mixture over 3 min. The reaction was stirred for 10 min 
at 0 °C, then diluted with CH2Cl2 (10 mL) and quenched with saturated NaHCO3 (20 mL). The 
organic layer was separated and the aqueous layer was extracted with CH2Cl2 (3 x 15 mL). The 
combined organic extracts were dried (Na2SO4) and concentrated. The residue was purified by 
column chromatography (10% - 20% EtOAc in hexanes containing 0.5% Et3N) to give the 
desired product (79.2 mg, 70.8%) as a white solid in a 1.0:2.0 diastereomeric ratio. Further 
purification (12% - 18% EtOAc in hexanes containing 0.5% Et3N) yielded analytically pure 
samples. For faster eluting anti-product 3.21: 1H NMR (300 MHz, CDCl3) 6.10 (d, J = 9.2 Hz, 
1H), 5.32 (dd, J = 9.4, 2.0 Hz, 1H), 3.84 (qd, J = 9.6, 7.1 Hz, 1H), 3.58 (qd, J = 9.6, 7.0 Hz, 1H), 
3.30-3.26 (m, 1H), 2.33 (sept, J = 6.9 Hz, 1H), 1.38-1.27 (m, 10H), 1.22 (s, 9H), 1.19-1.12 (m, 
9H), 0.87 (t, J = 6.8 Hz, 3H), 13C NMR (75 MHz, CDCl3) 175.8, 83.0, 75.5, 74.6, 67.6, 36.1, 
32.0, 31.6, 29.5, 28.6, 25.9, 22.8, 19.7, 19.4, 15.9, 14.3; IR (neat) 3246, 2969, 2922, 2858, 1648, 
1552, 1466, 1109, 1069; HRMS (ESI): m/z calcd for C18H37NO3Na [M+Na]+ 338.2671, found 
338.2663. For slower eluting syn-product 3.22: 1H NMR (300 MHz, CDCl3) 6.00 (d, J = 9.2 Hz, 
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1H), 5.39 (dd, J = 9.4, 4.0 Hz, 1H), 3.64-3.54 (m, 2H), 3.14-3.09 (m, 1H), 2.30 (sept, J = 6.9 Hz, 
1H), 1.51-1.38 (m, 2H), 1.35-1.24 (m, 8H), 1.20 (s, 9H), 1.19-1.11 (m, 9H), 0.87 (t, J = 6.9 Hz, 
3H); 13C NMR (75 MHz, CDCl3) 175.3, 82.1, 74.9, 74.3, 66.8, 36.1, 32.0, 30.2, 29.6, 28.5, 26.0, 
22.8, 19.5, 19.4, 15.8, 14.3; IR (neat) 3254, 2960, 2920, 2856, 1646, 1544, 1459, 1365, 1193, 
1109, 1072, 731; HRMS (ESI): m/z calcd for C18H37NO3Na [M+Na]+ 338.2671, found 338.2666. 
 
N-((1R,2R)-2-Ethoxy-1-phenoxyoctyl)isobutyramide (3.23) and N-((1S,2R)-2-ethoxy-1-
phenoxyoctyl)isobutyramide (3.24) 
The title compounds were prepared 
by following the representative 
procedure with the following 
amounts of reagents: ethoxynitrile 3.11 (60.0 mg, 0.354 mmol), CH2Cl2 (3.5 mL), Cp2Zr(H)Cl 
(110.0 mg, 0.425 mmol). After addition of isobutyryl chloride (52 μL, 0.500 mmol), the cold 
bath was removed and the mixture was stirred for 10 min. The mixture was cooled to °C and a 
solution of PhOH (333 mg, 3.54 mmol) in CH2Cl2 (0.5 mL) was added dropwise. The reaction 
was stirred at °C for 40 min, then quenched with saturated NaHCO3 solution (20 mL) and 
extracted with CH2Cl2 (4 x 15 mL). The organic extracts were washed with saturated Na2CO3 
solution (20 mL), dried (Na2SO4) and concentrated. The residue was purified by column 
chromatography (7% - 10% EtOAc in hexanes containing 0.5% Et3N) to give the desired product 
(81.7 mg, 68.7%) as a white solid in a 5.6:1.0 diastereomeric ratio. Further purification (7% - 
10% EtOAc in hexanes containing 0.5% Et3N) yielded analytically pure samples. For faster 
eluting anti-product 3.23: 1H NMR (300 MHz, CDCl3) 7.30-7.23 (m, 2H), 7.03 ( app td, J = 7.8, 
1.0 Hz, 2H), 6.96 (app tt, J = 7.3, 0.9 Hz, 1H), 6.36 (d, J = 9.9 Hz, 1H), 5.92 (dd, J = 9.9, 1.4 Hz, 
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1H), 3.96 (qd, J = 9.4, 7.0 Hz, 1H), 3.72 (qd, J = 9.5, 7.0 Hz, 1H), 3.68-3.64 (m, 1H), 2.37 (sept, 
J = 6.9 Hz, 1H), 1.47-1.37 (m, 4H), 1.33-1.24 (m, 9H), 1.15 (d, J = 6.9 Hz, 3H), 1.08 (d, J = 6.9 
Hz, 3H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 177.1, 156.4, 129.7, 121.8, 116.5, 
80.7, 80.0, 68.1, 36.0, 31.9, 29.4, 25.7, 22.8, 19.6, 19.5, 16.0, 14.2; IR (neat) 3290, 2964, 2929, 
2859, 1657, 1595, 1534, 1495, 1222, 1107, 753; HRMS (ESI): m/z calcd for C20H33NO3Na 
[M+Na]+ 358.2358, found 358.2359. For slower eluting syn-product 3.24 (containing trace 
amount of unknown impurity): 1H NMR (300 MHz, CDCl3) 7.30-7.24 (m, 2H), 7.07-7.04 (m, 
2H), 6.97 (app tt, J = 7.3, 0.9 Hz, 1H), 6.24 (d, J = 9.8 Hz, 1H), 6.02 (dd, J = 9.8, 3.4 Hz, 1H), 
3.72 (qd, J = 9.4, 7.0 Hz, 1H), 3.62 (qd, J = 9.4, 7.0 Hz, 1H), 3.44 (dt, J = 7.0, 3.3 Hz, 1H), 2.36 
(sept, J = 6.9 Hz, 1H), 1.71-1.62 (m, 2H), 1.47-1.21 (m, 11H), 1.15 (d, J = 6.9 Hz, 3H), 1.10 (d, 
J = 6.9 Hz, 3H), 0.87 (app t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 176.5, 156.8, 129.7, 
121.9, 116.2, 81.2, 77.8, 66.8, 36.0, 31.9, 30.1, 29.6, 25.7, 22.8, 19.6, 19.5, 15.9, 14.3; IR (neat) 
3288, 2963, 2926, 2857, 1653, 1535, 1495, 1220, 1109, 1042, 752; HRMS (ESI): m/z calcd for 
C20H33NO3Na [M+Na]+ 358.2358, found 358.2328. 
 
N-((1R,2R)-2-Ethoxy-1-(phenylthio)octyl)isobutyramide (3.25) and N-((1S,2R)-2-ethoxy-1-
(phenylthio)octyl)isobutyramide (3.26) 
The title compounds were prepared 
by following the representative 
procedure with the following amounts of reagents: ethoxynitrile 3.11 (60.0 mg, 0.354 mmol), 
CH2Cl2 (3.5 mL), Cp2Zr(H)Cl (110.0 mg, 0.425 mmol). After addition of isobutyryl chloride (52 
μL, 0.500 mmol), the cold bath was removed and the mixture was stirred for 10 min. The 
mixture was cooled to °C and a solution of PhSH (117 mg, 1.06 mmol) in CH2Cl2 (0.3 mL) was 
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added dropwise. The reaction was stirred at °C for 10 min, then quenched with saturated 
NaHCO3 solution (20 mL) and extracted with CH2Cl2 (4 x 15 mL). The organic extracts were 
dried (Na2SO4) and concentrated. The residue was purified by column chromatography (7% - 
13% EtOAc in hexanes containing 0.5% Et3N) to give the desired product (89.4 mg, 71.7%) as a 
white solid in a 1.0:7.1 diastereomeric ratio. Further purification (10% - 16% EtOAc in hexanes 
containing 0.5% Et3N) yielded analytically pure samples. For faster eluting anti-product 3.25: 1H 
NMR (300 MHz, CDCl3) 7.49-7.45 (m, 2H), 7.31-7.20 (m, 3H), 6.00 (d, J = 9.9 Hz, 1H), 5.58 
(dd, J = 10.0, 1.8 Hz, 1H), 3.76-3.63 (m, 2H), 3.56 (dt, J = 6.5, 1.7 Hz, 1H), 2.29 (sept, J = 6.9 
Hz, 1H), 1.60-1.48 (m, 1H), 1.40-1.14 (m, 12H), 1.08 (d, J = 6.9 Hz, 3H), 1.00 (d, J = 6.9 Hz, 
3H), 0.87 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 176.3, 133.9, 132.3, 129.1, 127.5, 
81.7, 67.3, 60.0, 35.9, 32.5, 31.9, 29.4, 25.7, 22.8, 19.7, 19.6, 15.9, 14.3; IR (neat) 3302, 2962, 
2928, 2859, 1652, 1497, 1440, 1379, 1223, 1098, 739; HRMS (ESI): m/z calcd for 
C20H33NO2SNa [M+Na]+ 374.2130, found 374.2130. For slower eluting syn-product 3.26: 1H 
NMR (300 MHz, CDCl3) 7.47-7.44 (m, 2H), 7.30-7.18 (m, 3H), 6.00 (d, J = 9.5 Hz, 1H), 5.63 
(dd, J = 9.7, 3.2 Hz, 1H), 3.69-3.49 (m, 3H), 2.25 (sept, J = 6.9 Hz, 1H), 1.73-1.66 (m, 2H), 
1.42-1.28 (m, 8H), 1.21 (t, J = 7.0 Hz, 3H), 1.06 (d, J = 6.9 Hz, 3H), 0.98 (d, J = 6.9 Hz, 3H), 
0.88 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 176.0, 133.6, 132.0, 129.1, 127.3, 82.0, 
66.0, 59.8, 35.8, 31.9, 31.6, 29.5, 25.8, 22.7, 19.6, 19.5, 15.7, 14.2; IR (neat) 3293, 2962, 2927, 
2858, 1650, 1526, 1223,, 1100, 736; HRMS (ESI): m/z calcd for C20H33NO2SNa [M+Na]+ 
374.2130, found 374.2115. 
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1-Cyanoheptyl benzoate (3.27) 
A solution of 2-hydroxyoctanenitrile (0.600 g, 4.25 mmol) in CH2Cl2 (14 mL) 
was treated with Et3N (1.2 mL, 8.50 mmol), DMAP (5.2 mg, 42.5 μmol) and 
benzoyl chloride (0.60 mL, 5.10 mmol). The reaction was stirred for 1 h, then quenched with 
water (30 mL) and extracted with CH2Cl2 (3 x 30 mL). The organic extracts were dried (Na2SO4) 
and concentrated. The residue was purified by column chromatography (5%- 10% Et2O in 
hexanes) to give the benzoate 3.27 (1.042 g, 94.1%) as a colorless oil. For spectral data, see ref. 
119.  
NC
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1-(Isobutyramido)-1-methoxyoctan-2-yl benzoate (3.28) 
The title compound was prepared by following the representative 
procedure with the following amounts of reagents: benzoate 3.27 (100.0 
mg, 0.408 mmol), CH2Cl2 (4.0 mL), Cp2Zr(H)Cl (158 mg, 0.612 mmol), isobutyryl chloride (52 
μL, 0.490 mmol), MeOH (0.7 mL, 17.3 mmol). After the reaction was complete, it was quenched 
with 1 N HCl (1.5 mL) and water (15 mL) and extracted with CH2Cl2 (3 x 25 mL). The organic 
extracts were washed with saturated NaHCO3 (15 mL), dried (Na2SO4) and concentrated. The 
residue was purified by column chromatography (15% - 30% EtOAc in hexanes) to give the 
product 3.28 (90.4 mg, 63.5%, containing 4% BnOH) as a white solid in a 1.4:1.0 diastereomeric 
ratio. Further purification (15% - 30% EtOAc in hexanes) yielded analytically pure materials. 
For faster eluting product: 1H NMR (500 MHz, CDCl3) 8.03-8.01 (m, 2H), 7.60-7.56 (m, 1H), 
7.48-7.44 (m, 2H), 5.97 (d, J = 9.5 Hz, 1H), 5.24 (dd, J = 9.6, 6.6 Hz, 1H), 5.19 (ddd, J = 8.6, 
6.6, 3.8 Hz, 1H), 3.38 (s, 3H), 2.32 (sept, J = 7.0 Hz, 1H), 1.86-1.80 (m, 1H), 1.78-1.70 (m, 1H), 
1.44-1.23 (m, 7H), 1.21-1.15 (m, 1H), 1.10 (d, J = 7.0 Hz, 3H), 1.00 (d, J = 7.0 Hz, 3H), 0.86 (t, 
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J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) 178.0, 167.0, 133.5, 130.0, 129.9, 128.7, 81.9, 
74.5, 56.3, 36.1, 31.8, 31.3, 29.3, 25.3, 22.8, 19.6, 19.5, 14.2; IR (neat) 3295, 2959, 2929, 2858, 
1721, 1663, 1529, 1452, 1273, 1113, 712; HRMS (ESI): m/z calcd for C20H31NO4Na [M+Na]+ 
372.2151, found 372.2123. For slower eluting product: 1H NMR (500 MHz, CDCl3) 8.08 (app d, 
J = 7.3 Hz, 2H), 7.59 (app t, J = 7.4 Hz, 1H), 7.47 (app t, J = 7.8 Hz, 2H), 6.01 (d, J = 9.6 Hz, 
1H), 5.33 (dd, J = 9.8, 4.0 Hz, 1H), 5.12 (td, J = 8.6, 4.4 Hz, 1H), 3.38 (s, 3H), 2.40 (sept, J = 6.9 
Hz, 1H), 1.82-1.73 (m, 2H), 1.44-1.26 (m, 8H), 1.18 (d, J = 7.0 Hz, 3H), 1.17 (d, J = 7.0 Hz, 
3H), 0.87 (t, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) 177.6, 166.7, 133.4, 130.1, 130.0, 
128.7, 81.0, 75.8, 56.7, 36.1, 31.8, 30.6, 29.3, 25.4, 22.7, 19.8, 19.7, 14.2; IR (neat) 3299, 2929, 
2858, 1722, 1661, 1527, 1453, 1273, 1113, 712; HRMS (ESI): m/z calcd for C20H31NO4Na 
[M+Na]+ 372.2151, found 372.2133. 
 
1-(Isobutyramido)-1-hydroxyoctan-2-yl benzoate (3.29) 
The title compound was prepared by following the representative 
procedure with the following amounts of reagents: benzoate 3.27 (100.0 
mg, 0.408 mmol), CH2Cl2 (4.0 mL), Cp2Zr(H)Cl (158 mg, 0.612 mmol), 
isobutyryl chloride (52 μL, 0.490 mmol). The reaction was quenched with water (15 mL) and 
extraction of the mixture with EtOAc (3 x 25 mL). After evaporation of the solvent, the crude 
product was purified by column chromatography (20% - 60% EtOAc in hexanes containing 0.5% 
Et3N) gave the product 3.29 (71.6 mg, 52.4%, containing trace amount of impurity) as a colorless 
oil in a 3.0:1.0 diastereomeric ratio. 1H NMR (300 MHz, CDCl3) 8.10-8.07 (m, 1.5H), 8.03-7.99 
(m, 0.5H), 7.61-7.56 (m, 1H), 7.48-7.42 (m, 2H), 7.11 (d, J = 7.5 Hz, 0.75H), 6.74 (d, J = 8.3 Hz, 
0.25H), 5.53-5.36 (m, 1H), 5.22-5.17 (m, 0.25H), 5.15-5.10 (m, 0.75H), 4.74 (br s, 0.25H), 4.52 
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(br s, 0.75H), 2.47-2.22 (m, 1H), 1.92-1.78 (m, 2H), 1.44-1.20 (m, 8H), 1.13 (d, J = 6.8 Hz, 
2.25H), 1.11 (d, J = 6.8 Hz, 2.25H), 1.04 (d, J = 6.9 Hz, 0.75H), 0.99 (d, J = 6.9 Hz, 0.75H), 0.85 
(t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) (for major diastereomer) 178.4, 167.7, 133.6, 
130.1, 128.6, 76.2, 75.0, 35.6, 31.8, 30.7, 29.2, 25.5, 22.7, 19.5, 19.3, 14.2; IR (neat) 3338, 2959, 
2928, 2858, 1720, 1657, 1530, 1451, 1274, 1119, 1070, 711; HRMS (EI): m/z calcd for 
C19H28NO3 (M-OH)+• 318.2069, found 318.2064. 
 
N-(1-Methoxynonyl)isobutyramide (3.31) 
The title compound was prepared by following the representative 
procedure with the following amounts of reagents: octyl cyanide 3.30 
(84.0 mg, 0.603 mmol), THF (6.0 mL), Cp2Zr(H)Cl (194 mg, 0.754 mmol). The 
hydrozirconation reaction was stirred for 30 min, then cooled to 0 °C and isobutyryl chloride (95 
μL, 0.904 mmol) was added dropwise. The reaction was stirred for 10 min at 0 °C and MeOH 
(0.73 mL, 18.1 mmol) was added dropwise. The reaction was stirred at 0 °C for 15 min, then 
quenched with a solution of Et3N (0.25 mL) in water (15 mL) and extracted with CH2Cl2 (4 x 20 
mL). The combined organic extracts were dried (Na2SO4) and concentrated in vacuo. The 
residue was purified by column chromatography (15% - 25% EtOAc in hexanes containing 0.5% 
Et3N) to gave the title product (91.7 mg, 62.3%) as a white solid: 1H NMR (300 MHz, CDCl3) 
5.66 (d, J = 9.5 Hz, 1H), 5.10 (td, J = 9.8, 6.1 Hz, 1H), 3.31 (s, 3H), 2.37 (sept, J = 6.9 Hz, 1H), 
1.66-1.59 (m, 1H), 1.52-1.43 (m, 1H), 1.38-1.24 (m, 12H), 1.18 (app d, J = 6.4 Hz, 3H), 1.16 
(app d, J = 6.4 Hz, 3H), 0.86 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) 177.4, 81.1, 55.9, 
36.1, 35.8, 32.0, 29.6, 29.5, 29.4, 25.0, 22.8, 19.9, 19.7, 14.2; IR (neat) 3281, 2920, 2853, 1651, 
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1538, 1466, 1377, 1236, 1081, 929, 720; HRMS (EI): m/z calcd for C13H26NO (M- CH3O)+• 
212.2014 found 212.2010. 
 
N-(1-Hydroxynonyl)isobutyramide (3.32) 
The title compound was prepared by following the representative 
procedure with the following amounts of reagents: octyl cyanide 3.30 
(84.0 mg, 0.603 mmol), CH2Cl2 (4.5 mL), Cp2Zr(H)Cl (171 mg, 0.663 mmol). After 
hydrozirconation was complete, a solution of isobutyryl chloride (76 μL, 0.724 mmol) and Et3N 
(0.25 mL, 1.81 mmol) in CH2Cl2 (0.5 mL) was added dropwise at 0 °C. The reaction was stirred 
for 15 min at 0 °C and quenched with water (20 mL). The mixture was acidified by adding 1 N 
HCl to pH~1.0 and extracted with CH2Cl2 (3 x 25 mL). The combined organic extracts were 
washed with saturated NaHCO3 (20 mL), dried (Na2SO4) and concentrated in vacuo. The residue 
was purified by column chromatography (10% - 70% EtOAc in hexanes) to give acyl 
hemiaminal 3.32 (74.7 mg, 54.0%) as white solids: 1H NMR (300 MHz, CDCl3) 6.17 (br s, 1H), 
5.30 (q, J = 6.6 Hz, 1H), 4.27 (br s, 1H), 2.35 (sept, J = 6.9 Hz, 1H), 1.73-1.61 (m, 1H), 1.59-
1.48 (m, 1H), 1.40-1.26 (m, 12H), 1.15 (d, J = 6.9 Hz, 3H), 1.14 (d, J = 6.9 Hz, 3H), 0.87 (t, J = 
6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) 178.4, 74.5, 35.7, 35.3, 32.0, 29.6, 29.5, 29.4, 25.1, 
22.8, 19.6, 19.4, 14.3; IR (neat) 3298, 2934, 2854, 1653, 1540, 1462, 1231, 1095; HRMS (EI): 
m/z calcd for C13H26NO (M-OH)+• 212.2014 found 212.2015. 
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N-(Methoxy(phenyl)methyl)isobutyramide (3.34) 
By following the representative procedure, reaction of benzonitrile 3.33 
(60.0 mg, 0.582 mmol) with Cp2Zr(H)Cl (240 mg, 0.931 mmol) in THF (5.8 NH
O OMe
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mL) for 2.5 h followed by acylation with isobutyryl chloride (92 μL, 0.873 mmol) and addition 
of MeOH (0.71 mL, 17.5 mmol) in CH2Cl2 (0.5 mL) gave the title product 3.34 (87.9 mg, 
72.9%) as a white solid: 1H NMR (300 MHz, CDCl3) 7.42-7.30 (m, 5H), 6.14 (d, J = 9.4 Hz, 
1H), 6.02 (d, J = 8.8 Hz, 1H), 3.45 (s, 3H), 2.40 (sept, J = 6.9 Hz, 1H), 1.21 (d, J = 6.9 Hz, 3H), 
1.18 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) 177.4, 139.6, 128.8, 128.6, 126.0, 81.3, 
56.1, 36.0, 19.8, 19.6; IR (neat) 3286, 2967, 1653, 1535, 1451, 1230, 1099, 1046, 951, 746; 
HRMS (EI): m/z calcd for C11H14NO2 (M-CH3O)+• 192.1024, found 192.1031. 
 
N-((E)-Non-1-enyl)isobutyramide (3.36) 
A solution of octyl cyanide 3.30 (84.0 mg, 0.603 mmol) in THF (6.0 mL) 
was treated with Cp2Zr(H)Cl (171 mg, 0.663 mmol). The reaction was 
stirred for 20 min, then cooled to 0 °C and a solution of isobutyryl chloride (60 μL, 0.573 mmol) 
and Et3N (0.25 mL, 1.81 mmol) in THF (4.0 mL) was added dropwise. The flask formerly 
containing the isobutyryl chloride and Et3N was rinsed with THF (2 x 1 mL). The reaction was 
stirred for 10 min at 0 °C and BF3•OEt2 (98 μL, 0.784 mmol) was added dropwise. The cold bath 
was removed and the mixture was stirred overnight. After that time, the reaction was quenched 
with water (30 mL) and extracted with EtOAc (4 x 30 mL). The combined organic extracts were 
washed with water (30 mL), dried (Na2SO4) and concentrated in vacuo. The residue was purified 
by column chromatography (10% - 20% EtOAc in hexanes) to gave the title product 3.36 (73.1 
mg, 57.3%) as a white solid: 1H NMR (300 MHz, CDCl3) 7.24 (d, J = 9.6 Hz, 1H), 6.74 (app dd, 
J = 14.2, 10.5 Hz, 1H), 5.15 (td, J = 14.2, 7.1 Hz, 1H), 2.37 (sept, J = 6.9 Hz, 1H), 2.00 (q, J = 
6.6 Hz, 2H), 1.36-1.22 (m, 10H), 1.17 (d, J = 6.9 Hz, 6H), 0.87 (t, J = 6.9 Hz, 3H); 13C NMR (75 
MHz, CDCl3) 174.2, 122.7, 113.3, 35.7, 32.0, 30.1, 29.9, 29.3, 29.2, 22.8, 19.6, 14.3; IR (neat) 
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3283, 2967, 2921, 2851, 1680, 1647, 1526, 1467, 1238, 950, 723; HRMS (EI): m/z calcd for 
C13H25NO (M+•) 211.1936, found 211.1938. 
 
N-(Isobutyryl)-N-((E)-non-1-enyl)isobutyramide (3.38) 
1H NMR (500 MHz, CDCl3) 6.22 (td, J = 13.9, 1.4 Hz, 1H), 5.47 (td, J = 
14.2, 7.2 Hz, 1H), 3.21 (sept, J = 6.8 Hz, 1H), 2.16 (dq, J = 7.3, 1.4 Hz, 
2H), 1.44 (pent, 2H), 1.34-1.26 (m, 8H), 1.17 (d, J = 6.8 Hz, 12H), 0.89 
(t, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) 181.0, 132.6, 125.8, 35.0, 32.0, 30.1, 29.4, 
29.3, 29.1, 22.8, 19.7, 14.3; IR (neat) 2962, 2928, 1706, 1466, 1383, 1187, 1162, 1092; HRMS 
(ESI): m/z calcd for C17H31NO2Na [M+Na]+ 304.2252, found 304.2246. 
5
N
O
O
 
(E)-2-Methyltridec-2-en-1-ol (3.39) 
A solution of 1-dodecene (freshly distilled, 0.842 g, 5.00 mmol) and 
methacrolein (90%, 3.89 g, 50.0 mmol) in CH2Cl2 (50 mL) was treated with 
Grubbs’ 2nd generation catalyst (64.0 mg, 75 µmol). The reaction was refluxed for 1.5 h and then 
concentrated. The residue was purified by column chromatography (1% - 5% EtOAc in hexanes) 
to give the desired product (1.222 g, contaminated with unknown impurities). This product was 
dissolved in MeOH (29 mL) and cooled to 0 °C. NaBH4 (219 mg, 5.80 mmol) was added. The 
reaction was stirred for 30 min and quenched with saturated NH4Cl solution (1 mL). The mixture 
was stirred for 10 min while warming to room temperature and then concentrated. The residue 
was purified by column chromatography (10% - 20% EtOAc in hexanes) to give the allylic 
alcohol 3.39 (0.621 g, 58.5%) as a colorless oil: 1H NMR (300 MHz, CDCl3) 5.41 (app t, J = 7.1 
Hz, 1H), 4.00 (s, 2H), 2.06-1.99 (m, 2H), 1.66 (s, 3H), 1.45 -1.27 (m, 16H), 0.88 (t, J = 7.0 Hz, 
8
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3H); 13C NMR (75 MHz, CDCl3) 134.7, 126.9, 69.3, 32.1, 29.9, 29.8, 29.7, 29.6, 27.8, 22.9, 
14.3, 13.8; IR (neat) 3335, 2924, 2854, 1464, 1378, 1012; HRMS (EI): m/z calcd for C14H28O 
(M+•) 212.2140, found 212.2150. 
 
(E)-3-Methyltetradec-3-enenitrile (3.40) 
A solution of allylic alcohol 3.39 (505 mg, 2.38 mmol) and Et3N (0.66 mL, 
4.78 mmol) in CH2Cl2 (12 mL)/THF (6 mL) was cooled to -42 °C and 
methanesulfonyl chloride (0.24 mL, 3.09 mmol) was added dropwise. The mixture was stirred 
for 30 min and anhydrous LiBr (620 mg, 7.14 mmol) was added followed by THF (18 mL). The 
mixture was warmed to 0 °C  and stirred for 1.5 h. After that time, the reaction was diluted with 
hexanes (150 mL), washed with water (80 mL) and brine (50 mL), dried (Na2SO4) and 
concentrated. The crude allylic bromide was dissolved in DMF (4.5 mL) and CuCN (213 mg, 
2.38 mmol) was added in one portion. The reaction was stirred overnight, then quenched with 
water (30 mL) and extracted with EtOAc (3 x 25 mL). The organic extract was dried (Na2SO4) 
and concentrated. The resulting residue was purified by column chromatography (3% - 5% 
EtOAc in hexanes) to give allylic nitrile 3.40 (295 mg, 56.0%) as a colorless oil: 1H NMR (300 
MHz, CDCl3) 5.49 (sext of t, J = 7.2, 1.4 Hz, 1H), 3.03 (s, 2H), 2.04 (q, J = 7.0 Hz, 2H), 1.73 (s, 
3H), 1.38-1.27 (m, 16H), 0.89 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) 130.2, 124.0, 
118.0, 32.0, 29.8, 29.6, 29.5, 29.4, 29.3, 28.2, 27.4, 22.8, 16.1, 14.2; IR (neat) 2925, 2854, 2249, 
1464, 1412, 1114, 721; HRMS (EI): m/z calcd for C15H27N (M+•) 221.2144, found 221.2152. 
8
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N-((1E,3E)-3-Methyltetrad
(2S,4R,6R)-Tetrahydro-4-m
, CDCl3) 4.90 (dd, J = 6.0, 1.2 Hz, 1H), 3.63 (q, J = 6.3 
eca-1,3-dienyl)isobutyramide (3.41) 
A solution of allylic nitrile 3.40 (90.0 mg, 0.406 mmol) in THF (5.0 
mL) was treated with Cp2Zr(H)Cl (157 mg, 0.609 mmol), The 
reaction was stirred for 30 min, then cooled to 0 °C and a solution of isobutyryl chloride (51 μL, 
0.487 mmol) and Et3N (0.18 mL, 1.26 mmol) in THF (2.0 mL) was added dropwise. The flask 
formerly containing the isobutyryl chloride and Et3N was rinsed with THF (0.5 mL). The 
reaction was stirred for 2 min at 0 °C and BF3•OEt2 (76 μL, 0.609 mmol) was added dropwise. 
The cold bath was removed and the mixture was stirred for 2 h. After that time, the reaction was 
diluted with Et2O (3 mL) and filtered through a small plug of silica gel. The residue was washed 
with Et2O (30 mL) and the combined filtrate was dried (Na2SO4) and concentrated in vacuo. The 
residue was purified by column chromatography (5% - 17% EtOAc in hexanes containing 0.5% 
Et3N) to gave the title product 3.41 (74.1 mg, 62.1%) as a colorless oil: 1H NMR (300 MHz, 
CDCl3) 7.10 (d, J = 10.3 Hz, 1H), 6.91 (dd, J = 14.2, 10.7 Hz, 1H), 5.83 (d, J = 14.3Hz, 1H), 
5.34 (t, J = 7.2 Hz, 1H), 2.40 (sept, J = 6.9 Hz, 1H), 2.10 (q, J = 7.0 Hz, 2H), 1.75 (s, 3H), 1.40-
1.27 (m, 16H), 1.20 (d, J = 6.9 Hz, 6H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
174.3, 131.8, 130.8, 120.4, 118.5, 35.9, 32.1, 30.0, 29.9, 29.8, 29.6, 28.4, 22.9, 19.7, 14.3, 12.7; 
IR (neat) 3276, 2924, 2854, 1644, 1531, 1467, 1253, 950; HRMS (EI): m/z calcd for C19H35NO 
(M+•) 293.2719, found 293.2717. 
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ethoxy-5,5,6-trimethyl-2H-pyran-2-carbonitrile (3.43) 
1H NMR (300 MHz
Hz, 1H), 3.37 (s, 3H), 3.17 (dd, J = 11.7, 4.5 Hz, 1H), 2.06 (ddd, J = 13.5, 
4.5, 1.4 Hz, 1H), 1.84 (ddd, J = 13.4, 11.8, 6.1 Hz, 1H), 1.12 (d, J = 6.3 Hz, 3H), 0.96 (s, 3H), 
O
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0.83 (s, 3H); 13C NMR (75 MHz, CDCl3) 118.0, 81.4, 78.0, 64.2, 57.8, 39.4, 29.3, 22.6, 14.6, 
12.2; IR (neat) 2980, 2941, 2874, 1470, 1450, 1391, 1164, 1104, 954, 867, 718; HRMS (EI): m/z 
calcd for C10H17NO2 (M+•) 183.1259, found 183.1255. 
 
N-((S)-((2S,4R,6R)-Tetrahydro-4-methoxy-5,5,6-trimethyl-2H-pyran-2-
ro-4-methoxy-5,5,6-
A 
soluti
eated w
yl)(methoxy)methyl)isobutyramide (3.44), N-((R)-((2S,4R,6R)-Tetrahyd
trimethyl-2H-pyran-2-yl)(methoxy)methyl)isobutyramide (3.45) and N-(((2S,4R,6R)-
Tetrahydro-4-methoxy-5,5,6-trimethyl-2H-pyran-2-yl)methyl)isobutyramide (3.46) 
on 
of 
ith 
Schwartz reagent (84.5 mg, 0.328 mmol). The mixture was stirred for 15 min, then cooled to 0 
°C and isobutyryl chloride (40 μL, 0.382 mmol) was added dropwise. The cold bath was 
removed and the mixture was stirred for 10 min. After that time, the flask was cooled to -78 °C 
and Mg(ClO4)2 (61 mg, 0.273 mmol) was added in one portion. After 30 min, a pre-cooled 
solution (-78 °C) of MeOH (0.22 ml, 5.46 mmol) in CH2Cl2 (0.5 mL) was cannulated dropwise 
to the reaction mixture over 5 min. After completion of addition, the reaction was stirred at -78 
°C for 15 min, then quenched with saturated NaHCO3 solution (15 mL) and warmed to room 
temperature. The biphasic mixture was extracted with CH2Cl2 (3 x 20 mL) and the combined 
organic extracts were dried (Na2SO4) and concentrated. The residue was purified by column 
chromatography (20% - 70% EtOAc in hexanes containing 0.5% Et3N) to give the desired 
products 3.44 and 3.45 (60.2 mg, 76.8%) in a 2.3:1.0 diastereomeric ratio as a colorless oil and 
tetrahydropyranyl cyanide 3.43 (50.0 mg, 0.273 mmol) in CH2Cl2 (2.7 mL) was tr
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the over-reduction product 3.46 (6.8 mg, 9.7%) as a colorless oil. For 3.46: 1H NMR (300 MHz, 
CDCl3) 5.77 (br s, 1H), 4.05-3.97 (m, 1H), 3.48-3.39 (m, 3H), 3.32 (s, 3H), 3.03 (t, J = 6.4 Hz, 
1H), 2.38 (sept, J = 6.9 Hz, 1H), 1.74-1.69 (m, 2H), 1.18-1.14 (m, 9H), 0.96 (s, 3H), 0.88 (s, 
3H); 13C NMR (75 MHz, CDCl3) 177.3, 82.0, 74.5, 69.0, 57.7, 41.0, 38.6, 35.9, 27.6, 24.5, 19.9, 
19.8, 15.6, 15.5; IR (neat) 3305, 2970, 2933, 2874, 1651, 1548, 1468, 1386, 1243, 1103; HRMS 
(ESI): m/z calcd for C14H27NO3Na [M+Na]+ 280.1889, found 280.1899. Further purification 
(20% - 40% EtOAc in hexanes containing 0.5% Et3N) of the mixture of 3.44 and 3.45 yielded 
analytically pure diastereomers. For the faster eluting product 3.44 (major, white solid): 1H NMR 
(500 MHz, CDCl3) 6.01 (d, J = 9.0 Hz, 1H), 5.26 (dd, J = 9.5, 6.5 Hz, 1H), 3.84-3.80 (m, 1H), 
3.39 (s, 3H), 3.36 (q, J = 6.5 Hz, 1H), 3.33 (s, 3H), 3.04 (dd, J = 8.6, 4.1 Hz, 1H), 2.44 (sept, J = 
6.9 Hz, 1H), 1.92 (td, J = 13.7, 4.5 Hz, 1H), 1.66 (ddd, J = 13.8, 8.6, 5.2 Hz,1H), 1.20 (d, J = 6.9 
Hz, 3H), 1.19 (d, J = 6.9 Hz, 3H), 1.10 (d, J = 6.6 Hz, 3H), 0.94 (s, 3H), 0.86 (s, 3H); 13C NMR 
(125 MHz, CDCl3) 178.2, 82.0, 80.0, 76.2, 70.9, 57.7, 56.4, 38.2, 36.2, 26.0, 24.5, 19.9, 19.8, 
16.1, 15.3; IR (neat) 3300, 2972, 2938, 1659, 1536, 1468, 1387, 1103; HRMS (ESI): m/z calcd 
for C15H29NO4Na [M+Na]+ 310.1994, found 310.1985. For the slower eluting product 3.45 
(minor, colorless oil): 1H NMR (300 MHz, CDCl3) 6.26 (d, J = 9.3 Hz, 1H), 5.16 (dd, J = 9.6, 
3.9 Hz, 1H), 3.83-3.78 (m, 1H), 3.67 (q, J = 6.6 Hz, 1H), 3.38 (s, 3H), 3.31 (s, 3H), 3.18 (dd, J = 
7.0, 3.8 Hz, 1H), 2.42 (sept, J = 6.9 Hz, 1H), 1.96 (ddd, J = 13.7, 6.6, 3.9 Hz, 1H), 1.71-1.63 (m, 
1H), 1.22-1.17 (m, 9H), 1.00 (s, 3H), 0.88 (s, 3H); 13C NMR (75 MHz, CDCl3) 177.5, 82.4, 81.7, 
70.3, 57.8, 56.7, 38.0, 36.1, 26.3, 25.4, 19.9, 19.7, 17.6, 15.6; IR (neat) 3293, 2970, 2934, 1658, 
1531, 1468, 1387, 1170, 1102; HRMS (ESI): m/z calcd for C15H29NO4Na [M+Na]+ 310.1994, 
found 310.2002. 
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